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Unless otherwise stated, all reagents were purchased from commercial suppliers and used without 
further purification. All solvents used in the reactions were distilled from appropriate drying agents 
prior to use. Reactions were monitored by thin layer chromatography on silica gel pre-coated plastic 
sheets (0.2 mm, Machery-Nagel). Visualization was accomplished by irradiation with UV light at 254 
nm and/or p-anisaldehyde stain (0.7 mL p-anisaldehyde, 250 mL EtOH, 9.5 mL conc. H2SO4, 2.7 mL 
glacial AcOH) or potassium permanganate stain (1.5 g KMnO4, 10 g K2CO3, 1.25 mL 10% NaOH, 200 
mL H2O). Column chromatography was performed on Merck silica gel (60, particle size 0.040-0.063 
mm). Proton and carbon NMR spectra were recorded on Bruker AV-600,  Bruker AV-500, Bruker AV-
400 or Bruker AV-300 spectrometer in deuterated solvent. Proton chemical shifts are reported in ppm 
(δ) relative to tetramethylsilane (TMS) with the solvent resonance employed as the internal standard 
(CDCl3 δ 7.26). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, q = 
quartet, m = multiplet, c. m = centered multiplet, br = broad), coupling constants (Hz) and integration. 
13C chemical shifts are reported in ppm from tetramethylsilane (TMS) with the solvent resonance as the 
internal standard (CDCl3, δ 77.0). High resolution mass spectra were determined on a Bruker APEX III 
FTMS (7 T magnet). Infrared spectra were taken on a Perkin Elmer Spectrum 100 FTIR and are 
reported in reciprocal centimeters (cm-1). Optical rotations were determined with Autopol IV 
polarimeter (Rudolph Research Analytical) at 589 nm and 25 °C. Data are reported as follows: [α]λtemp, 
concentration (c in g/100 mL), and solvent. The enantiomeric excesses were determined by GC or 
HPLC analysis employing a chiral stationary phase column specified in the individual experiment, by 
comparing the samples with the appropriate racemic mixtures. Diastereomeric ratios were determined 
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Table 1. The effect of the acid co-catalysts (HX) and temperature on the peroxyhemiketal 3a to 
epoxide 4a ratio in the reaction of 3-decen-2-one (2a). 
 
 
Entry Acid co-catalyst (HX) pKa (H2O)a [mol%] T [° C] Conv. [%]b      3a:4ac er(4a)d 
1 
pTsOH • H2O -2.80 
20 28 82 (48 h) 35:65 98:2 
2 30 28 98 (48 h)e 31:69 92:8 





20 50 full (20 h) 57:43 >99.5:0.5 
5 20 32 full (24 h) 68:32 >99.5:0.5 
6 20 28 95 (24 h) 70:30 >99.5:0.5 
7 30 28 97 (48 h) 72:28 >99.5:0.5 
8 30 10 76 (48 h) 73:27 >99.5:0.5 
9 
 
n.a. 20 32 97 (24 h) 69:31 >99.5:0.5 
10 
 
3.07 20 32 44 (28 h) n.d. 99.5:0.5 
11 
 
n.a. 20 32 full (24 h) 68:32 >99.5:0.5 
12 
 





20 50 full (20 h) 60:40 >99.5:0.5 
14 20 32 full (24 h) 70:30 >99.5:0.5 
15 20 28 97 (24 h) 72:28 >99.5:0.5 
16 20 20 90 (48 h) 75:25 >99.5:0.5 









Entry Acid pKa (H2O)a [mol%] T [° C] Conv. [%]b 3a:4ac er(4a)d 
23 PhCO2H 4.20 20 28 15 n.d. 95.5:4.5 
19 
HOAc 4.76 
20 28 <10 n.d. n.d.
20 30 28 <10 n.d. n.d.
21 EtCO2H 4.87 20 28 <10 n.d. n.d.
22 i-PrCO2H n.a. 20 28 <10 n.d. n.d.
24 2,4-(NO2)2-C6H4CO2H 2.17f 20 32 98% (48 h) 75:25 99.5:0.5 
25 4-NO2-C6H4CO2H 3.44 20 32 45 (28 h) n.d. n.d.
26 2,6-F2-C6H3CO2H n.a. 20 32 52 (28 h) n.d. n.d.
27 3,5-(CF3)2-C6H3CO2H n.a. 20 32 43 (28 h) n.d. n.d.
28 4-Cl-C6H4CO2H 3.99 20 32 23 (28 h) n.d. n.d.
29 (PhO)2PO(OH) 1.29g 20 32 96 (24 h) 64:36 99.5:0.5 
aThe pKa values are adopted from the pKa compilations of Williams and Bordwell 
(http://www.chem.wisc.edu/areas/reich/pkatable/). bDetermined by GC. cDetermined by 1H NMR of the crude mixture. 




Table 2. The effect of the water content (hydrogen peroxide concentration) on the peroxyhemiketal 3a 
to epoxide 4a ratio in the reaction of 3-decen-2-one (2a). 
 
 
Entry H2O2 equiv. H2O2 conc. [wt%] Conv. [%]a 3a:4a ratiob er(4a)c 
1 1.2 50 full (24 h) 65:35 >99.5:0.5 
2 1.5 50 full (24 h) 70:30 >99.5:0.5 
3 2 50 full (24 h) 71:29 >99.5:0.5 
4 5 50 full (24 h) 76:24 99.5:0.5 
5 1.5 30 full (24 h) 76:24 >99.5:0.5 
6d 1.5 30 full (36 h) 77:23 >99.5:0.5 
7 3 30 full (24 h) 80:20 >99.5:0.5 
8 1.5 25 full (30 h) 78:22 >99.5:0.5 
9 3 25 full (30 h) 81:19 99.5:0.5 
10 1.5 10 79 (6 d) 78:22 99:1 
11 1.5 5 57 (6 d) n.d. 98:2 









Entry t [h] Conv. [%]a 3a:4a ratioa 
1 4.5 42 71:29 
2 24 97 72:28 
3 28 full 72:28 
4 10 d full 66:34 




Synthetic Procedures and Spectral Data 
Catalyst Synthesis 
 




Quinine (6.48 g, 20.0 mmol) and triphenylphosphine (6.30 g, 24.0 mmol, 1.2 equiv) were dissolved in 
THF (100 mL) and the solution was cooled to 0 °C. Then diisopropyl azodicarboxylate (4.64 mL, 24.0 
mmol, 1.2 equiv) was added all at once followed by the dropwise addition of a solution of diphenyl 
phosphoryl azide (5.16 mL, 24.0 mmol, 1.2 equiv) in THF (40 mL). Then the reaction mixture was 
allowed to warm to room temperature, stirred overnight (12 h), and the resulting solution was further 
heated to 50 °C for additional 2 h. Next, triphenylphosphine (6.82 g, 26.0 mmol, 1.3 equiv) was added 
                                                 




and the heating (50 °C) was maintained until the gas evolution has ceased (3 h). Then, the solution was 
cooled to room temperature, and water (2 mL) was added. After stirring for 12 h, the solvents were 
removed under reduced pressure, and the residue was extracted with CH2Cl2 and 10% aqueous HCl 
(1:1, 200 mL). The phases were separated, and the aqueous phase was repeatedly washed with CH2Cl2 
(4 × 100 mL). Then the aqueous phase was made alkaline with excess aqueous ammonia at 0 °C and 
subsequently extracted with CH2Cl2 (4 × 100 mL). The combined organic phases were dried (Na2SO4), 
filtered, and concentrated in vacuo. The residue was purified by flash column chromatography (silica 
gel, methanol/EtOAc 50:50 with 1% aq. NH4OH) affording the title compound as a white semi-solid 
(4.93 g, 15.3 mmol, 76%). The analytical data were identical in all respects to those previously 
reported.2  
1H NMR (400 MHz, CDCl3) δ 8.73 (d, J = 4.5 Hz, 1H, CH2'), 8.01 (d, J = 9.2 Hz, 1H, CH8'), 7.64 (br 
s, 1H, CH5'), 7.43 (br d, J = 4.2 Hz, 1H, CH3'), 7.36 (dd, J = 9.1, 2.8 Hz, 1H, CH7'), 5.78 (ddd, J = 17.3, 
10.1, 7.3 Hz, 1H, CH=CH2), 5.00-4.93 (m, 2H, CH=CH2), 4.57 (br d, J = 9.7 Hz, 1H, CH9NH2), 3.94 
(s, 3H, OCH3), 3.26 (dd, J = 13.8, 10.0 Hz, 1H, CHH2), 3.21-3.15 (m, 1H, CHH6), 3.11-3.02 (m, 1H, 
CH8), 2.82-2.75 (m, 2H, CHH6 and CHH2), 2.30-2.23 (m, 1H, CH3), 1.94 (br s, 2H, NH2), 1.62-1.58 
(m, 1H, CH4), 1.57-1.50 (m, 2H, CH25), 1.45-1.36 (m, 1H, CHH7), 0.75 (ddt, J = 13.6, 7.5, 1.9 Hz, 1H, 
CHH7). 
13C NMR (100 MHz, CDCl3) δ 157.6 (Cq6'OMe), 147.8 (C2'H), 147.0 (Cq), 144.7 (Cq), 141.7 
(CH=CH2), 131.8 (C8'H), 128.7 (Cq4a'), 121.2 (C7'H), 119.9 (C3'H), 114.3 (CH=CH2), 102.0 (C5'H), 
61.9 (C8H), 56.3 (C2H2), 55.5 (OCH3), 52.5 (C9HNH2), 40.9 (C6H2), 39.8 (C3H), 28.2 (C5H2), 27.5 
(C4H), 26.0 (C7H2). 
MS (EI-DE) m/z (%) 323 [M+] (2), 199 (1), 187 (15), 160 (2), 136 (100), 108 (6), 95 (3), 82 (8), 70 (5), 
56 (4), 42 (4). 
HRMS (ESI+) calcd for C20H25N3NaO [(M+Na)+] 346.1889, found 346.1890. 
 
 
                                                 





9-Amino(9-deoxy)epiquinidine (1b)2: Amine 1b was prepared starting from quinidine (1.95 g, 6.0 
mmol) following the same procedure described for the synthesis of 9-amino(9-
deoxy)epiquinine (1a). After hydrolyzing the reaction overnight (12 h), the 
solvents were removed under reduced pressure, and the residue was extracted with 
CH2Cl2 and 10% aqueous HCl (1:1, 200 mL). The phases were separated, the 
aqueous phase was concentrated in vacuo, and the residue was crystallized from 
methanol. The white precipitate was collected and dissolved in water. Then the 
aqueous phase was made alkaline by the addition of K2CO3, and repeatedly 
extracted with CH2Cl2 (3 × 50 mL). The combined organic phases were dried (Na2SO4) and evaporated 
under reduced pressure affording the pure title compound (820 mg, 2.54 mmol, 42%) as a pale yellow 
viscous oil. 
1H NMR (400 MHz, CDCl3) δ 8.72 (d, J = 4.6 Hz, 1H, CH2'), 8.00 (d, J = 9.1 Hz, 1H, CH8'), 7.60 (br 
s, 1H, CH5'), 7.50 (br s, 1H, CH3'), 7.34 (dd, J = 9.2, 2.7 Hz, 1H, CH7'), 5.86 (ddd, J = 17.0, 10.6, 6.4 
Hz, 1H, CH=CH2), 5.07-5.01 (m, 2H, CH=CH2), 4.64 (br d, J = 9.1 Hz, 1H, CH9NH2), 3.94 (s, 3H, 
OCH3), 3.04-2.88 (m, 5H, CH8, CH26and CH22), 2.24 (app. br q, J = 8.0 Hz, 1H, CH3), 2.02 (br s, 2H, 
NH2), 1.60-1.56 (m, 1H, CH4), 1.54-1.48 (m, 2H, CH25), 1.11 (dd, J = 13.4, 8.8 Hz, 1H, CHH7), 0.96-
0.88 (m, 1H, CHH7). 
13C NMR (100 MHz, CDCl3) δ 157.6 (Cq6'OMe), 147.8 (C2'H), 147.5 (Cq), 144.7 (Cq), 140.7 
(CH=CH2), 131.8 (C8'H), 128.7 (Cq4a'), 121.6 (C7'H), 119.9 (C3'H), 114.4 (CH=CH2), 101.4 (C5'H), 
62.4 (C8H), 55.4 (OCH3), 51.6 (C9HNH2), 49.5 (C6H2), 47.4 (C2H2), 39.4 (C3H), 27.6 (C4H), 26.7 
(C5H2), 25.0 (C7H2). 
MS (EI-DE) m/z (%) 323 [M+] (63), 306 (10), 282 (3), 265 (2), 240 (2), 200 (8), 187 (100),  160 (11), 
137 (67), 122 (11), 108 (33), 95 (10), 82 (43), 70 (15), 56 (11), 42 (7). 
HRMS (ESI+) calcd for C20H26N3O [(M+H)+] 324.2067, found 324.2070. 
 
(S)-(6-methoxy-2-phenylquinolin-4-yl)((2S, 4S, 8R)-8-vinylquinuclidin-2-yl)methanamine (1c): 
Amine 1a (220 mg, 0.680 mmol) was suspended in dry tBuOMe (8 
mL) and cooled to -10 °C in an ice/EtOH bath. Phenyllithium (3.40 
mmol, 5 equiv) was added to this solution and the reaction mixture 










was quenched with HOAc (440 µL) at 0 oC, followed by the addition of water (10 mL) and EtOAc (10 
mL). Then iodine (340 mg) was added and mixture was stirred for 10 min, and a solution of sodium 
metabisulfite (130 mg in 5 mL water) was added. The mixture was basified with ammonia (20% 
solution in water, 4.8 mL) and then the organic layer was washed with water. The aqueous phase was 
extracted with CH2Cl2 (20 mL x 3). The collected organic phases were dried over anhydrous MgSO4, 
filtrated, evaporated under reduced pressure. Purification by column chromatography 
(EtOAc/MeOH/aq NH4OH = 9/1/0.1) afforded the title compound in 61% yield. 
1H NMR (500 MHz, CDCl3) δ 8.11-8.16 (m, 3H), 7.99 (br s, 1H), 7.71 (br s, 1H), 7.51-7.54 (m, 2H), 
7.39-7.46 (m, 2H), 5.76-5.83 (m, 1H), 4.95-5.02 (m, 2H), 4.68 (br s, 1H), 3.99 (s, 3H), 3.16-3.33 (m, 
3H), 2.83-2.85 (m, 2H), 2.30 (br s, 1H), 2.05 (br s, 2H), 1.59-1.64 (m, 2H), 1.45 (m, 1H), 0.84-0.88 (m, 
3H, CH2CH3). 
13C NMR (125 MHz, CDCl3) δ 157.5, 154.9, 144.9, 141.7, 139.8, 132.2, 129.0, 128.8, 127.3, 121.3, 
114.4, 60.4, 60.4, 56.3, 55.6, 53.4, 41.0, 39.8, 28.2, 27.6, 26.0, 21.1, 14.2. 
HRMS (ESI+) m/z calcd for C26H30N3O1 [(M+H)]+ 400.2383, found 400.2383.  
 
 
9-Amino(9-deoxy)epicinchonidine (1d):1 Amine 1d was prepared starting from cinchonidine (1.77 g, 
6.0 mmol) following the same procedure described for the synthesis of 
9-amino(9-deoxy)epiquinine (1a). Purification by flash column 
chromatography (silica gel, methanol/EtOAc 50:50 with 1% 
aq. NH4OH) gave the title compound as colorless viscous oil (1.23 g, 
4.19 mmol, 70%). 
1H NMR (400 MHz, CDCl3) δ 8.87 (d, J = 4.6 Hz, 1H, CH2'), 8.33 (br s, 1H, CH5'), 8.11 (dd, J = 8.6, 
0.8 Hz, 1H, CH8'), 7.68 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H, CH7'), 7.56 (ddd, J = 8.5, 6.9, 1.3 Hz, 1H, CH6'), 
7.49 (br d, J = 4.1 Hz, 1H, CH3'), 5.77 (ddd, J = 17.2, 10.1, 7.3 Hz, 1H, CH=CH2), 4.99-4.91 (m, 2H, 
CH=CH2), 4.67 (br d, J = 9.1, 1H, CH9NH2), 3.24 (dd, J = 13.9, 10.1 Hz, 1H, CHH2), 3.20-3.13 (m, 
1H, CHH6), 3.04 (app. br q, J = 8.7 Hz, 1H, CH8), 2.81-2.73 (m, 2H, CHH2 and CHH6), 2.27-2.21 (m, 
1H, CH3), 2.01 (br s, 2H, NH2), 1.59-1.50 (m, 3H, CH4 and CH25), 1.38 (app. br t, J = 11.6 Hz, 1H, 
CHH7), 0.71 (ddt, J = 13.6, 7.5, 1.9 Hz, 1H, CHH7). 
13C NMR (100 MHz, CDCl3) δ 150.3 (C2'H), 148.7 (Cq4'), 148.6 (Cq8a'), 141.8 (CH=CH2), 130.4 




(C8H), 56.3 (C2H2), 51.8 (C9HNH2), 40.9 (C6H2), 39.8 (C3H), 28.1 (C5H2), 27.5 (C4H), 26.0 (C7H2). 
MS (EI-DE) m/z (%) 293 [M+] (1), 196 (1), 181 (1), 169 (3), 157 (12), 136 (100), 108 (6), 95 (4), 81 
(9), 70 (4), 56 (4), 42 (6), 30 (2). 
HRMS (ESI+) calcd for C19H24N3 [(M+H)+] 294.1964, found 294.1965. 






Catalyst salt [1a • 2 TCA] was prepared in situ by the addition of 9-amino(9-deoxy)epiquinine (1a; 
32.3 mg, 0.1 mmol, 10 mol%) to a solution of trichloroacetic acid (32.6 mg, 0.2 mmol, 20 mol%) in 
dioxane (4 mL). Then, enone 2 (1.0 mmol, 1.0 equiv) was added, and 20 minutes later, aqueous 
hydrogen peroxide (30 wt%, 304 L, 3.0 mmol, 3 equiv). After 20-48 h of stirring at 32°C, the reaction 
mixture was extracted with Et2O (325 mL) and the combined organic phases were washed with brine, 
dried (Na2SO4), filtered, and concentrated in vacuo. The crude product was subjected to flash column 
chromatography (silica gel, eluent: Et2O-pentane) to afford the corresponding pure peroxyhemiketal 3. 
The optical purity was determined after converting the peroxyhemiketal to the corresponding epoxide 
(with 1N NaOH (1 equiv) in Et2O) or to the corresponding aldol-type product (with triethylphosphite (2 
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(5R)-5-Hexyl-3-methyl-1,2-dioxolan-3-ol ((5R)-3a): Peroxyhemiketal 3a was prepared according to 
the general procedure. The reaction mixture was stirred for 36 h at 32 °C. 
Purification of the crude product by flash column chromatography (silica 
gel, 5-10% Et2O in pentane) provided the title compound 3a as a colorless 




peroxyhemiketal 3a into the corresponding epoxide 4a. The enantiomers were analyzed by GC using a 
chiral BGB-176/SE-52 column 29.5 m (80 °C, 1.2 C/min until 115 C, 18 C/min until 220 C, 10 min 
at 220 C, 0.6 bar H2); major enantiomer: τR = 24.41 min, minor enantiomer: τR = 26.10 min. 
Characterized as mixture of hemiketal epimers (1:1 dr). 
1H NMR (500 MHz, CD2Cl2) δ 4.41-4.36 (m, 1H), 4.31-4.26 (m, 1H), 2.96 (br s, 2H), 2.77-2.72 (m, 
1H), 2.69-2.65 (m, 1H), 2.26-2.18 (m, 2H), 1.72-1.55 (m, 4H), 1.52 (s, 3H), 1.51 (s, 3H), 1.47-1.35 (m, 
2H), 1.34-1.24 (m, 14H), 0.89-0.87 (m, 6H). 
13C NMR (125 MHz, CD2Cl2) δ 105.9, 105.0, 82.7, 81.3, 53.1, 52.8, 35.2, 32.6, 32.3, 32.2, 29.8, 29.7, 
26.7, 26.5, 23.4, 23.1, 23.1, 22.9, 14.4, 14.4. 
MS (EI-DE) m/z (%) 188 [M+] (1), 155 (56), 137 (3), 113 (8), 95 (7), 81 (5), 71 (63), 55 (14), 43 (100), 
29 (12). 
HRMS (EI-FE) calcd for C10H20O3 [M+] 188.1413, found 188.1412. 
 
 
(5R)-3-Methyl-5-phenethyl-1,2-dioxolan-3-ol ((5R)-3b): Peroxyhemiketal 3b was prepared according 
to the general procedure. The reaction mixture was stirred for 36 h at 32 °C. 
Purification of the crude product by flash column chromatography (silica gel, 5-
40% Et2O in pentane) provided the title compound 3b as a colorless oil (141 mg, 
677 μmol, 68%; 97:3 er). The enantiomeric ratio was determined after converting peroxyhemiketal 3b 
into the corresponding epoxide 4b. The enantiomers were analyzed by GC using a chiral BGB-
176/BGB-15 column 30 m (80 °C, 1.2 C/min until 145 C, 20 C/min until 220 C, 10 min at 220 C, 
0.6 bar H2); major enantiomer: τR = 46.17 min, minor enantiomer: τR = 47.42 min. The absolute 
configuration of 3b was assigned by converting it to the corresponding aldol product 16b and 
comparing its optical rotation to the literature value (cf. characterization of 16b). The absolute 
configuration of all other peroxyhemiketals was assigned by analogy. Characterized as mixture of 
hemiketal epimers (1:1 dr).  
1H NMR (500 MHz, CD2Cl2) δ 7.30-7.27 (m, 4H), 7.21-7.18 (m, 6H), 4.43-4.37 (m, 1H), 4.34-4.28 
(m, 1H), 2.94-2.93 (m, 2H), 2.80-2.61 (m, 6H), 2.30-2.22 (m, 2H), 2.06-1.97 (m, 2H), 1.95-1.88 (m, 
1H), 1.77-1.70 (m, 1H), 1.54 (s, 3H), 1.51 (s, 3H). 
13C NMR (125 MHz, CD2Cl2) δ 142.0, 141.8, 129.0, 129.0, 128.9, 128.9, 126.6, 126.5, 106.0, 105.0, 




MS (EI-DE) m/z (%) 208 [M+] (trace), 190 (3), 174 (10), 159 (2), 148 (2), 131 (15), 117 (21), 104 (93), 
91 (100), 87 (7), 77 (15), 65 (14), 58 (4), 51 (9), 43 (77), 39 (6). 
HRMS (CI-FE, i-butane) calcd for C12H17O3 [M+H]+ 209.1175, found 209.1178. 
 
 
(5R)-5-Isobutyl-3-methyl-1,2-dioxolan-3-ol ((5R)-3c): Peroxyhemiketal 3c was prepared according to 
the general procedure. The reaction mixture was stirred for 36 h at 32 °C. 
Purification of the crude product by flash column chromatography (silica gel, 5-
30% Et2O in pentane) provided the title compound 3c as a colorless oil (98 mg, 
612 μmol, 61%; 97.5:2.5 er). The enantiomeric ratio was determined after converting peroxyhemiketal 
3c into the corresponding epoxide 4c. The enantiomers were analyzed by GC using a chiral BGB-
176/BGB-15 column 30 m (60 °C, 0.8 C/min until 80 C, 20 C/min until 220 C, 10 min at 220 C, 
0.6 bar H2); major enantiomer: τR = 15.10 min, minor enantiomer: τR = 17.20 min. Characterized as 
mixture of hemiketal epimers (1:1 dr). 
1H NMR (500 MHz, CD2Cl2) δ 4.53-4.47 (m, 1H), 4.39-4.33 (m, 1H), 3.03-2.98 (m, 2H), 2.79-2.75 
(m, 1H), 2.71-2.67 (m, 1H), 2.25-2.21 (m, 1H), 2.20-2.17 (m, 1H), 1.73-1.56 (m, 4H), 1.53 (s, 3H), 
1.51 (s, 3H), 1.50-1.44 (m, 1H), 1.30-1.25 (m, 1H), 0.93-0.90 (m, 12H). 
13C NMR (125 MHz, CD2Cl2) δ 105.9, 104.9, 81.3, 79.7, 53.7, 53.2, 44.1, 41.7, 26.6, 26.1, 23.5, 23.3, 
23.2, 22.9, 22.8, 22.5. 
MS (EI-DE) m/z (%) 160 [M+] (2), 135 (0.09), 127 (39), 109 (10), 95 (3), 85 (12), 77 (1), 71 (96), 69 
(14), 57 (23), 43 (100), 41 (25), 29 (18). 
HRMS (EI-FE) calcd for C8H16O3 [M]+ 160.1098, found 160.1099. 
 
 
(5S)-5-Cyclohexyl-3-methyl-1,2-dioxolan-3-ol ((5S)-3d): Peroxyhemiketal 3d was prepared 
according to the general procedure. The reaction mixture was stirred for 48 h at 32 
°C. Purification of the crude product by flash column chromatography (silica gel, 
5-30% Et2O in pentane) provided the title compound 3d as a colorless oil (101 mg, 
542 μmol, 54%; 98:2 er). The enantiomeric ratio was determined after converting peroxyhemiketal 3d 
into the corresponding epoxide 4d. The enantiomers were analyzed by GC using a chiral BGB-176/SE-
52 column 29.5 m (80 °C, 1.2 C/min until 130 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar 








hemiketal epimers (1:1 dr). 
1H NMR (500 MHz, CD2Cl2) δ 4.11-4.06 (m, 1H), 4.05-4.00 (m, 1H), 3.00 (br s, 2H), 2.68-2.64 (m, 
1H), 2.60-2.56 (m, 1H), 2.34-2.28 (m, 2H), 1.91-1.86 (m, 1H), 1.83-1.79 (m, 1H), 1.75-1.53 (m, 10H), 
1.52 (s, 3H), 1.50 (s, 3H), 1.31-1.12 (m, 6H), 1.08-0.90 (m, 4H). 
13C NMR (125 MHz, CD2Cl2) δ 105.8, 105.0, 86.7, 85.2, 51.1, 50.3, 42.6, 41.2, 30.3, 29.9, 29.7, 29.3, 
26.8, 26.7, 26.4, 26.3, 26.1, 26.0, 23.4, 22.6. 
MS (EI-DE) m/z (%) 186 [M+] (2), 153 (50), 135 (14), 125 (1), 111 (8), 95 (16), 83 (71), 71 (60), 67 
(20), 55 (100), 43 (95), 29 (21). 
HRMS (CI-FE, NH3) calcd for C10H22NO3 [M+NH4]+ 204.1598, found 204.1600. 
 
 
(5R)-5-(3-Butenyl)-3-methyl-1,2-dioxolan-3-ol ((5R)-3e): Peroxyhemiketal 3e was prepared 
according to the general procedure. The reaction mixture was stirred for 36 h 
at 32 °C. Purification of the crude product by flash column chromatography 
(silica gel, 5-30% Et2O in pentane) provided the title compound 3e as a 
colorless oil (109 mg, 689 μmol, 69%; 97.5:2.5 er). The enantiomeric ratio 
was determined after converting peroxyhemiketal 3e into the corresponding aldol-type product 16e. 
The enantiomers were analyzed by HPLC using a chiral Chiralpak IA column (10% iPrOH/heptane, 0.5 
mL/min); major enantiomer: τR = 13.19 min, minor enantiomer: τR = 12.41 min. Characterized as 
mixture of hemiketal epimers (1:1 dr). 
1H NMR (500 MHz, CD2Cl2) δ 5.86-5.77 (m, 2H), 5.07-5.02 (m, 2H), 5.00-4.96 (m, 2H), 4.44-4.39 
(m, 1H), 4.34-4.28 (m, 1H), 3.10 (br s, 2H), 2.80-2.76 (m, 1H), 2.69-2.65 (m, 1H), 2.29-2.25 (m, 1H), 
2.24-2.21 (m, 1H), 2.19-2.05 (m, 4H), 1.83-1.75 (m, 2H), 1.73-1.54 (m, 2H), 1.53 (s, 3H), 1.51 (s, 3H). 
13C NMR (125 MHz, CD2Cl2) δ 138.3, 138.1, 115.5, 115.4, 105.9, 105.0, 81.9, 80.6, 52.8, 52.7, 34.4, 
31.9, 30.9, 30.7, 23.4, 22.8. 
MS (EI-DE) m/z (%) 140 (trace), 125 (10), 107 (2), 97 (2), 83 (10), 71 (18), 55 (28), 43 (100), 41 (13), 
29 (14). 
HRMS (CI-FE, i-butane) calcd for C8H15O3 [M+H]+ 159.1020, found 159.1021. 
 
 
(5R)-5-(3-Bromopropyl)-3-methyl-1,2-dioxolan-3-ol ((5R)-3f): Peroxyhemiketal 3f was prepared 




32 °C. Purification of the crude product by flash column chromatography (silica gel, 25-40% Et2O in 
pentane) provided the title compound 3f as a colorless oil (81 mg, 360 μmol, 72%; 97:3 er). The 
enantiomeric ratio was determined after converting dioxolane 3f into the corresponding epoxide 4f. The 
enantiomers were analyzed by GC using a chiral BGB-176/BGB-15 column 30 m (100 °C, 1.2 C/min 
until 135 C, 18 C/min until 220 C, 5 min at 320 C, 0.5 bar H2); major enantiomer: τR = 19.07 min, 
minor enantiomer: τR = 20.64 min. Contains traces of (E)-7-chloro-3,4-epoxyheptan-2-one. 
Characterized as mixture of hemiketal epimers (1:1 dr). 
1H NMR (400 MHz, THF-d8) δ 5.36 (s, 1H, OH), 5.33 (s, 1H, OH), 4.38-4.32 (m, 1H, CH), 4.25-4.18 
(m, 1H, CH), 3.51-3.40 (m, 4H, CH2Br), 2.68-2.64 (m, 1H, CH2COH), 2.61-2.55 (m, 1H, CH2COH), 
2.22-2.17 (m, 1H, CH2COH), 2.16-2.10 (m, 1H, CH2COH), 2.00-1.80 (m, 4H, CH2), 1.79-1.68 (m, 3H, 
CH2), 1.63-1.54 (m, 1H, CH2), 1.41 (s, 3H, CH3), 1.39 (s, 3H, CH3). 
13C NMR (100 MHz, THF-d8): δ 105.9 (Cq), 104.9 (Cq), 81.9 (CH), 80.7 (CH), 53.6 (COCH2CO), 





Peroxyhemiketal 3g was prepared according to the general procedure. 
The reaction mixture was stirred for 36 h at 32 °C. Purification of the 
crude product by flash column chromategraphy (silica gel, 30-40% 
Et2O in pentane) provided the title compound 3g (87 mg, 318 μmol, 
64%; 96.5:3.5 er) as a colorless oil. The enantiomeric ratio was determined after converting 
peroxyhemiketal 3g into the corresponding THP-deprotected epoxide 4k The enantiomers were 
analyzed by GC using a chiral Ivadex 1 column 25m (80 °C, 1.0 C/min until 155 C, 18 C/min until 
220 C, 10 min at 320 C, 0.6 bar H2); major enantiomer: τR = 60.79 min, minor enantiomer: τR = 61.52 
min. Characterized as mixture of diastereomers. 
1H NMR (400 MHz, THF-d8) δ 5.30 (s, 2H, OH), 5.26 (s, 2H, OH), 4.53 (t, J = 3.2 Hz, 4H, CHTHP), 
4.34-4.28 (m, 2H, CH), 4.21-4.14 (m, 2H, CH), 3.80-3.74 (m, 4H, OCHHTHP), 3.67 (dt, J = 9.5, 6.6 
Hz, 4H, THPOCHH), 3.44-3.38 (m, 4H, OCHHTHP), 3.30 (dt, J = 9.5, 6.4 Hz, 4H, THPOCHH), 2.65-
2.53 (m, 4H, CH2CqOH), 2.18-2.07 (m, 4H, CH2CqOH), 1.84-1.76 (m, 4H, CH2), 1.65-1.42 (m, 40H, 




13C NMR (100 MHz, THF-d8) δ 105.8 (2C, CqOH), 104.9 (2C, CqOH), 99.3 (4C, OCHO), 82.7 (2C, 
CH2CHCH2), 81.3 (2C, CH2CHCH2), 68.0 (4C, THPOCH2), 62.3 (4C, OCH2, THP), 54.0 (2C, 
CH2CqOH), 53.6 (2C, CH2CqOH), 35.8 (2C, CH2), 33.3 (2C, CH2), 31.9 (4C, CH2), 31.0 (2C, CH2), 30.9 
(2C, CH2), 27.6 (2C, CH2), 27.5 (2C, CH2), 27.5 (2C, CH2), 27.3 (2C, CH2), 26.9 (4C, CH2), 24.4 (2C, 
CH3), 23.8 (2C, CH3), 20.5 (4C, CH2). 
MS (EI-DE) m/z (%) 274 [M+] (trace), 185 (2), 173 (1), 155 (1), 139 (1), 115 (1), 99 (6), 85 (100), 81 
(9), 69 (9), 55 (13), 43 (38). 
HRMS (ESI+) calcd for C14H26O5Na [(M+Na)+] 297.1670, found 297.1672. 
 
 
(5R)-5-(2-(tert-Butyldimethylsilyloxy)ethyl)-3-methyl-1,2-dioxolan-3-ol ((5R)-3h): Peroxyhemiketal 
3h was prepared according to the general procedure. The reaction mixture was 
stirred for 36 h at 32 °C. Purification of the crude product by flash column 
chromatography (silica gel, 15-20% Et2O in pentane) provided the title 
compound as a colorless oil (89 mg, 340 μmol, 68%; 98:2 er). The enantiomeric ratio was determined 
after converting peroxyhemiketal 3h into the corresponding epoxide 4h. The enantiomers were 
analyzed by GC using a chiral BGB-176/BGB-15 column 30 m (80 °C, 1.2 C/min until 150 C, 18 
C/min until 220 C, 5 min at 320 C, 0.5 bar H2); major enantiomer: τR = 34.84 min, minor enantio-
mer: τR = 35.96 min. Characterized as mixture of hemiketal epimers (1:1 dr). 
1H NMR (400 MHz, THF-d8) δ 5.34 (s, 1H, OH), 5.28 (s, 1H, OH), 4.52-4.46 (m, 1H, CH), 4.35-4.28 
(m, 1H, CH), 3.85-3.64 (m, 4H, TBSOCH2), 2.69-2.55 (m, 2H, CH2CqOH), 2.25-2.15 (m, 2H, 
CH2CqOH), 1.92-1.75 (m, 3H, TBSOCH2CH2), 1.64-1.55 (m, 1H, TBSOCH2CH2), 1.41 (s, 3H, 
CqOHCH3), 1.39 (s, 3H, CqOHCH3), 0.90 (s, 18H, Cq(CH3)3), 0.04 (s, 12H, Si(CH3)2). 
13C NMR (100 MHz, THF-d8) δ 105.8 (CqOH), 104.9 (CqOH), 79.9 (CH), 78.3 (CH), 61.3 (TBSOCH2), 
61.0 (TBSOCH2), 53.8 (CH2CqOH), 53.6 (CH2CqOH), 38.9 (TBSOCH2CH2), 36.7 (TBSOCH2CH2), 
26.6 (6C, Cq(CH3)3), 24.3 (CqOHCH3), 23.7 (CqOHCH3), 19.2 (2C, CqMe3), 5.02 (2C, Si(CH3)2), 5.05 
(2C, Si(CH3)2). 
MS (EI-DE) m/z (%) 205 (1), 187 (1), 173 (1), 157 (2), 145 (8), 131 (32), 115 (22), 101 (26), 89 (9), 75 
(100), 59 (12), 43 (24), 29 (4). 






(5R)-5-(3-Ethoxy-3-oxopropyl)-3-methyl-1,2-dioxolan-3-ol ((5R)-3i): Peroxyhemiketal 3i was 
prepared according to the general procedure. The reaction mixture was stirred 
for 24 h at 32 °C. Purification of the crude product by flash column 
chromatography (silica gel, 25-50% Et2O in pentane) provided the title 
compound 3i (71 mg, 348 μmol, 70%; 96.5:3.5 er) as a colorless oil. The enantiomeric ratio was 
determined after converting peroxyhemiketal 3i into the corresponding epoxide 4i. The enantiomers 
were analyzed by GC using a chiral BGB-176/SE-52 column 30 m (80 °C, 1.2 C/min until 130 C, 18 
C/min until 220 C, 5 min at 320 C, 0.5 bar H2); major enantiomer: τR = 36.32 min, minor 
enantiomer: τR = 37.59 min. Characterized as mixture of hemiketal epimers (1:1 dr). 
1H NMR (400 MHz, CD2Cl2) δ 4.47-4.41 (m, 1H, CH), 4.38-4.31 (m, 1H, CH), 4.11 (q overlapped, J 
= 7.2 Hz, 2H, CH2CH3), 4.10 (q overlapped, J = 7.1 Hz, 2H, CH2CH3), 2.83-2.78 (m, 1H, CH2CqOH), 
2.71-2.51 (m, 3H, CH2COH and OH), 2.45-2.22 (m, 6H, CH2), 2.05-1.90 (m, 3H, CH2), 1.81-1.73 (m, 
1H, CH2), 1.53 (s, 3H, CH3), 1.51 (s, 3H, CH3), 1.24 (t overlapped, J = 7.2 Hz, 3H, CH2CH3), 1.23 (t 
overlapped, J = 7.3 Hz, 3H, CH2CH3). 
13C NMR (100 MHz, CD2Cl2) δ 172.9 (C=O), 172.8 (C=O), 105.5 (CqOH), 104.5 (CqOH), 80.8 (CH), 
79.8 (CH), 60.7 (CH2CH3), 60.5 (CH2CH3), 52.3 (CH2, cycl.), 51.9 (CH2, cycl.), 30.7 (CH2), 30.6 (CH2), 
29.9 (CH2), 27.2 (CH2), 22.9 (CH3), 22.3 (CH3), 14.1 (CH2CH3), 14.0 (CH2CH3). 
MS (EI) m/z (%) 172 (3), 141 (2), 126 (11), 115 (5), 98 (28), 85 (13), 73 (12), 55 (13), 43 (100), 29 
(37). 
HRMS (ESI+) calcd for C9H16O5Na [(M+Na)+] 227.0890, found 227.0890. 
 
 
(5R)-5-(3-Oxobutyl)-3-methyl-1,2-dioxolan-3-ol ((5R)-3j): Peroxyhemiketal 3j was prepared 
according to the general procedure. Catalyst [1a • 2 TFA] (10 mol%) was used 
together with 50 wt% aqueous hydrogen peroxide (1.5 equiv) as oxidant. The 
reaction mixture was stirred for 24 h at 32 °C. Purification of the crude product 
by flash column chromatography (silica gel, 30-50% Et2O in pentane) provided the title compound 3j 
(26 mg, 151 mol, 30%; 96:4 er) as a colorless oil. The enantiomeric ratio was determined after 
converting peroxyhemiketal 3j into the corresponding epoxide 4j The enantiomers were analyzed by 
GC using a chiral BGB-176/SE-52 column 30 m (80 °C, 1.2 C/min until 120 C, 20 C/min until 220 




min. Characterized as a mixture of three hemiketal isomers (~1:1:0.8). 
1H NMR (500 MHz, THF-d8) 3-hydroxy-1,2-dioxolane (mixture of hemiketal 
epimers (dr~1:1)): δ 5.33 (br s, 1H, OH), 5.30 (br s, 1H, OH), 4.37-4.28 (m, 1H, 
CH), 4.21-1.25 (m, 1H, CH), 2.64 (dd, J = 12.0, 7.0 Hz, 1H, CH2, cycl.), 2.58-2.46 
(m, 3H, CH2, cycl.), 2.20-2.05 (m, 10H, CH3C(=O) and CH2(C=O)), 1.88-1.62 (m, 
4H, CH2CH2CH), 1.40 (s, 3H, CH3CqOH), 1.38 (s, 3H, CH3CqOH); 3-hydroxy-
1,2-dioxane: 5.34 (br s, 1H, OH), 4.37-4.28 (m, 1H, CH), 2.58-2.46 (m, 4H, 
CH2CqOH and CH2C(=O)), 2.20-2.05 (m, 3H, CH3C(=O)), 1.88-1.62 (m, 2H, CHCH2, cycl.), 1.39 (s, 3H, 
CH3CqOH). 
13C NMR (125 MHz, THF-d8) 3-hydroxy-1,2-dioxolane (mixture of hemiketal epimers (dr~1:1)): δ 
206.8 (C=O), 206.5 (C=O), 105.9 (CqOH), 105.0 (CqOH), 81.8 (CH), 80.6 (CH), 53.5 (CH2, cycl.), 53.4 
(CH2, cycl.), 40.3 (CH2C(=O)), 40.2 (CH2C(=O)), 29.8 (CH3C(=O)), 29.8 (CH3C(=O)), 29.7 (CH2CH), 
27.1 (CH2CH), 24.3 (CH3CqOH), 23.6 (CH3CqOH); 3-hydroxy-1,2-dioxane: δ 204.4 (C=O), 99.2 (CqOH), 
77.5 (CH), 47.6 (CH2C(=O)), 34.2 (CH2CqOH), 31.0 (CH3C(=O)), 26.9 (CHCH2, cycl.), 26.7 (CH3CqOH). 
 
 
(5R)-5-(5-Hydroxypentyl)-3-methyl-1,2-dioxolan-3-ol ((5R)-3k): Peroxyhemiketal 3k was prepared 
according to the general procedure. Catalyst [1a • 2 TFA] (10 mol%) was 
used together with 50 wt% aqueous hydrogen peroxide (1.5 equiv) as 
oxidant. The reaction mixture was stirred for 36 h at 50 °C. Purification of 
the crude reaction mixture by flash column chromatography (silica gel, 10-40% Et2O in CH2Cl2) 
provided the title compound 3k (12 mg, 63.1 μmol, 25%) as a colorless oil along with a mixture of the 
corresponding epoxide 4k (11 mg, 64.0 μmol, 26%; 98:2 er) and unreacted starting material 2k (10 mg, 
65.0 μmol, 26%). Characterized as a mixture of hemiketal epimers (1:1 dr). 
1H NMR (400 MHz, THF-d8) δ 5.31 (s, 1H, CqOH), 5.27 (s, 1H, CqOH), 4.34-4.28 (m, 1H, CH), 4.17 
(quint, J = 7.3 Hz, 1H, CH), 3.46 (t, J = 5.5 Hz, 4H, CH2OH), 3.35 (br s, 2H, CH2OH), 2.64-2.55 (m, 
2H, CH2, cycl.), 2.20-2.07 (m, 2H, CH2, cycl.), 1.67-1.31 (m, 16H, -(CH2)4-), 1.40 (s overlapped, 3H, 
CH3), 1.38 (s overlapped, 3H, CH3). 
13C NMR (100 MHz, THF-d8) 105.8 (CqOH), 104.9 (CqOH), 82.7 (CH), 81.4 (CH), 62.7 (CH2OH), 62.7 
(CH2OH), 54.0 (CH2, cycl.), 53.6 (CH2, cycl.), 35.9 (CH2), 34.3 (CH2), 34.2 (CH2), 33.4 (CH2), 27.6 (CH2), 











MS (EI-DE) m/z (%) 157 (5), 139 (5), 125 (1), 121 (3), 111 (2), 103 (1), 97 (13), 81 (15), 79 (4), 71 
(21), 55 (18), 43 (100), 41 (26), 31 (13). 
HRMS (ESI+) calcd for C9H18AgO4 [(M+Ag)+] 297.0249, found 297.0249. 
 
 
(5R)-3,5-Dipentyl-1,2-dioxolan-3-ol ((5R)-3l): Peroxyhemiketal 3l was prepared according to the 
general procedure. The reaction mixture was stirred for 48 h at 32 °C. 
Purification of the crude product by flash column chromatography 
(silica gel, 10-20% Et2O in pentane) provided the title compound 3l as a 
colorless oil (46 mg, 201 μmol, 40%; 97:3 er). The enantiomeric ratio was determined after converting 
dioxolane 3l into the corresponding epoxide 4l. The enantiomers were analyzed by GC using a chiral 
G-TA column 30 m (80 °C, 1 C/min until 130 C, 18 C/min until 180 C, 10 min at 320 C, 0.9 bar 
H2); major enantiomer: τR = 43.80 min, minor enantiomer: τR = 43.02 min. Characterized as a mixture 
of hemiketal epimers (1:1 dr). 
1H NMR (500 MHz, THF-d8) δ 5.20 (s, 1H, OH), 5.16 (s, 1H, OH), 4.33-4.28 (m, 1H, CH), 4.15-4.09 
(m, 1H, CH), 2.61-2.52 (m, 2H, CH2CqOH), 2.10-2.04 (m, 2H, CH2CqOH), 1.68-1.26 (m, 32H, CH2), 
0.92-0.88 (m, 12H, CH3). 
13C NMR (125 MHz, THF-d8) δ 107.7 (CqOH), 106.9 (CqOH), 82.6 (CH), 81.0 (CH), 52.4 (CH2, cycl.), 
52.1 (CH2, cycl.), 38.3 (CH2), 37.9 (CH2), 35.8 (CH2), 33.4 (CH2), 33.4 (CH2), 33.3 (CH2), 33.1 (CH2), 
33.0 (CH2), 27.4 (CH2), 27.2 (CH2), 25.9 (CH2), 25.7 (CH2), 23.8 (3C, CH2), 23.7 (CH2), 14.7 (2C, 
CH3), 14.7 (CH3), 14.6 (CH3). 
MS (EI) m/z (%) 230 [M+] (1), 197 (100), 159 (1), 141 (3), 127 (30), 117 (5), 99 (50), 81 (6), 71 (30), 
55 (30), 43 (90), 29 (24). 
HRMS (EI-DE) calcd for C13H26O3 [M+] 230.1880, found 230.1882. 
 
 
(5R)-3-Isopropyl-5-methyl-1,2-dioxolan-3-ol ((5R)-3n): Peroxyhemiketal 3n was obtained by the 
general procedure. Catalyst salt [1a • 2 TCA] (20 mol%) was used and the reaction 
mixture was stirred for 48 h at 32 °C. Purification of the crude product by flash 
column chromatography (silica gel, 30-40% Et2O in pentane) provided the title 
compound 3n (57 mg, 391 μmol, 39%; 96:4 er) as a colorless oil. The enantiomeric ratio was 




were analyzed by GC using a chiral Lipodex G column 25 m (50 °C, 1.2 C/min until 80 C, 18 C/min 
until 220 C, 10 min at 230 C, 0.5 bar H2); major enantiomer: τR = 8.36 min, minor enantiomer: τR = 
8.80 min. Characterized as a mixture of hemiketal epimers (1:1 dr). 
1H NMR (400 MHz, THF-d8) δ 6.98 (s, 1H, OH), 6.97 (s, 1H, OH), 6.34 (app. sext, J = 6.3 Hz, 1H, 
CHCH2), 6.10-6.03 (m, 1H, CHCH2), 4.51 (dd, J = 12.6, 7.3 Hz, 1H, CHH), 4.33 (dd, J = 12.1, 6.8 Hz, 
1H, CHH), 3.93 (dd, J = 12.0, 6.3 Hz, 1H, CHH), 3.81 (dd, J = 12.6, 8.5 Hz, 1H, CHH), 3.72 (hept, J = 
7.0 Hz, 2H, CHMe2), 3.09 (d, J = 6.0 Hz, 3H, CH3CH), 3.04 (d, J = 6.3 Hz, 3H, CH3CH), 2.81 (t, J = 
6.8 Hz, 12H, CH(CH3)2). 
13C NMR (125 MHz, THF-d8) δ 110.2 (CqOH), 109.2 (CqOH), 78.6 (CHCH2), 76.9 (CHCH2), 52.0 
(CH2), 51.8 (CH2), 36.1 (CHMe2), 35.9 (CHMe2), 20.3 (CH3), 19.1 (CH3), 18.8 (CH3), 18.3 (CH3), 18.1 
(CH3), 17.4 (CH3). 
GC-MS (GC-EI) m/z (%) 146 [M+] (trace), 128 (1), 113 (12), 103 (6), 85 (4), 71 (22), 61 (17), 43 
(100), 27 (8). 
HRMS (EI-FE) calcd for C7H14O3 [M+] 146.0941, found 146.0943. 
 
 
(5R)-3-Ethyl-5-methyl-1,2-dioxolan-3-ol ((5R)-3o): The title compound was isolated after 24 h at 
32 °C and purification by flash column chromatography (silica gel, 10-30% Et2O in 
pentane) as a colorless oil (74 mg, 560 μmol, 56%; 97:3 er). The enantiomeric ratio 
was determined after converting dioxolane 3o to the corresponding epoxide 4o. The 
enantiomers were analyzed by GC using a chiral BGB-178/BGB-15 column 30 m (60 °C, 1.0 C/min 
until 80 C, 18 C/min until 220 C, 10 min at 220 C, 0.4 bar H2); major enantiomer: τR = 14.73 min, 
minor enantiomer: τR = 15.98 min. Characterized as a mixture of hemiketal epimers (1:1 dr). 
1H NMR (400 MHz, CD2Cl2) δ 4.60 (app. sext, J = 6.2 Hz, 1H, CH), 4.40-4.32 (m, 1H, CH), 3.12 (br 
s, 2H, OH), 2.71 (dd overlapped, J = 12.8, 7.5 Hz, 1H, CHHcycl.), 2.69 (dd overlapped, J = 12.6, 7.1 
Hz, 1H, CHHcycl.), 2.17 (dd overlapped, J = 12.6, 5.8 Hz, 1H, CHHcycl.), 2.13 (dd overlapped, J = 12.8, 
8.5 Hz, 1H, CHHcycl.), 1.84-1.71 (m, 4H, CH2CH3), 1.30 (d, J = 6.3 Hz, 3H, CH3CH), 1.26 (d, J = 6.1 
Hz, 3H, CH3CH), 1.02 (t overlapped, J = 7.5 Hz, 3H, CH2CH3), 1.00 (t overlapped, J = 7.6 Hz, 3H, 
CH2CH3). 
13C NMR (100 MHz, CD2Cl2) 108.5 (CqOH), 107.3 (CqOH), 78.4 (CH), 76.9 (CH), 52.3 (CH2, cycl.), 52.0 











MS (EI-DE) m/z (%) 132 [M+] (3), 115 (1), 99 (100), 91 (1), 87 (3), 85 (27), 81 (4), 75 (3), 71 (24), 69 
(3), 61 (25), 57 (59), 43 (60), 31 (9), 29 (40), 27 (14). 
HRMS (EI-FE) calcd for C6H12O3 [M+] 132.0785, found 132.0786. 
 
 
3-Ethyl-5-nonyl-1,2-dioxolan-3-ol (3p): Peroxyhemiketal 3p was prepared according to the general 
procedure. The reaction mixture was stirred for 48 h at 32 °C. 
Purification of the crude product by flash column chromatography 
(silica gel, 10-20% Et2O in pentane) provided the title compound 3p 
as a colorless oil (59 mg, 240 μmol, 48%; 98:2 er). The enantiomeric ratio was determined after 
converting dioxolane 3p into the corresponding epoxide 4p. The enantiomers were analyzed by GC 
using a chiral Lipodex E column 25 m (100 °C, 1.2 C/min until 180 C, 18 C/min until 220 C, 10 
min at 320 C, 0.5 bar H2); major enantiomer: τR = 37.10 min, minor enantiomer: τR = 35.28 min. 
Characterized as a mixture of hemiketal epimers (1:1 dr). 
1H NMR (500 MHz, THF-d8) δ 5.18 (s, 1H, OH), 5.15 (s, 1H, OH), 4.33-4.28 (m, 1H, CH), 4.12 
(quint, J = 7.1 Hz, 1H, CH), 2.61-2.50 (m, 2H, CH2CqOH), 2.10-2.02 (m, 2H, CH2CqOH), 1.71-1.52 (m, 
7H, CH2), 1.42-1.36 (m, 3H, CH2), 1.35-1.26 (m, 26H, CH2), 0.97 (t, J = 7.6 Hz, 3H, CqOHCH2CH3), 
0.96 (t, J = 7.6 Hz, 3H, CqOHCH2CH3), 0.89 (t, J = 6.8 Hz, 6H, CH3). 
13C NMR (125 MHz, THF-d8) 108.1 (CqOH), 107.2 (CqOH), 82.7 (CH), 81.1 (CH), 51.9 (CH2, cycl.), 
51.5 (CH2, cycl.), 35.7 (CH2), 33.3 (CH2), 33.2 (2C, CH2), 31.2 (CH2), 30.9 (CH2), 30.9 (CH2), 30.9 
(CH2), 30.8 (CH2), 30.8 (CH2), 30.8 (CH2), 30.8 (CH2), 30.6 (2C, CH2), 27.7 (CH2), 27.5 (CH2), 23.9 
(2C, CH2), 14.7 (2C, (CH2)8CH3), 9.9 (CqOHCH2CH3), 9.7 (CqOHCH2CH3). 
MS (EI) m/z (%) 244 [M+] (1), 211 (77), 197 (1), 181 (1), 155 (9), 137 (2), 95 (8), 85 (50), 71 (17), 57 
(100), 43 (46), 29 (34). 
HRMS (EI-DE) calcd for C14H28O3 [M+] 244.2038, found 244.2038. 
 
Achiral peroxyhemiketal 11 has been described in the literature3 
                                                 












Catalyst salt [1a • 2 TFA] was prepared in situ by the addition of amine 1a (32.3 mg, 0.1 mmol, 10 
mol%) to a solution of trifluoroacetic acid (15.3 L, 0.2 mmol, 20 mol%) in dioxane (4 mL). Then 
enone 2 (1.0 mmol, 1.0 equiv) was added, and 20 minutes later, aqueous hydrogen peroxide (50 wt%, 
92 L, 1.5 mmol, 1.5 equiv). After 12-48 h at 50°C, the reaction mixture was extracted with Et2O 
(325 mL). The combined organic phases were washed with brine and concentrated under reduced 
pressure to a volume of 5 mL. Aqueous 1N NaOH solution (1.0 mL, 1.0 mmol, 1.0 equiv) was added 
and the reaction mixture stirred until TLC analysis indicated complete conversion to the epoxide (10 
min to 1 h). The reaction mixture was extracted with Et2O (325 mL), and the combined organic 
phases were washed with brine, dried (Na2SO4), and filtered. Evaporation of the solvent furnished the 
crude product, which was purified by flash column chromatography (silica gel, eluent: Et2O-pentane) 




Scope of Optically Active ,-Epoxyketones 4 
 
(3S,4R)-3,4-Epoxy-2-decanone (3S,4R)-4a): Epoxide (3S,4R)-4a was prepared according to the 
general procedure. The reaction mixture was stirred for 12 h at 50 °C. 
Purification by flash column chromatography (silica gel, 1-20% Et2O in 
pentane) provided the title compound 4a as a colorless oil (127 mg, 747 μmol, 
75%; 98.5:1.5 er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 
column 30 m (80 °C, 1.2 C/min until 120 C, 20 C/min until 220 C, 10 min at 220 C, 0.6 bar H2); 




1H NMR (500 MHz, CD2Cl2) δ 3.14 (d, J = 2.0 Hz, 1H, CHepoC(=O)), 3.05 (td, J = 5.5, 1.9 Hz, 1H, 
CH2CHepo), 2.02 (s, 3H, CH3C(=O)), 1.64-1.55 (m, 2H, CH2CHepo), 1.49-1.41 (m, 2H, CH2CH2CHepo), 
1.37-1.25 (m, 6H, (CH2)3CH3), 0.89 (t, J = 7.0 Hz, 3H, (CH2)5CH3). 
13C NMR (125 MHz, CD2Cl2) δ 206.2 (C=O), 60.4 (CHepoC(=O)), 58.6 (CH2CHepo), 32.4 (CH2CHepo), 
32.2 (CH2), 29.5 (CH2), 26.3 (CH2CH2CHepo), 24.8 (CH3C(=O)), 23.1 (CH2), 14.4 ((CH2)5CH3). 
GC-MS (GC-EI) m/z (%) 170 [M+] (trace), 139 (7), 125 (1), 109 (4), 97 (12), 85 (54), 81 (9), 69 (21), 
55 (41), 43 (100), 39 (9), 29 (17). 
HRMS (CI-FE, i-butane) calcd for C10H19O2 [(M+H)+] 171.1384, found 171.1385. 
 
 
(3R,4S)-3,4-Epoxy-2-decanone ((3R,4S)-4a): 9-Amino(9-deoxy)epiquinidine (1b) was used instead of 
1a under otherwise identical conditions. The reaction mixture was 
stirred for 12 h at 50 °C. Purification by flash column 
chromatography (silica gel, 1-20% Et2O in pentane) provided the 
title compound ent-4a as a colorless oil (137 mg, 807 μmol, 81%; 
96:4 er). The enantiomeric ratio was determined by GC using a chiral BGB-176/SE-52 column 30 m 
(80 °C, 1.2 C/min until 115C, 20 C/min until 220 C, 10 min at 220 C, 0.6 bar H2); major 
enantiomer: τR = 25.06 min, minor enantiomer: τR = 24.13 min. 
 
 
(3S,4R)-3,4-Epoxy-6-phenyl-2-hexanone ((3S,4R)-4b): Epoxide (3S,4R)-4b was prepared according 
to the general procedure. The reaction mixture was stirred for 12 h at 50 °C. 
Purification by flash column chromatography (silica gel, 1-20% Et2O in pentane) 
provided the title compound 4b as a colorless oil (162 mg, 854 μmol, 85%; 98.5:1.5 
er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 30 m (80 
°C, 1.2 C/min until 140 C, 20 C/min until 220 C, 10 min at 220 C, 0.6 bar H2); major enantiomer: 
τR = 45.23 min, minor enantiomer: τR = 46.65 min. 
1H NMR (500 MHz, CD2Cl2) δ 7.32-7.28 (m, 2H, CHPh), 7.23-7.20 (m, 3H, CHPh), 3.15 (d, J = 1.8 Hz, 
1H, CHepoC(=O)), 3.09 (td, J = 5.6, 1.8 Hz, 1H, CH2CHepo), 2.85-2.72 (m, 2H, PhCH2), 1.99 (s, 3H, 
CH3), 1.96-1.91 (m, 2H, CH2CHepo). 
13C NMR (125 MHz, CD2Cl2) δ 205.7 (C=O), 141.3 (CqPh), 129.1 (2C, CHPh), 128.9 (2C, CHPh), 126.7 




MS (EI-DE) m/z (%) 190 [M+] (4), 172 (4), 157 (2), 147 (14), 134 (5), 129 (37), 117 (38), 104 (34), 91 
(100), 85 (22), 77 (8), 65 (17), 57 (8), 51 (6), 43 (64), 27 (5). 
HRMS (EI-FE) calcd for C12H14O2 [M+] 190.0992, found 190.0994. 
 
 
(3R,4S)-3,4-Epoxy-6-phenyl-2-hexanone ((3R,4S)-4b): Epoxide (3R,4S)-4b was prepared according 
to the general procedure. 9-Amino(9-deoxy)epiquinidine  (1b) was used instead of 
1a under otherwise identical conditions. The reaction mixture was stirred for 12 h at 
50 °C. Purification by flash column chromatography (silica gel, 1-20% Et2O in 
pentane) provided the title compound ent-4b as a colorless oil (171 mg, 901 μmol, 
90%; 95:5 er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 
30 m (80 °C, 1.2 C/min until 160 C, 20 C/min until 220 C, 10 min at 220 C, 0.6 bar H2); major 
enantiomer: τR = 47.30 min, minor enantiomer: τR = 46.86 min. 
 
 
(3S,4R)-3,4-Epoxy-5-phenyl-2-pentanone ((3S,4R)-4q): Epoxide (3S,4R)-4q was prepared according 
to the general procedure. Catalyst [1a • 3 TFA] was used under otherwise identical 
conditions. After 12 h at 50 °C, the conversion was determined to be 94% by 1H NMR 
of the crude mixture (37% epoxide 4q, 33% 5-benzyl-3-methyl-1,2-dioxolan-3-ol 
(3q), 24% (E)-5-phenylpent-4-en-2-one (iso-2q, vide infra)). The enantiomeric ratio of epoxide 4q was 
determined to be 99:1 er by GC using a chiral Lipodex E column 25 m (80 °C, 1.2 C/min until 145 C, 
18 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major enantiomer: τR = 42.87 min, minor 
enantiomer: τR = 41.72 min. 
1H NMR (500 MHz, CDCl3) δ 7.32-7.21 (m, 5H, C6H5), 3.28 (td, J = 5.2, 1.9 Hz, 1H, CH2CHepo), 3.22 
(d, J = 1.6 Hz 1H, CHepoC(=O)), 2.93 (app. qd, J = 14.4, 5.2 Hz, 2H, PhCH2), 2.02 (s, 3H, CH3). 
 
 
(E)-5-Phenylpent-4-en-2-one (iso-2q): 1H NMR (500 MHz, CDCl3) δ 7.35-7.21 (m, 5H, C6H5), 6.45 
(d, J = 16.0 Hz, 1H, PhCH=), 6.28 (dt, J = 15.8, 7.5 Hz, 1H, =CHCH2), 3.31 (d, J = 









(3S,4R)-3,4-Epoxy-6-methyl-2-heptanone ((3S,4R)-4c): Epoxide (3S,4R)-4c was prepared according 
to the general procedure. The reaction mixture was stirred for 18 h at 50 °C. 
Purification by flash column chromatography (silica gel, 1-20% Et2O in pentane) 
provided the title compound 4c as a colorless oil (109 mg, 768 μmol, 77%; 98.5:1.5 
er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 30 m (60 
°C, 0.8 C/min until 80 C, 18 C/min until 220 C, 10 min at 220 C, 0.6 bar H2); major enantiomer: 
τR = 15.45 min, minor enantiomer: τR = 17.76 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.12 (d, J = 1.9 Hz, 1H, CHepoC(=O)), 3.06 (td, J = 5.8, 1.9 Hz, 1H, 
CH2CHepo), 2.03 (s, 3H, CH3C(=O)), 1.83 (hept, J = 6.7 Hz, 1H, CHMe2), 1.48 (dd, J = 6.5 Hz, 2H, 
CH2), 0.98 (d, J = 4.6 Hz, 3H, CH(CH3)2), 0.97 (d, J = 4.6 Hz, 3H, CH(CH3)2). 
13C NMR (125 MHz, CD2Cl2) δ 206.2 (C=O), 60.5 (CHepoC(=O)), 57.6 (CH2CHepo), 41.1 (CH2), 27.0 
(CHMe2), 24.9 (CH3C(=O)), 23.1 (CH(CH3)2), 22.6 (CH(CH3)2). 
MS (EI-DE) m/z (%) 142 [M+] (2), 127 (6), 100 (10), 85 (100), 81 (6), 74 (2), 69 (3), 57 (26), 55 (12), 
43 (79), 41 (14), 27 (11). 
HRMS (CI-FE, i-butane) calcd for C8H15O2 [(M+H)+] 143.1071, found 143.1072. 
 
 
(3S,4R)-3,4-Epoxy-6,6-dimethyl-2-heptanone ((3S,4R)-4r): Epoxide (3S,4R)-4r was prepared 
according to the general procedure. The reaction mixture was stirred for 18 h at 50 
°C. Purification by flash column chromatography (silica gel, 1-20% Et2O in pentane) 
provided the title compound 4r as a colorless oil (127 mg, 812 μmol, 81%; >99.5:0.5 
er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 30 m (80 
°C, 1.0 C/min until 100 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major enantiomer: 
τR = 15.39 min, minor enantiomer: τR = 16.03 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.10-3.07 (m, 2H, CHepo), 2.04 (s, 3H, CH3C(=O)), 1.53-1.44 (m, 2H, 
CH2), 1.00 (s, 9 H, Cq(CH3)3). 
13C NMR (125 MHz, CD2Cl2) δ 206.2 (C=O), 60.2 (CHepoC(=O)), 56.2 (CH2CHepo), 46.3 (CH2), 31.1 
(CqMe3), 29.9 (3C, Cq(CH3)3), 25.0 (CH3C(=O)). 
GC-MS (GC-EI) m/z (%) 156 [M+] (trace), 141 (1), 125 (1), 107 (1), 100 (11), 95 (4), 85 (53), 69 (16), 
57 (97), 43 (100), 41 (41), 29 (24), 27 (7). 




(3S,4R)-3,4-Epoxy-5-methyl-2-hexanone ((3S,4R)-4s): Epoxide (3S,4R)-4s was prepared according to 
the general procedure. 20 mol% of catalyst [1a • 2 TFA] was used under otherwise 
identical conditions. The reaction mixture was stirred for 48 h at 50 °C. Purification by 
flash column chromatography (silica gel, 1-20% Et2O in pentane) provided the title 
compound 4s as a colorless oil (64 mg, 497 μmol, 50% (reduced yield due to the high volatility of 4s); 
98:2 er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 30 m 
(15 min at 60 °C, 20 C/min until 220 C, 10 min at 220 C, 0.6 bar H2); major enantiomer: τR = 8.34 
min, minor enantiomer: τR = 10.30 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.19 (d, J = 1.9 Hz, 1H, CHepoC(=O)), 2.87 (dd, J = 6.6, 1.9 Hz, 1H, 
CHCHepo), 2.03 (s, 3H, CH3C(=O)), 1.62 (hept, J = 6.7 Hz, 1H, CHMe2), 1.03 (d, J = 6.6 Hz, 3H, 
CH(CH3)2), 0.97 (d, J = 7.0, 3H, CH(CH3)2). 
13C NMR (125 MHz, CD2Cl2) δ 206.1 (C=O), 63.4 (CHCHepo), 59.2 (CHepoC(=O)), 30.8 (CHMe2), 
24.6 (CH3C(=O)), 18.9 (CH(CH3)2), 18.2 (CH(CH3)2). 
GC-MS (GC-EI) m/z (%) 128 [M+] (trace), 113 (14), 97 (2), 95 (13), 85 (94), 83 (1), 69 (5), 67 (33), 65 
(3), 59 (13), 55 (9), 45 (4), 43 (100), 41 (21), 39 (7), 29 (10). 
 
 
(3S,4R)-3,4-Epoxy-4-cyclohexyl-2-butanone ((3S,4R)-4d): Epoxide (3S,4R)-4d was prepared 
according to the general procedure. 20 mol% of catalyst [1a • 2 TFA] was used under 
otherwise identical conditions. The reaction mixture was stirred for 48 h at 50 °C. 
Purification by flash column chromatography (silica gel, 1-20% Et2O in pentane) 
provided the title compound 4d as a colorless oil (140 mg, 842 μmol, 84%; 98.5:1.5 er). The 
enantiomeric ratio was determined by GC using a chiral BGB-176/SE-52 column 29.5 m (80 °C, 1.2 
C/min until 135 C, 18 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major enantiomer: τR = 
33.22 min, minor enantiomer: τR = 34.35 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.21 (d, J = 2.3 Hz, 1H, CHepoC(=O)), 2.86 (dd, J = 6.5, 2.3 Hz, 1H, 
CHCHepo), 2.02 (s, 3H, CH3), 1.85-1.80 (m, 1H, CH2), 1.78-1.72 (m, 2H, CH2), 1.72-1.64 (m, 2H, 
CH2), 1.35-1.07 (m, 6H, CHcycl. and CH2). 
13C NMR (125 MHz, CD2Cl2) δ 206.3 (C=O), 62.7 (CHCHepo), 59.3 (CHepoC(=O)), 40.4 (CHcycl.), 30.0 
(CH2), 29.3 (CH2), 26.7 (CH2), 26.1 (CH2), 26.0 (CH2), 24.8 (CH3). 




(22), 70 (5), 67 (17), 55 (24), 43 (45), 29 (10). 
HRMS (ESI+) calcd for C10H16NaO2 [(M+Na)+] 191.1042, found 191.1042. 
 
 
(3S,4R)-3,4-Epoxy-7-octen-2-one ((3S,4R)-4e): Epoxide (3S,4R)-4e was prepared according to the 
general procedure. The reaction mixture was stirred for 12 h at 50 °C. Purification 
by flash column chromatography (silica gel, 1-20% Et2O in pentane) provided the 
title compound 4e as a colorless oil (107 mg, 764 μmol, 76%; 98.5:1.5 er). The 
enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 30 m (80 °C, 0.8 
C/min until 100 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major enantiomer: τR = 
11.06 min, minor enantiomer: τR = 12.59 min. 
1H NMR (500 MHz, CD2Cl2) δ 5.84 (ddt, J = 17.0, 10.3, 6.6 Hz, 1H, CH=CH2), 5.07 (ddd, J = 17.1, 
3.4, 1.7 Hz, 1H, CH=CHtransH), 5.01 (ddd, J = 10.2, 2.9, 1.3 Hz, 1H, CH=CHHcis), 3.18 (d, J = 1.9 Hz, 
1H, CHepoC(=O)), 3.08 (td, J = 5.5, 1.9 Hz, 1H, CH2CHepo), 2.28-2.17 (m, 2H, CH2=CHCH2), 2.03 (s, 
3H, CH3), 1.75-1.66 (m, 2H, CH2CHepo). 
13C NMR (125 MHz, CD2Cl2) δ 205.9 (C=O), 137.7 (CH=CH2), 115.9 (CH=CH2), 60.4 (CHepoC(=O)), 
58.1 (CH2CHepo), 31.6 (CH2), 30.5 (CH2), 25.0 (CH3). 
MS (EI-DE) m/z (%) 140 [M+] (trace), 107 (3), 97 (34), 85 (30), 79 (8), 73 (3), 67 (11), 57 (22), 55 
(11), 43 (100), 41 (34), 39 (18), 27 (13). 
HRMS (CI-FE, i-butane) calcd for C8H13O2 [(M+H)+] 141.0916, found 141.0916. 
 
 
(3S,4R)-7-Bromo-3,4-epoxy-2-heptanone ((3S,4R)-4f): Epoxide (3S,4R)-4f was prepared according to 
the general procedure. The reaction mixture was stirred for 18 h at 50 °C. 
Purification by flash column chromatography (silica gel, 10-25% Et2O in 
pentane) provided the title compound 4f as a colorless oil (77 mg, 374 μmol, 
75%; 98.5:1.5 er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 
column 30 m (100 °C, 1.2 C/min until 135 C, 18 C/min until 220 C, 5 min at 220 C, 0.5 bar H2); 
major enantiomer: τR = 19.40 min, minor enantiomer: τR = 20.75 min. Contains 11% (determined by 
GC) of (E)-7-chloro-3,4-epoxyheptan-2-one. 
1H NMR (400 MHz, CD2Cl2) δ 3.47 (td, J = 6.6, 1.5 Hz, 2H, BrCH2), 3.20 (d, J = 2.1 Hz, 1H, 




1.83 (m, 1H, CHHCepoH), 1.73-1.65 (m, 1H, CHHCepoH). 
13C NMR (100 MHz, CD2Cl2): δ 205.2 (C=O), 59.5 (CepoHC(=O)), 57.1 (CepoHCH2), 33.0 (BrCH2), 
30.3 (CH2CepoH), 29.1 (BrCH2CH2), 24.4 (CH3). 
MS (EI) m/z (%) 165 (35), 163 (36), 135 (2), 121 (1), 109 (2), 95 (1), 85 (67), 69 (1), 55 (32), 43 (100), 
27 (15). 




Epoxide (3S,4R)-4g was prepared according to the general procedure. The 
reaction mixture was stirred for 18 h at 50 °C. Purification by flash 
column chromatography (silica gel, 20-30% Et2O in pentane) provided 
the title compound 4g as a colorless oil (113 mg, 440 mol, 88%). The enantiomeric ratio was 
determined after deprotection of the THP ether (cf. epoxide 4l; vide infra). Characterized as mixture of 
THP ether diastereomers. 
1H NMR (500 MHz, CD2Cl2) δ 4.53 (t, J = 3.7 Hz, 1H, O-CH-O), 3.84-3.79 (m, 1H, OCHHTHP), 3.69 
(dt, J = 9.5, 6.6 Hz, 1H, THPOCHH), 3.48-3.43 (m, 1H, OCHHTHP), 3.35 (dt, J = 9.5, 6.6 Hz, 1H, 
THPOCHH), 3.15 (d, J = 1.9 Hz, 1H, CepoHC(=O)), 3.06 (td, J = 5.2, 1.9 Hz, 1H, CepoHCH2), 2.03 (s, 
3H, CH3), 1.83-1.75 (m, 1H, CH2), 1.69-1.39 (m, 13H, CH2). 
13C NMR (125 MHz, CD2Cl2) 205.7 (C=O), 98.9 (O-CH-O), 67.2 (THPOCH2), 62.2 (OCH2, THP), 59.9 
(CepoHC(=O)), 58.0 (CepoHCH2), 31.8 (CH2), 30.9 (OCHCH2), 29.7 (CH2), 26.0 (CH2), 25.7 (CH2), 
25.6 (CH2), 24.3 (CH3), 19.8 (CH2). 
MS (EI-DE) m/z (%) 256 [M+] (trace), 239 (1), 225 (2), 185 (1), 156 (11), 140 (10), 126 (6), 111 (2), 
97 (17), 85 (100), 81 (10), 67 (14), 55 (14), 43 (50), 29 (8). 







(3S,4R)-3,4-Epoxy-6-tert-butyldimethylsilyloxyhexan-2-one ((3S,4R)-4h): Epoxide 4h was prepared 
according to the general procedure. The reaction mixture was stirred for 18 h at 
50 °C. Purification by flash column chromatography (silica gel, 1-10% Et2O in 
pentane) provided the title compound 4h as a colorless oil (88 mg, 359 μmol, 
72%; 98.5:1.5 er). The enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 
column 30 m (80 °C, 1.2 C/min until 125 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); 
major enantiomer: τR = 34.31 min, minor enantiomer: τR = 35.48 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.76 (t, J = 6.3 Hz, 2H, TBSOCH2), 3.22-3.19 (m, 2H, CepoH), 2.03 (s, 
3H, CH3C(=O)), 1.87-1.81 (m, 1H, CepoHCHH), 1.79-1.73 (m, 1H, CepoHCHH), 0.90 (s, 9H, 
Cq(CH3)3), 0.07 (s, 3H, Si(CH3)2), 0.06 (s, 3H, Si(CH3)2). 
13C NMR (125 MHz, CD2Cl2) δ 205.4 (C=O), 59.9 (CepoHC(=O)), 59.6 (TBSOCH2), 55.9 (CH2CepoH), 
35.1 (CH2CepoH), 25.7 (3C, C(CH3)3), 24.3 (CqMe3), 18.2 (CH3C(=O)), 5.7 (2C, Si(CH3)2). 
MS (EI) m/z (%) 220 (1), 205 (2), 199 (4), 187 (11), 169 (1), 157 (100), 143 (8), 131 (2), 115 (7), 99 
(4), 85 (3), 75 (16), 59 (4), 43 (9), 29 (1). 
HRMS (ESI+) calcd for C12H24O3SiNa [(M+Na)+] 267.1386, found 267.1387. 
 
 
(3S,4R)-Ethyl 4,5-epoxy-6-oxoheptanoate ((3S,4R)-4i: Epoxide (3S,4R)-4i was prepared according to 
the general procedure. The reaction mixture was stirred for 24 h at 50 °C. Base 
treatment of the crude product with sodium ethoxide in THF followed by 
purification by flash column chromatography (silica gel, 15-30% Et2O in 
pentane) provided the title compound as a colorless oil (75 mg, 405 μmol, 81%; 98:2 er). The 
enantiomeric ratio was determined by GC using a chiral BGB-176/SE-52 column 30 m (80 °C, 1.2 
C/min until 130 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major enantiomer: τR = 
35.76 min, minor enantiomer: τR = 37.27 min. 
1H NMR (500 MHz, CD2Cl2) δ 4.12 (q, J = 7.2 Hz, 2H, CH2CH3), 3.20 (d, J = 2.1 Hz, 1H, 
CepoHC(=O)), 3.16-3.14 (m, 1H, CepoHCH2), 2.45 (t, J = 7.3 Hz, 2H, CH2CO2Et), 2.03 (s, 3H, 
CH3C(=O)), 2.03-1.97 (m, 1H, CHHCepoH), 1.90-1.82 (m, 1H, CHHCepoH), 1.24 (t, J = 7.3 Hz, 3H, 
CH2CH3). 
13C NMR (125 MHz, CD2Cl2): δ 205.1 (C=O), 172.3 (CO2Et), 60.7 (CH2CH3), 59.8 (CepoHC(=O)), 




MS (EI) m/z (%) 186 [M+] (trace), 143 (13), 125 (1), 115 (29), 99 (15), 85 (30), 69 (7), 55 (13), 43 
(100), 29 (29). 
HRMS (CI-FE) calcd for C9H15O4 [(M+H)+] 187.0972, found 187.0970. 
 
 
(3S,4R)-7-Oxo-3,4-epoxy-2-octanone ((3S,4R)-4j): Epoxide (3S,4R)-4j was prepared according to the 
general procedure. The reaction mixture was stirred for 24 h at 50 °C. Base 
treatment of the crude product was omitted. Purification by flash column 
chromatography (silica gel, 10-30% Et2O in pentane) provided the title compound 
as a colorless oil (31 mg, 202 μmol, 40%; 98.5:1.5 er). The enantiomeric ratio was determined by GC 
using a chiral BGB-176/SE-52 column 30 m (80 °C, 1.2 C/min until 120 C, 20 C/min until 220 C, 
10 min at 220 C, 0.5 bar H2); major enantiomer: τR = 29.03 min, minor enantiomer: τR = 30.33 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.17 (d, J = 1.8 Hz, 1H, CHepoC(=O)), 3.12-3.10 (m, 1H, CepoHCH2), 
2.56 (t, J = 7.0 Hz, 2H, CH2C(=O)), 2.13 (s, 3H, CH2C(=O)CH3), 2.01 (s, 3H, CHepoC(=O)CH3), 2.00-
1.93 (m, 1H, CHHCepoH), 1.78-1.72 (m, 1H, CHHCepoH). 
13C NMR (125 MHz, CD2Cl2) δ 207.1 (CH2C=O), 205.6 (CepoHC=O), 60.2 (CepoHC(=O)), 57.3 
(CH2CepoH), 39.2 (CH2C(=O)), 30.0 (CH3C(=O)CH2), 25.9 (CH2CepoH), 24.7 (CH3C(=O)CHepo). 
 
 
(4S,5R)-4,5-Epoxy-3-hexanone ((4S,5R)-4o): Epoxide (4S,5R)-4o was prepared according to the 
general procedure. The reaction mixture was stirred for 12 h at 50 °C. Purification by 
flash column chromatography (silica gel, 1-20% Et2O in pentane) provided the title 
compound 4o as a colorless oil (63 mg, 552 μmol, 55% (reduced yield due to the high 
volatility of 4o); 98.5:1.5 er). The enantiomeric ratio was determined by GC using a chiral BGB-
178/OV-1701 30 m column (60 °C, 1.0 C/min until 70 C 20 C/min until 220 C, 10 min at 220 C, 
0.4 bar H2); major enantiomer: τR = 12.45 min, minor enantiomer: τR = 12.74 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.15 (d, J = 2.0 Hz, 1H, CHepoC(=O)), 3.10 (qd, J = 5.1, 2.0 Hz, 1H, 
CH3CHepo), 2.44 (dq, J = 18.3, 7.4 Hz, 1H, CHH), 2.31 (dq, J = 18.5, 7.2 Hz, 1H, CHH), 1.37 (d, J = 
5.2 Hz, 3H, CH3CHepo), 1.00 (t, J = 7.3 Hz, 3H, CH2CH3). 
13C NMR (125 MHz, CD2Cl2) δ 208.3 (C=O), 60.9 (CHepoC(=O)), 55.0 (CH3CHepo), 31.2 (CH2), 17.9 
(CH3CHepo), 7.3 (CH2CH3). 




(42), 39 (18), 29 (100), 27 (26). 
HRMS (EI-FE) calcd for C6H10O2 [M+] 114.0680, found 114.0681. 
 
 
(4S,5R)-4,5-Epoxy-3-tetradecanone ((4S,5R)-4p): Epoxide (4S,5R)-4p was prepared according to the 
general procedure. The reaction mixture was stirred for 24 h at 50 
°C. Purification by flash column chromatography (silica gel, 1-20% 
Et2O in pentane) provided the title compound 4p as a colorless oil 
(185 mg, 817 μmol, 82%; 99:1 er). The enantiomeric ratio was determined by GC using a chiral 
Lipodex E column 25 m (100 °C, 1.2 C/min until 180 C, 18 C/min until 220 C, 5 min at 220 C, 
0.5 bar H2); major enantiomer: τR = 30.53 min, minor enantiomer: τR = 29.18 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.19 (d, J = 2.0 Hz, 1H, CHepoC(=O)), 3.01 (td, J = 5.5, 1.9 Hz, 1H, 
CH2CHepo), 2.44 (dq, J = 18.3, 7.3 Hz, 1H, CHHC(=O)), 2.32 (dq, J = 18.4, 7.2 Hz, 1H, CHHC(=O)), 
1.62-1.55 (m, 2H, CH2CHepo), 1.48-1.41 (m, 2H, CH2CH2CHepo), 1.35-1.26 (m, 12H, (CH2)6CH3), 1.01 
(t, J = 7.2 Hz, 3H, C(=O)CH2CH3), 0.88 (t, J = 7.0 Hz, 3H, (CH2)8CH3). 
13C NMR (125 MHz, CD2Cl2) δ 208.4 (C=O), 60.0 (CHepoC(=O)), 59.0 (CH2CHepo), 32.4 (2C, CH2), 
31.2 (CH2), 30.0 (2C, CH2), 29.8 (2C, CH2), 26.3 (CH2), 23.2 (CH2), 14.4 ((CH2)8CH3), 7.4 
(C(=O)CH2CH3). 
MS (EI-DE) m/z (%) 226 [M+] (2), 197 (1), 179 (1), 169 (2), 151 (3), 127 (1), 109 (4), 99 (43), 95 (11), 
81 (7), 69 (6), 57 (100), 41 (15), 29 (26). 
HRMS (ESI+) calcd for C14H26NaO2 [(M+Na)+] 249.1826, found 249.1825. 
 
 
(7S,8R)-7,8-Epoxy-6-tridecanone ((7S,8R)-4l): Epoxide (7S,8R)-4l was prepared according to the 
general procedure. The reaction mixture was stirred for 24 h at 50 °C. 
Purification by flash column chromatography (silica gel, 1-20% Et2O 
in pentane) provided the title compound 4l as a colorless oil (161 mg, 
758 μmol, 76%; 99:1 er). The enantiomeric ratio was determined by GC using a chiral G-TA column 
30 m (80 °C, 1.0 C/min until 125 C, 20 C/min until 180 C, 10 min at 180 C, 0.9 bar H2); major 
enantiomer: τR = 44.18 min, minor enantiomer: τR = 43.42 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.18 (d, J = 2.0 Hz, 1H, CHepoC(=O)), 3.01 (td, J = 5.5, 2.0 Hz, 1H, 




CHHC(=O)), 1.62-1.52 (m, 4H, CH2), 1.48-1.42 (m, 2H, CH2), 1.34-1.23 (m, 8H, CH2), 0.91-0.87 (m, 
6H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 208.1 (C=O), 60.1 (CHepoC(=O)), 58.9 (CH2CHepo), 37.8 (CH2C(=O)), 
32.4 (CH2), 32.0 (CH2), 31.9 (CH2), 26.0 (CH2), 23.4 (CH2), 23.1 (CH2), 23.0 (CH2), 14.3 (CH3), 14.2 
(CH3). 
MS (EI-DE) m/z (%) 212 [M+] (6), 169 (1), 156 (3), 141 (58), 125 (4), 112 (7), 99 (98), 95 (12), 82 (8), 
71 (76), 55 (18), 43 (100), 29 (30). 
HRMS (ESI+) calcd for C13H24NaO2 [(M+Na)+] 235.1670, found 235.1668. 
 
 
(5S,6R)-5,6-Epoxy-2-methyl-4-undecanone ((5S,6R)-4m): Epoxide (5S,6R)-4m was prepared 
according to the general procedure. 20 mol% of catalyst [1a • 2 TFA] was 
used under otherwise identical conditions. The reaction mixture was stirred 
for 48 h at 50 °C. Base treatment of the crude product was omitted. 
Purification by flash column chromatography (silica gel, 1-20% Et2O in pentane) provided the title 
compound 4m as a colorless oil (161 mg, 812 μmol, 81%; >99.5:0.5 er). The enantiomeric ratio was 
determined by GC using a chiral G-TA column 30 m (80 °C, 1.0 C/min until 115 C, 20 C/min until 
180 C, 10 min at 180 C, 0.9 bar H2); major enantiomer: τR = 30.89 min, minor enantiomer: τR = 30.09 
min. 
1H NMR (500 MHz, CD2Cl2) δ 3.16 (d, J = 2.0 Hz, 1H, CHepoC(=O)), 2.99 (td, J = 5.5, 1.9 Hz, 1H, 
CH2CHepo), 2.31 (dd, J = 16.0, 6.0 Hz, 1H, CHHi-Pr), 2.15 (dd, J = 16.2, 7.1 Hz, 1H, CHHi-Pr), 2.11 
(hept, J = 6.5 Hz, 1H, CHMe2), 1.64-1.55 (m, 2H, CH2CHepo), 1.48-1.42 (m, 2H, CH2CH2CHepo), 1.34-
1.30 (m, 4H, (CH2)2CH3), 0.92-0.88 (m, 9H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 207.7 (C=O), 60.2 (CHepoC(=O)), 58.7 (CH2CHepo), 46.7 (CH2i-Pr), 
32.4 (CH2), 32.0 (CH2), 26.0 (CH2), 24.6 (CHMe2), 23.1 (CH2), 22.9 (CH(CH3)2), 22.8 (CH(CH3)2), 
14.3 ((CH2)4CH3). 
MS (EI-DE) m/z (%) 198 [M+] (1), 183 (1), 155 (1), 141 (2), 127 (33), 113 (5), 95 (6), 85 (75), 69 (5), 
57 (100), 41 (30), 29 (18). 







(4S,5R)-4,5-Epoxy-2-Methyl-3-hexanone ((4S,5R)-4n): Epoxide (4S,5R)-4n was prepared according 
to the general procedure. 20 mol% of catalyst [1a • 2 TFA] was used under otherwise 
identical conditions. The reaction mixture was stirred for 48 h at 50 °C. Purification by 
flash column chromatography (silica gel, 2-7% Et2O in pentane) provided the title 
compound as a colorless liquid (77 mg, 604 μmol, 60% (reduced yield due to the high volatility of 4n); 
96.5:3.5 er). THF (5 mL) was used as solvent for the base treatment with aqueous 1N NaOH. The 
enantiomeric ratio was determined by GC using a chiral Lipodex G column 25 m (50 °C, 1.2 C/min 
until 110 C, 18 C/min until 230 C, 5 min at 230 C, 0.5 bar H2); major enantiomer: τR = 8.24 min, 
minor enantiomer: τR = 8.76 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.25 (d, J = 1.9 Hz, 1H, CepoHC(=O)), 3.03 (dq, J = 5.1, 2.0 Hz, 1H, 
MeCepoH), 2.70 (hept, J = 6.9 Hz, 1H, CHMe2), 1.38 (d, J = 5.0 Hz, 3H, CH3CepoH), 1.09 (d, J = 7.3 
Hz, 3H, CH(CH3)2), 1.06 (d, J = 6.9 Hz, 3H, CH(CH3)2). 
13C NMR (125 MHz, CD2Cl2) δ 210.5 (C=O), 59.5 (CepoHC(=O)), 55.0 (MeCepoH), 36.7 (CHMe2), 
18.3 (CH3CepoH), 17.7 (CH(CH3)2), 17.4 (CH(CH3)2). 
GC-MS (GC-EI) m/z (%) 128 [M+] (1), 113 (10), 85 (16), 83 (2), 71 (41), 69 (4), 58 (21), 55 (6), 45 
(5), 43 (100), 41 (31), 39 (10), 29 (26). 
HRMS (EI-FE) calcd for C7H12O2 [M+] 128.0836, found 128.0837. 
 
Studies on Hydroxy-Group Containing Substrates 
 
Other substrates containing unprotected hydroxy groups were also examined. However, depending on 
the chain length separating the hydroxy group, various side reactions were encountered. Substrate 2t 
was found to undergo a competitive intramolecular oxa-Michael reaction, furnishing racemic 
tetrahydrofuran in quantitative yield (a). Substrate 2u containing a shorter linker was found to undergo 
elimination as the major side reaction, giving dienone in addition to the expected products. A reliable 
route to epoxide products containing a hydroxyl moiety was found to be the epoxidation of THP 
protected substrates (e.g. 2g, Table 2 entry 13), followed by a facile deprotection with ceric ammonium 
nitrate (CAN) without any loss of enantioselectivity (c).4 
 
                                                 
4 (a) Bailey, M.; Staton, I.; Ashton, P. R.; Markó, I. E.; Ollis, W. D. Tetrahedron: Asymmetry 1991, 2, 495; (b) Maulide, N.; Vanherck, J.-C.; Gautier, A.; 
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(3S,4R)-3,4-Epoxy-9-hydroxy-2-nonanone (4k): To a vial containing THP ether 4g (40.0 mg, 156 
μmol) dissolved in acetonitrile (1.6 mL) and borate buffer (pH = 8) (1.6 
mL), was added with stirring CAN (2.7 mg, 4.68 μmol, 3 mol%). After 3 h 
at 60 °C, the mixture was cooled to room temperature, diluted with water (4 
mL) and repeatedly extracted with Et2O (3×10 mL). The combined organic layers were washed with 
brine, dried over Na2SO4, filtered and concentrated under reduced pressure. After purification of the 
crude product by flash column chromatography (silica gel, 5-30% Et2O in CH2Cl2) the alcohol 4g (24 
mg, 138 μmol, 88%; 98:2 er) was obtained as a colorless oil. The enantiomeric ratio was determined by 
GC using a chiral Ivadex 1 column 25 m (80 °C, 1.0 C/min until 155 C, 20 C/min until 220 C, 10 
min at 320 C, 0.6 bar H2); major enantiomer: τR = 60.50 min, minor enantiomer: τR = 61.21 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.60 (t, J = 6.5 Hz, 2H, CH2OH), 3.15 (d, J = 1.6 Hz, 1H, CepoHC=O), 
3.06 (td, J = 5.6, 1.6 Hz, 1H, CH2CepoH), 2.03 (s, 3H, CH3), 1.69-1.37 (m, 9H, CH2 and OH). 
13C NMR (125 MHz, CD2Cl2) 205.7 (C=O), 62.6 (CH2OH), 59.9 (CepoHC(=O)), 58.0 (CH2CepoH), 
32.7 (CH2), 31.8 (CH2), 25.7 (CH2), 25.5 (CH2), 24.3 (CH3). 
MS (EI) m/z (%) 129 (1), 111 (2), 99 (3), 93 (4), 85 (36), 81 (13), 67 (8), 55 (31), 43 (100), 39 (9), 31 
(18). 
HRMS (CI-DE) calcd for C9H17O3 [(M+H)+] 173.1176, found 173.1178. 
 
 
The tetrahydrofuran-derivative S-15 has been described in the literature.  
 
                                                 





Further Studies on the Hydroperoxidation and Epoxidation of Enones 
 
This hypothesis is further supported by the formation of deconjugated enones iso-2b and iso-2q in 
the presence of catalytic salt [1a·2 TFA]. The observation that epoxide trans-4b was formed from (Z)-
2b with a slightly lower optical purity than in the reaction of the corresponding (E)-enone (Scheme 3) 
may be rationalized by a minor contribution of conjugate addition of hydrogen peroxide to the (Z)-
configured substrate which possibly delivers the opposite enantiomeric product. 
 
 We briefly tested β,β-disubstituted enones in the epoxidation, including the citral-derived enone 
S-3 and the symmetrically substituted mesityl oxide S-6. In both cases, incomplete conversion was 
observed due to considerably lower reactivity of these substrates. The conversion could be improved by 
higher reaction temperatures and longer times, although at the expense of enantioselectivity in the case 
of 10. Under the more forcing conditions, an E/Z mixture of enone S-36 afforded peroxyhemiketal S-4 
with a 56% yield and moderate enantioselectivity (78:22 er) along with epoxide S-5, which was formed 
with good diastereoselectivity and enantioselectivity for the major diastereomer, albeit a very low yield 
(Scheme 8a). Intriguingly, the symmetrically β,β-disubstituted mesityl oxide S-6 afforded an 
enantioenriched epoxide S-8 (81:19 er) along with the peroxyhemiketal S-7, suggesting that the 
                                                 




epoxide formation from the initially formed achiral hydroperoxidation product S-7 is under significant 
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1-(3,3-dimethyloxiran-2-yl)ethanone (S-8): The epoxyketone S-87 has been described in the literature. 
The enantiomeric ratio of epoxyketone S-8 was determined by GC using a chiral 
BGB-176/SE52 column 30 m (60 C, 1 C/min until 85 C, 20 C/min until 220 °C, 10 
min at 220 C, 0.4 bar H2); major enantiomer: R = 7.71 min, minor enantiomer: R = 
7.39 min. 
 
Hydroperoxidation and Epoxidation of 4,8-Dimethylnona-3,7-dien-2-one (S-3) 
 
The general procedure for the catalytic asymmetric hydroperoxidation of ,-unsaturated ketones 2 
was adapted to ,-disubstituted enone 7 by using 20 mol% catalyst [1a • 2 TFA] and 3 equiv. of 
hydrogen peroxide (50 wt%) and the reaction temperature was increased to 70 °C. 
 
3,5-Dimethyl-5-(4-methylpent-3-enyl)-1,2-dioxolan-3-ol (S-4). The title 
compound was isolated after 48 h. Purification by flash column chromatography 
(silica gel; 5-10% Et2O in pentane) as a colorless oil (56 mg, 280 mol, 56%; 
78:22 er). The enantiomeric ratio was determined after converting peroxyhemi-
ketal S-4 into the corresponding epoxide S-5 (1:1 E/Z). The enantiomers were analyzed by GC using a 
                                                 





chiral BGB-176/SE-52 column 30 m (60 °C, 0.5 C/min until 105 C, 20 C/min until 220 C, 10 min 
at 320 C, 0.4 bar H2); (E)- S-5: major enantiomer: R = 81.04 min, minor enantiomer: R = 80.47 min; 
(Z)- S-5: major enantiomer: R = 71.83 min, minor enantiomer: R = 73.16 min. Characterized as a 
mixture of hemiketal epimers. 
1H NMR (500 MHz, CDCl3) δ 5.10-5.06 (m, 2H, =CHCH2), 2.93 (br s overlapped, 1H, OH), 2.90 (br s 
overlapped, 1H, OH), 2.53 (d, 1H, J = 12.8 Hz, CHHcycl.), 2.44 (s, 2H, CH2, cycl.), 2.31 (d, 1H, J = 12.7 
Hz, CHHcycl.), 2.09-1.94 (m, 4H, =CHCH2), 1.73 (ddd, 1H, J = 13.8, 11.4, 5.3 Hz, =CHCH2CHH), 
1.68-1.64 (m overlapped, 2H, =CHCH2CH2), 1.66 (s overlapped, 6H, CqolCH3), 1.59 (s, 6H, CqolCH3), 
1.54-1.48 (m overlapped, 1H, =CHCH2CHH), 1.53 (s overlapped, 3H, CqOHCH3), 1.51 (s overlapped, 
3H, CqOHCH3), 1.34 (s, 3H, CqalCH3), 1.33 (s, 3H, CqalCH3). 
13C NMR (125 MHz, CDCl3) δ 132.3 (Cqol), 131.9 (Cqol), 123.8 (CHol), 123.5 (CHol), 105.9 (CqOH), 
105.7 (CqOH), 86.3 (Cqal), 85.9 (Cqal), 57.7 (CH2, cycl.), 57.1 (CH2, cycl.), 39.8 (CHolCH2CH2), 37.9 
(CHolCH2CH2), 25.7 (2C, Cqol(CH3)2), 25.2 (CH3Cqal), 23.5 (CHolCH2), 23.2 (CH3CqOH), 23.1 
(CH3CqOH), 23.0 (CHolCH2), 22.3 (CH3Cqal), 17.7 (Cqol(CH3)2), 17.6 (Cqol(CH3)2). 
MS (EI-DE) m/z (%) 185 (1), 167 (1), 139 (1), 123 (2), 109 (5), 97 (3), 82 (16), 69 (32), 55 (22), 43 
(100), 29 (9). 
HRMS (ESI+) calcd for C11H20NaO3 [(M+Na)+] 223.1307, found 223.1305. 
 
 
3,4-Epoxy-4,8-dimethyl-7-nonen-2-one (S-5): Epoxy ketone S-5 was obtained as a colorless oil (9.1 
mg, 50 μmol, 10% (88:12 dr((E)- S-5/(Z)- S-5); 95.5:4.5 er((E)- S-5), 59.5:40.5 
er((Z)- S-5)). Purification by flash column chromatography (silica gel; 1-10% 
Et2O in pentane) provided pure samples of (E)- and (Z)-isomers of epoxy ketone 
9. The enantiomeric ratio was determined by GC using a chiral BGB-176/SE-52 column 30 m (60 °C, 
0.5 C/min until 105 C, 20 C/min until 220 C, 10 min at 320 C, 0.4 bar H2); (E)- S-5: major 
enantiomer: τR = 81.25 min, minor enantiomer: τR = 80.71 min; (Z)- S-5: major enantiomer: τR = 73.29 
min, minor enantiomer: τR = 72.18 min. The analytical data were identical in all respects to those 
previously reported.8  
 
 
                                                 
8 (a) H. Usuda, A. Kuramochi, M. Kanai, M. Shibasaki, Org. Lett. 2004, 6, 4387; (b) T. Sato, T. Kikuchi, H. Tsujita, A. 
Kaetsu, N. Sootome, K.-i. Nishida, K. Tachibana, E. Murayama, Tetrahedron 1991, 47, 32813304; (c) M. E. Scheller, B. 









1H NMR (500 MHz, CD2Cl2) δ 5.12 (t, J = 7.1 Hz, 1H, =CHCH2), 3.40 (s, 1H, 
CepoH), 2.17 (s, 3H, CH3C(=O)), 2.12 (app. q, 2H, =CHCH2), 1.77 (dd, J = 14.2, 
7.1 Hz, 1H, CHHCqepo), 1.70 (s, 3H, CH3Cqol), 1.62 (s, 3H, CH3Cqol), 1.56-1.49 (m, 1H, CHHCqepo), 
1.20 (s, 3H, CH3Cqepo). 
13C NMR (125 MHz, CD2Cl2) δ 204.1 (C=O), 132.8 (Cqol), 123.4 (CHol), 65.2 (CepoH), 63.4 (Cqepo), 
38.5 (CHolCH2), 28.2 (CH3C(=O)), 25.8 (CH3), 24.1 (CH2Cqepo), 17.7 (CH3), 16.1 (CH3). 
MS (EI-DE) m/z (%) 182 [M+] (1), 164 (2), 149 (4), 139 (3), 121 (7), 109 (43), 99 (23), 82 (45), 69 
(56), 67 (24), 55 (18), 43 (100), 27 (10). 




1H NMR (500 MHz, CD2Cl2) δ 5.02 (t, J = 7.2 Hz, 1H, =CHCH2), 3.37 (s, 1H, 
CepoH), 2.19 (s, 3H, CH3), 2.14-1.98 (m, 2H, =CHCH2), 1.66 (s, 3H, CH3Cqol), 
1.59 (s, 3H, CH3Cqol), 1.57-1.42 (m, 2H, CH2Cqepo), 1.40 (s, 3H, CH3Cqepo). 
13C NMR (125 MHz, CD2Cl2) δ 204.0 (C=O), 132.8 (Cqol), 123.3 (CHol), 66.0 (CepoH), 64.0 (Cqepo), 


















Catalyst salt [1a • 2 TCA] was prepared in situ by the addition of 9-amino(9-deoxy)epiquinine (1a; 
32.3 mg, 0.1 mmol, 10 mol%) to a solution of trichloroacetic acid (32.6 mg, 0.2 mmol, 20 mol%) in 
dioxane (4 mL). Then, enone 2 (1.0 mmol, 1.0 equiv) was added, and 20 minutes later, aqueous 
hydrogen peroxide (30 wt%, 304 μL, 3.0 mmol, 3 equiv). After 36-48 h of stirring at 32°C, 
triethylphosphite (519 μL, 3.0 mmol, 3 equiv) was added dropwise at 0 °C and the reaction mixture 
was stirred for 10 h at room temperature. Additional triethylphosphite (346 μL, 2 mmol, 2 equiv) was 
added and the reaction was further stirred until TLC analysis indicated complete reduction of the 
peroxyhemiketals (2 h). The reaction mixture was repeatedly extracted with Et2O (325 mL) and the 
combined organic phases were washed with brine, dried (Na2SO4), and filtered. Removal of the 
volatiles under reduced pressure furnished the crude product, which was subjected to flash column 
chromatography (silica gel, eluent: Et2O-pentane) to afford the corresponding pure aldol-type product 
6. 
 
Catalytic hydrogenation procedure: General hydroperoxidation procedure for enones 2 using 0.5 
mmol substrate 2a was followed. Upon the standard aqueous workup, crude 1H NMR analysis revealed 
100% conversion and a 76:24 ratio of hydroperoxide 3a and epoxide 4a, respectively. The crude 
product mixture was dissolved in MeOH (25 mL), and Pd/C (15% wt, 11.6 mg) was added. The flask 
was equipped with a H2 balloon, purged with H2 5 times and the reaction mixture was stirred under 1 
atm. of H2 for 4 h at room temperature, upon which all of the starting hydroperoxide was consumed. 
The crude reaction mixture was filtered through a pad of Celite and extracted with diethyl ether (3 x 10 




Evaporation of the solvent under reduced pressure followed by flash column chromatography (20% 
Et2O in pentane) afforded pure 6a as a colourless oil (52.2 mg, 0.30 mmol, 61%, 97:3 er) along with 
unchanged epoxide 4a (yield not determined). 
 
Scope of Optically Active Aldol Products 6 
 
 
(R)-4-Hydroxy-2-decanone ((R)-6a): Aldol product (R)-6a was prepared according to the general 
procedure. The reaction mixture was stirred for 36 h at 32 °C followed by 
in situ reduction with triethylphosphite. Purification of the crude product by 
flash column chromatography (silica gel, 10-50% Et2O in pentane) provided 
the title compound as a colorless oil (102 mg, 592 μmol, 59%; 97:3 er). The enantiomeric ratio was 
determined by GC using a chiral G-TA column 30 m (80 °C, 1.0 °C/min until 115 °C, 20 °C/min, until 
180 °C, 10 min at 320 °C, 0.9 bar H2); major enantiomer: τR = 31.94 min, minor enantiomer: τR = 31.38 
min. 
1H NMR (500 MHz, CD2Cl2) δ 4.00-3.95 (m, 1H, CH(OH)), 2.81 (br s, 1H, OH), 2.61 (dd, J = 17.5, 
2.7 Hz, 1H, C(=O)CHH), 2.48 (dd, J = 17.5, 9.3 Hz, 1H, C(=O)CHH), 2.14 (s, 3H, C(=O)CH3), 1.46-
1.35 (m, 2H, CH2CH2CH(OH)), 1.34-1.26 (m, 8H, CH3(CH2)4), 0.88 (t, J = 6.9 Hz, 3H, CH3CH2). 
13C NMR (125 MHz, CD2Cl2) δ 210.3 (C(=O)), 67.9 (CH(OH)), 50.3 (C(=O)CH2), 36.9 
(CH2CH2CH(OH)), 32.2 (CH2), 30.9 (C(=O)CH3), 29.6 (CH2), 25.8 (CH2), 23.0 (CH2), 14.2 
((CH2)5CH3). 
MS (EI-DE) m/z (%) 172 [M+] (trace), 154 (1), 139 (1), 125 (1), 111 (1), 96 (6), 87 (44), 84 (2), 69 (5), 
55 (17), 43 (100), 29 (11). 
HRMS (CI-FE, NH3) calcd for C10H24NO2 [(M+NH4)+] 190.1805, found 190.1807. 
 
 
(R)-4-Hydroxy-6-phenyl-2-hexanone ((R)-6b): Aldol product (R)-6b was prepared according to the 
general procedure. The reaction mixture was stirred for 36 h at 32 °C followed 
by in situ reduction with triethylphosphite. Purification of the crude product by 
flash column chromatography (silica gel, 10-60% Et2O in pentane) provided the 
title compound as a colorless oil (102 mg, 531 μmol, 53%; 96.5:3.5 er). The enantiomeric ratio was 










enantiomer: τR = 16.75 min, minor enantiomer: τR = 15.41 min. 
Optical rotation [α]25D = 14.8 (c = 1.1, CHCl3, 96.5:3.5 er (R)) [Lit.9: (R)-16b, [α]rtD = 12.0 (c = 1.1, 
CHCl3, 94:6 er]. 
1H NMR (500 MHz, CD2Cl2) δ 7.29-7.26 (m, 2H, CHar, m), 7.21-7.16 (m, 3H, CHar, o, p), 4.03-3.97 (m, 
1H, CH(OH)), 2.95 (d, J = 3.5 Hz, 1H, OH), 2.81-2.75 (m, 1H, PhCHH), 2.69-2.64 (m, 1H, PhCHH), 
2.63 (dd, J = 17.7, 2.9 Hz, 1H, C(=O)CHH), 2.53 (dd, J = 17.7, 9.2 Hz, 1H, C(=O)CHH), 2.14 (s, 3H, 
CH3), 1.80-1.73 (m, 1H, PhCH2CHH), 1.70-1.64 (m, 1H, PhCH2CHH). 
13C NMR (125 MHz, CD2Cl2) δ 210.2 (C(=O)), 142.5 (Cqar), 128.8 (2C, CHar, o), 128.7 (2C, CHar, m), 
126.1 (CHar, p), 67.2 (CH(OH)), 50.3 (C(=O)CH2), 38.5 (PhCH2CH2), 32.0 (PhCH2), 30.9 (CH3). 
MS (EI-DE) m/z (%) 192 (2), 174 (34), 159 (4), 131 (29), 117 (17), 104 (17), 91 (73), 87 (9), 77 (10), 
65 (11), 58 (4), 51 (6), 43 (100), 39 (6), 27 (4). 
HRMS (CI-FE, NH3) calcd for C12H20NO2 [(M+NH4)+] 210.1493, found 210.1494. 
 
 
(R)-4-Hydroxy-6-methyl-2-heptanone ((R)-6c): Aldol product (R)-6c was prepared according to the 
general procedure. The reaction mixture was stirred for 36 h at 32 °C followed by 
in situ reduction with triethylphosphite. Purification of the crude product by flash 
column chromatography (silica gel, 10-40% Et2O in pentane) provided the title 
compound as a colorless oil (81 mg, 562 μmol, 56%; 96.5:3.5 er). The enantiomeric ratio was 
determined by HPLC using a chiral Chiralpak IA column (10% i-PrOH in heptane, 0.5 mL/min); major 
enantiomer: τR = 11.84 min, minor enantiomer: τR = 11.39 min. 
1H NMR (500 MHz, CD2Cl2) δ 4.10-4.04 (m, 1H, CH(OH)), 2.84 (br s, 1H, OH), 2.58 (dd, J = 17.7, 
2.9 Hz, 1H, CHHC(=O)), 2.47 (dd, J = 17.7, 9.2 Hz, 1H, CHHC(=O)), 2.14 (s, 3H, C(=O)CH3), 1.80-
1.72 (m, 1H, CHMe2), 1.41 (ddd, J = 13.6, 9.1, 5.6 Hz, 1H, i-PrCHH), 1.12 (ddd, J = 13.4, 8.6, 4.5 Hz, 
1H, i-PrCHH), 0.90 (d, J = 6.6 Hz, 6H, CH(CH3)2). 
13C NMR (125 MHz, CD2Cl2) δ 210.3 (C(=O)), 66.0 (CH(OH)), 50.8 (C(=O)CH2), 46.0 (i-PrCH2), 
30.9 (C(=O)CH3), 24.7 (CHMe2), 23.4 (CH(CH3)2), 22.1 (CH(CH3)2). 
MS (EI-DE) m/z (%) 144 [M+] (trace), 126 (9), 111 (10), 108 (25), 93 (5), 87 (100), 83 (7), 69 (17), 58 
(20), 43 (90), 29 (5). 
HRMS (CI-FE, NH3) calcd for C8H20NO2 [(M+NH4)+] 162.1494, found 162.1494. 
                                                 






(S)-4-Cyclohexyl-4-hydroxy-2-butanone ((S)-6d): Aldol product (S)-6d was prepared according to 
the general procedure. The reaction mixture was stirred for 48 h at 32 °C followed 
by in situ reduction with triethylphosphite. Purification of the crude product by flash 
column chromatography (silica gel, 10-40% Et2O in pentane) provided the title 
compound as a colorless oil (78 mg, 458 μmol, 46%; 96:4 er). The enantiomeric ratio was determined 
by HPLC using a chiral Chiralpak IA column (10% i-PrOH in heptane, 0.5 mL/min); major 
enantiomer: τR = 14.65 min, minor enantiomer: τR = 13.19 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.78-3.73 (m, 1H, CH(OH)), 2.77 (br s, 1H, OH), 2.61 (dd, J = 17.3, 
2.7 Hz, 1H, CHHC(=O)), 2.49 (dd, J = 17.4, 9.9 Hz, 1H, CHHC(=O)), 2.15 (s, 3H, CH3), 1.84-1.79 
(m, 1H, CH2), 1.77-1.71 (m, 2H, CH2), 1.68-1.61 (m, 2H, CH2), 1.35-1.27 (m, 1H, CHcycl.), 1.26-1.10 
(m, 3H, CH2), 1.07-0.94 (m, 2H, CH2). 
13C NMR (125 MHz, CD2Cl2) δ 210.6 (C(=O)), 72.0 (CH(OH)), 47.5 (C(=O)CH2), 43.4 (CHcycl.), 30.9 
(CH3), 29.2 (CH2), 28.5 (CH2), 26.9 (CH2), 26.6 (CH2), 26.5 (CH2). 
MS (EI-DE) m/z (%) 170 [M+] (trace), 152 (3), 137 (2), 112 (5), 109 (3), 95 (12), 87 (80), 83 (6), 67 
(14), 58 (9), 55 (26), 43 (100), 39 (9), 29 (10). 
HRMS (CI-FE, NH3) calcd for C10H22NO2 [(M+NH4)+] 188.1650, found 188.1651. 
 
 
4-Hydroxyoct-7-en-2-one (6e): Aldol product 6e was prepared according to the general procedure. 
The reaction mixture was stirred for 36 h at 32 °C followed by in situ reduction 
with triethylphosphite. Purification of the crude product by flash column 
chromatography (silica gel, 10-40% Et2O in pentane) provided the title compound 
as a colorless oil (78 mg, 549 μmol, 55%; 96:4 er). The enantiomeric ratio was determined by HPLC 
using a chiral Chiralpak IA column (10% i-PrOH in heptane, 0.5 mL/min); major enantiomer: τR = 
13.35 min, minor enantiomer: τR = 12.51 min. 
1H NMR (500 MHz, CD2Cl2) δ 5.84 (dddd, J = 17.0, 9.3, 7.7, 5.9 Hz, 1H, CH2=CH), 5.04 (app. dq, 
1H, J = 17.2, 1.8 Hz, CHtransH=CH), 4.96 (app. dq, 1H, J = 9.4, 1.5 Hz, 1H, CHHcis=CH), 4.03-3.98 
(m, 1H, CH(OH)), 2.86 (d, J = 3.8 Hz, 1H, OH), 2.61 (dd, J = 17.3, 3.0 Hz, 1H, CHHC(=O)), 2.50 (dd, 
J = 17.7, 9.3 Hz, 1H, CHHC(=O)), 2.24-2.07 (m, 2H, CH2), 2.14 (s, 3H, CH3), 1.57-1.42 (m, 2H, 
CH2). 







50.3 (C(=O)CH2), 35.9 (=CHCH2CH2), 30.9 (CH3), 30.1 (=CHCH2). 
MS (EI-DE) m/z (%) 142 [M+] (trace), 127 (1), 124 (2), 109 (4), 100 (7), 94 (3), 87 (11), 81 (6), 67 (8), 
58 (10), 43 (100), 41 (16), 29 (10). 
HRMS (CI-FE, NH3) calcd for C8H18NO2 [(M+NH4)+] 160.1337, found 160.1338. 
 
 
Organoselenium-Mediated Reductive Cleavage of Epoxide 4m 
 
 To access the aldol-like products 6 from enone substrates that do not form peroxyhemiketals but 
only furnish epoxides, we found that reductive epoxide cleavage with in situ generated phenyl selenide 
represents an excellent alternative strategy.10 Thus, epoxide 4m could be reduced to the corresponding 





 (R)-6-hydroxy-2-methylundecan-4-one (S-9). Under argon, acetic acid (15 μL, 0.075 mmol, 0.5 
equiv) was added to an ethanolic solution of sodium phenylselenide, 
prepared by the reduction of diphenylselenide (52.5 mg, 0.225 mmol, 1.5 
equiv) with sodium borohydride (17 mg, 0.45 mmol, 3.0 equiv) in ethanol 
(1 mL), and the mixture was stirred for five minutes at room temperature. 
The resulting solution was added at once to a solution of ,-epoxy ketone 4m (30 mg, 0.15 mmol, 1.0 
equiv) in ethanol (0.6 mL) at 0 °C. After five minutes at room temperature, the reaction mixture was 
diluted with EtOAc and washed with brine. The aqueous layer was extracted with EtOAc twice, and the 
combined organic layers were washed with brine, dried over Na2SO4, filtered and concentrated under 
reduced pressure. Purification of the crude product by flash column chromatography (silica gel, 0-20% 
Et2O in pentane) provided the corresponding -hydroxy ketone S-9 as a colorless oil (27.0 mg, 0.135 
mmol, 89%; 98.5:1.5 er). The enantiomeric ratio was determined by GC using a chiral Lipodex-G 
                                                 
10 For the reduction of α,β-epoxy ketones to aldols using selenide compounds, see for example: (a) Inokuchi, T.; Kusumoto, 
M.; Torii, S.; J. Org. Chem. 1990, 55, 1548; (b) Engman, L.; Stern, D.; J. Org. Chem. 1994, 59, 5179; (c) Miyashita, M.; 




column 25 m (isocratic at 85C, 0.5 bar H2); major enantiomer: τR = 96.02 min, minor enantiomer: τR = 
97.99 min. 
1H NMR (500 MHz, CDCl3) δ 4.02 (c. m, 1H), 3.08 (br s, 1H), 2.57 (dd, J = 17.6 Hz, J = 2.6 Hz, 1H), 
2.45 (dd, J = 17.6 Hz, J = 9.2 Hz, 1H), 2.30 (d, J = 7.0 Hz, 2H), 2.14 (sept, J = 6.8 Hz, 1H), 1.54-1.22 
(m, 8H), 0.92 (s, 3H), 0.91 (s, 3H), 0.88 (t, J = 6.8 Hz, 3H) 
13C NMR (125 MHz, CDCl3) δ 212.4, 67.6, 52.6, 49.5, 36.4, 31.8, 25.2, 24.6, 22.62, 22.55, 14.05. 









Direct reduction of peroxyhemiketal 3a:  Peroxyhemiketal 3a (20.0 mg, 106 mol, 1.0 equiv) and 
triethylsilane (25.3 L, 158 mol, 3.2 equiv) were dissolved in CH2Cl2 (1 mL). At −78 °C, TfOH (10.3 
μL, 116.6 μmol, 1.1 equiv) was added dropwise. After stirring for 5 min, the reaction was quenched by 
the addition of saturated aqueous NaHCO3 solution and extracted with Et2O three times. The combined 
organic layers were dried (Na2SO4), filtered, and evaporated. Flash column chromatography (silica gel, 
0-5% Et2O in pentane) afforded spectroscopically pure dioxolane 8 as a colourless oil (13.6 mg, 79.1 
mol, 80%; 3:1 dr (cis/trans)) 
 
 
(5R)-5-hexyl-3-methoxy-3-methyl-1,2-dioxolane (7).  p-Toluenesulfonic acid monohydrate (4.6 mg, 
0.027 mmol) was added to a solution of peroxyhemiketal 3a (50 mg, 0.27 
mmol; 98.5:1.5 er) in methanol (3 mL). After stirring for 22 h at room 
temperature, the solvent was removed in vacuo and the residue washed 
with water and diethyl ether three times to afford peroxyketal 7 (49.6 mg, 
0.245 mmol, 92%) as a spectroscopically pure colourless oil. Characterized as a mixture of 
diastereoisomers d1 + d2 (6:4 dr). 
1H NMR (500 MHz, CDCl3) δ 4.42 (pent, J = 6.0 Hz, 1H, d1), 4.32 (pent, J = 7.1 Hz, 1H, d2) 
3.33 (s, 3H, d1), 3.32 (s, 3H, d2), 2.80 (dd, J = 12.4 Hz, J = 7.1 Hz, 1H, d1), 2.58 (dd, J = 12.5 Hz, J = 




1.76-1.66 (m, 1H, d1+d2), 1.64-1.53 (m, 1H, d1+d2), 1.49 (s, 3H, d1), 1.48 (s, 3H, d2), 1.48-1.19 (m, 8H, 
d1+d2), 0.88 (c. m, 3H, d1+ d2) 
13C NMR (125 MHz, CDCl3) δ 107.9, 106.8, 82.1, 80.9, 52.5, 52.3, 49.5, 49.3, 34.8, 31.8, 31.7, 31.6, 
29.2, 29.1, 26.3, 26.1, 22.57, 22.55, 19.2, 18.0, 14.1. 
HRMS (m/z) calcd for C11H22O3 [M]+: 202.156895, found: 202.156812. 
 
 
cis-(3R,5S)-3-Hexyl-5-methyl-1,2-dioxolane (cis-8): Peroxyketal 7 (20.0 mg, 98.9 mol, 1.0 equiv) 
and triethylsilane (25.3 L, 158 mol, 1.6 equiv) were dissolved in CH2Cl2 (1 
mL). At 78 °C, TiCl4 (12 L, 108.8 mol, 1.1 equiv) was added dropwise. 
After stirring for 5 min, the reaction was quenched by the addition of saturated 
aqueous NaHCO3 solution and extracted with Et2O three times. The combined organic layers were 
dried (Na2SO4), filtered, and evaporated. Flash column chromatography (silica gel, 0-5% Et2O in 
pentane) afforded spectroscopically pure dioxolane 8 as a colourless oil (13.6 mg, 79.1 mol, 80%; 3:1 
dr (cis/trans)). 
1H NMR (400 MHz, CD2Cl2) cis-isomer: δ 4.37-4.28 (m, 1H, CHMe), 4.25-4.14 (m, 1H, n-HexCH), 
2.79 (dd, J = 11.6, 7.2 Hz, 1H, CHCHHCH), 1.76 (dd, J = 11.9, 6.8 Hz, 1H, CHCHHCH), 1.70-1.59 
(m, 1H, CH2CHHCH), 1.53-1.43 (m, 1H, CH2CHHCH), 1.37-1.22 (m, 8H, (CH2)4CH3), 1.25 (d 
overlapped, 3H, J = 6.1 Hz, 1H, CHCH3), 0.88 (t, J = 6.8 Hz, 3H, (CH2)5CH3); trans-isomer: δ 4.37-
4.28 (m, 1H, CHMe), 4.25-4.14 (m, 1H, n-HexCH), 2.31-2.18 (m, 2H, CHCH2CH), 1.70-1.59 (m, 1H, 
CH2CHHCH), 1.53-1.43 (m, 1H, CH2CHHCH), 1.37-1.22 (m, 8H, (CH2)4CH3), 1.23 (d overlapped, 
3H, J = 6.1 Hz, 1H, CHCH3), 0.88 (t, J = 6.8 Hz, 3H, (CH2)5CH3). 
13C NMR (100 MHz, CD2Cl2) cis-isomer: δ 81.7 (n-HexCH), 77.3 (CHMe), 48.1 (CHCH2CH), 34.5 
(CH2CH2CH), 32.1 (CH2), 29.6 (CH2), 26.7 (CH2), 23.0 (CH2), 19.1 (CHCH3), 14.2 ((CH2)5CH3); 
trans-isomer: δ 81.4 (n-HexCH), 77.1 (CHMe), 47.4 (CHCH2CH), 33.6 (CH2CH2CH), 32.1 (CH2), 
29.6 (CH2), 26.5 (CH2), 23.0 (CH2), 18.5 (CHCH3), 14.2 ((CH2)5CH3). 
GC-MS (GC-EI) m/z (%) 172 [M+] (1), 131 (1), 113 (3), 95 (15), 87 (10), 81 (8), 69 (28), 55 (36), 43 
(100), 29 (15). 











Synthesis of Epoxyalcohol S-10 
 
(S)-1-((2S,3S)-3-hexyloxiran-2-yl)ethanol (S-10) : According to the procedure adapted from 
Yamaguchi and colleagues,11 a suspension of Zn(ClO4)2·6H2O (244 mg, 
0.66 mmol, 1.12 equiv) in dry diethyl ether (1 mL) was cooled to 0 °C, and 
epoxide 4a (100 mg, 0.59 mmol, 1 equiv) was added. After stirring for 10 
min, NaBH4 (47.4 mg, 1.25 mmol, 2 equiv) was added. The solution was 
stirred for 1 hour at 0 °C, warmed up to r.t. and 0.5 mL of MeOH were added. After 1 h, the reaction 
was quenched with Rochelle’s salt, extracted with diethyl ether three times, washed with brine, dried 
over MgSO4 and filtered. Removal of the solvent under reduced pressure and flash chromatography 
(40% Et2O in pentane) afforded S-10 as a colourless oil (96.1 mg, 0.56 mmol, 95%, dr determined from 
the crude mixture = 94:6). 
1H NMR (500 MHz, CDCl3) δ 3.97 (c. m, 1H), 2.98 (td, J = 5.7 Hz, J = 2.0 Hz, 1H), 2.75 (t, J = 2.9 
Hz, 1H), 2.06 (br s, 1H), 1.65-1.26 (m, 10H), 1.24 (d, J = 6.7 Hz, 3H), 0.88 (t, J = 6.8 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ 64.7, 61.7, 55.0, 31.7, 31.6, 29.0, 26.0, 22.5, 18.8, 14.0. 
HRMS (m/z) calcd for C10H20O2Na [M+Na]+: 195.1356, found: 195.1356. 
 
                                                 










Catalyst salt [1a • 2 TFA] was prepared in situ by the addition of 9-amino(9-deoxy)epiquinine (1a; 32.3 
mg, 0.1 mmol, 10 mol%) to a solution of trifluoroacetic acid (TFA; 15.3 L, 0.2 mmol, 20 mol%) in 
dioxane (4 mL). Then, cyclic enone 9 (1.0 mmol, 1.0 equiv) was added, and 20 minutes later, aqueous 
hydrogen peroxide (50 wt%; 92 L, 1.5 mmol, 1.5 equiv). After 12-72 h of stirring at 30°C (unless 
otherwise specified), the reaction mixture was extracted with Et2O (325 mL). The combined organic 
phases were washed with brine, dried (Na2SO4), and filtered. For the highly volatile product 10a, the 
resulting solution was analyzed by GC for yield and er determination. Removal of the volatiles 
furnished the crude product, which was purified by flash column chromatography (silica gel, eluent: 
Et2O-pentane) to afford pure cyclic ,-epoxy ketone 10. 
 
Scope of Optically Active Cyclic ,-Epoxyketones 10 
 
2,3-Epoxycyclohexanone (10a): After 24 h at 30 °C, the conversion was determined to be 91% by GC 
using an Optima-5-Accent column (5 min at 40°C, 5.0 C/min until 100 C, 25 C/min 
until 250 C, 1.0 min at 250°C, 0.35 bar He; starting material: R = 12.34 min, product: 
R = 15.65 min). After purification by flash column chromatography (silica gel, 5-10% 
Et2O in pentane) (2S,3S)-10a was obtained as a clear liquid (65 mg, 580 µmol, 58% (reduced yield due 
to the high volatility of 10a); 97:3 er). The enantiomeric ratio was determined by GC using a chiral 
BGB-176/BGB-15 column 30 m (80 °C, 1.2 C/min until 105 C, 20 C/min until 220 C, 10 min at 




1H NMR (500 MHz, CD2Cl2) δ 3.57-3.55 (m, 1H, CH2CepoH), 3.15 (d, J = 4.2 Hz, 1H, CepoHC(=O)), 
2.47 (dt, J = 17.5, 4.6 Hz, 1H, CHHC(=O)), 2.26-2.19 (m, 1H, CHHCepoH), 2.07-2.00 (m, 1H, 
CHHC(=O)), 1.94-1.84 (m, 2H, CHHCepoH and CH2CHHCH2), 1.69-1.60 (m, 1H, CH2CHHCH2). 
13C NMR (100 MHz, CD2Cl2) δ 206.0 (C=O), 56.2 (CH2CHepo), 55.4 (CHepoC(=O)), 36.7 (CH2C(=O)), 
23.2 (CH2CHepo), 17.3 (CH2CH2CH2). 
The analytical data were identical in all respects to those of the commercially available 2,3-
epoxycyclohexanone (10a; Sigma-Aldrich). 
 
 
 (2R,3R)- 4,4-Dimethyl-2,3-epoxycyclohexanone ((2R,3R)-10b): The title compound was isolated 
after purification by flash column chromatography (silica gel, 2% Et2O in pentane) 
as a clear liquid (118 mg, 840 µmol, 84%; 97:3 er). The enantiomeric ratio was 
determined by GC using a chiral Hydrodex--TBDAc column 25 m (80 C, 1.5 
C/min until 170 C, 20 C/min until 220 °C, 10 min at 220 C, 0.6 bar H2); major 
enantiomer: R = 21.91 min, minor enantiomer: R = 25.75 min. 
1H NMR (500 MHz, CDCl3) δ 3.20 (d, J = 3.9 Hz, 1H, CepoHC(=O)), 3.15 (dd, J = 4.0, 1.3 Hz, 1H, 
CMe2CepoH), 2.37 (ddd, J = 18.9, 6.3, 3.1 Hz, 1H, CHHC(=O)), 2.20-2.13 (m, 1H, CHHC(=O)), 1.88 
(ddd, J = 13.6, 11.8, 6.4 Hz, 1H, CHHCqMe2), 1.31 (dddd, J = 13.6, 7.1, 3.0, 1.2 Hz, 1H, 
CHHCqMe2), 1.19 (s, 3H, CH3), 1.04 (s, 3H, CH3). 
13C NMR (75 MHz, CD2Cl2) δ 205.9 (C=O), 64.1 (CMe2CHepo), 55.9 (CHepoC(=O)), 33.1 
(CH2C(=O)), 30.7 (CqMe2), 29.7 (CH2CqMe2), 27.4 (CH3), 22.8 (CH3). 
MS (EI) m/z (%) 140 [M+] (14), 124 (2), 111 (20), 97 (27), 85 (58), 69 (100), 55 (73), 43 (29), 41 (95), 
39 (32), 29 (31). 
HRMS calcd for C8H12O2 [M+] 140.0839, found 140.0837. 
 
 
(2R,3R)-5,5-Dimethyl-2,3-epoxycyclohexanone ((2R,3R)-10c): The title compound was isolated after 
purification by flash column chromatography (silica gel, 3% Et2O in pentane) as a 
clear liquid (101 mg, 720 µmol, 72%; 96:4 er). The enantiomeric ratio was 
determined by GC using a chiral Hydrodex--TBDAc column 25 m (80 C, 1.2 
C/min until 120 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major 




1H NMR (300 MHz, CD2Cl2) δ 3.48 (t, J = 4.1 Hz, 1H, CH2CepoH), 3.14 (d, J = 3.8 Hz, 1H, 
CepoHC(=O)), 2.61 (d, J = 13.2 Hz, 1H, CHHC(=O)), 2.00 (d, J = 15.4 Hz, 1H, CHHCHepo), 1.86-1.74 
(m, 2H, CHHC(=O) and CHHCHepo), 1.00 (s, 3H, CH3), 0.90 (s, 3H, CH3). 
13C NMR (75 MHz, CD2Cl2) δ 207.5 (C=O), 57.4 (CHepoC(=O)), 55.0 (CH2CHepo), 49.0 (CH2C(=O)), 
37.5 (CH2CHepo), 37.4 (CqMe2), 31.0 (CH3), 28.1 (CH3). 
GC-MS (EI-DE) m/z (%) 140 [M+] (20), 125 (1), 112 (4), 97 (20), 83 (100), 79 (8), 69 (28), 55 (90), 53 
(13), 43 (19), 41 (73), 39 (34), 27 (20). 
HRMS calcd for C8H12O2 [M+] 140.0839, found 140.0837.  
 
 
(2R,3R)-3,5,5-Trimethyl-2,3-epoxycyclohexanone ((2R,3R)-10d): The title compound was isolated 
after purification by flash column chromatography (silica gel, 1.5% Et2O in 
pentane) as a clear liquid (80 mg, 520 µmol, 52%; 95.5:4.5 er). The enantiomeric 
ratio was determined by GC using a chiral Hydrodex--TBDAc column 25 m (60 
C, 1.0 C/min until 90 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); 
major enantiomer: R = 27.24min, minor enantiomer: R = 27.80 min. 
1H NMR (500 MHz, CDCl3) δ 3.01 (s, 1H, CepoH), 2.58 (d, J = 13.5 Hz, 1H, CHHC(=O)), 2.04 (d, J = 
14.7 Hz, 1H, CqepoCHH), 1.77 (ddd, J = 13.4, 2.0, 1.0 Hz, 1H, CHHC(=O)), 1.70 (dd, J = 14.8, 2.2 Hz, 
1H, CqepoCHH), 1.38 (s, 3H, CqepoCH3), 0.98 (s, 3H, CH3), 0.87 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 207.8 (C=O), 64.2 (Cqepo), 61.4 (CHepo), 48.0 (CH2C(=O)), 42.7 
(CH2Cqepo), 36.1 (CqMe2), 30.8 (Cq(CH3)2), 27.8 (Cq(CH3)2), 24.0 (CqepoCH3). 
MS (EI-DE) m/z (%) 154 [M+] (30), 139 (33), 126 (17), 111 (12), 97 (25), 83 (100), 69 (50), 55 (39), 
53 (9), 43 (40), 41 (65), 29 (23). 
HRMS calcd for C9H14O2 [M+] 154.0992, found 154.0994. 
 
 
(2R,3S)-2,6,6-Trimethyl-2,3-epoxy-1,4-cyclohexanedione ((2R,3S)-10e): 20 mol% catalytic salt 
[1a • 2 TFA] was used. The title compound was isolated after 48 h at 50 °C and 
purification by flash column chromatography (silica gel, 2.5% Et2O in pentane) as 
a clear oil (82 mg, 488 mol, 49%; 96:4 er). The enantiomeric ratio was 
determined by GC using a chiral BGB-178/OV-1701 column 30 m (80 C, 1.2 




19.27 min, minor enantiomer: R = 22.67 min. 
1H NMR (300 MHz, CD2Cl2) δ 3.49 (d, J = 1.1 Hz, 1H, CepoH), 3.15 (d, J = 13.6 Hz, 1H, CHH), 2.15 
(dd, J = 13.5, 1.2 Hz, 1H, CHH), 1.55 (s, 3H, CH3), 1.28 (s, 3H, CH3), 1.08 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 205.6 (C=O), 204.1 (C=O), 64.8 (Cqepo), 62.8 (CHepo), 47.0 (CH2), 45.5 
(CqMe2), 26.9 (CH3), 26.1 (CH3), 15.9 (CqepoCH3). 
MS (EI) m/z (%) 168 [M+] (59), 153 (27), 125 (65), 85 (77), 83 (21), 69 (34), 56 (100), 43 (91), 41 
(95), 39 (41), 27 (34). 
HRMS calcd for C9H12O3 [M+] 168.0785, found 168.0786. 
 
 
(2S,3S)-2,3-Epoxy-3-methylcyclohexanone ((2S,3S)-10f): The title compound was isolated after 24 h 
at 30 °C and purification by flash column chromatography (silica gel, 2-10% Et2O in 
pentane) as a clear oil (88 mg, 698 µmol, 70% (reduced yield due to the high volatility 
of 20g); 98:2 er). The enantiomeric ratio was determined by GC using a chiral BGB-
178/OV-1701 column 30 m (80 °C, 1.2 °C/min until 105 °C, 20 °C/min until 220 °C, 
10 min at 220 °C, 0.5 bar H2); major enantiomer: R = 16.79 min, minor enantiomer: R = 19.18 min. 
1H NMR (400 MHz, CD2Cl2) δ 3.01 (s, 1H, CepoH), 2.42 (dt, J = 17.6, 4.1 Hz, 1H, CHHC(=O)), 2.13-
1.84 (m, 4H, CHHC(=O), CH2Cqepo, and CH2CHHCH2), 1.66-1.58 (m, 1H, CH2CHHCH2), 1.42 (s, 
3H, CH3). 
13C NMR (75 MHz, CD2Cl2) δ 206.7 (C=O), 62.6 (Cqepo), 62.3 (CHepo), 36.1 (CH2C(=O)), 28.7 
(CH2Cqepo), 22.3 (CH3), 17.5 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 126 [M+] (78), 111 (8), 97 (46), 83 (35), 81 (21), 79 (5), 71 (79), 69 (26), 67 (8), 
58 (3), 55 (61), 53 (12), 43 (89), 41 (100), 39 (49), 31 (2), 27 (36). 
HRMS (EI-FE) calcd for C7H10O2 [M+] 126.0680, found 126.0681. 
 
 
(2S,3S)-3-Ethyl-2,3-epoxycyclohexanone ((2S,3S)-10g): The title compound was isolated after 30 h at 
50 °C and purification by flash column chromatography (silica gel, 5-10% Et2O in 
pentane) as a clear oil (102 mg, 728 µmol, 73% ; 98.5:1.5 er). The enantiomeric ratio 
was determined by GC using a chiral BGB-178/OV-1701 column 30 m (80 °C, 1.2 
°C/min until 115 °C, 20 °C/min until 220 °C, 10 min at 220 °C, 0.5 bar H2); major 




1H NMR (400 MHz, CD2Cl2) δ 3.03 (s, 1H, CepoH), 2.45 (dt, J = 17.4, 4.3 Hz, 1H, CHHC(=O)), 2.12-
1.95 (m, 2H, CHHC(=O) and CHHCqepo), 1.94-1.83 (m, 2H, CHHCqepo and CH2CHHCH2), 1.78-1.61 
(m, 3H, CH2CH3 and CH2CHHCH2), 0.96 (t, J = 7.5 Hz, 3H, CH3). 
13C NMR (100 MHz, CD2Cl2) δ 206.9 (C=O), 66.3 (Cqepo), 61.1 (CHepo), 36.4 (CH2C(=O)), 29.2 
(CH2CH3), 26.5 (CH2Cqepo), 17.8 (CH2CH2CH2), 8.8 (CH3). 
MS (EI-DE) m/z (%) 140 [M+] (90), 125 (5), 111 (49), 107 (1), 97 (55), 95 (24), 85 (79), 79 (12), 67 
(24), 57 (30), 55 (84), 43 (38), 41 (100), 39 (58), 29 (92), 27 (77). 
HRMS (EI-FE) calcd for C8H12O2 [M+] 140.0836, found 140.0837. 
 
 
(2S,3R)-2,3-Epoxy-3-isobutylcyclohexanone ((2S,3R)-10h): The title compound was isolated after 
48 h at 50 °C and purification by flash column chromatography (silica gel, 5-10% 
Et2O in pentane) as a clear oil (123 mg, 731 µmol, 73%; 98:2 er). The enantiomeric 
ratio was determined by GC using a chiral BGB-178/OV-1701 column 30 m (80 °C, 
0.8 °C/min until 120 °C, 20 °C/min until 220 °C, 10 min at 220 °C, 0.5 bar H2); 
major enantiomer: R = 43.77 min, minor enantiomer: R = 45.20 min. 
1H NMR (400 MHz, CD2Cl2) δ 2.98 (s, 1H, CepoH), 2.45 (dt, J = 17.4, 4.3 Hz, 1H, C(=O)CHH), 2.11-
1.81 (m, 5H, C(=O)CHH, CH2Cqepo, CHMe2, and CH2CHHCH2), 1.67-1.60 (m, 2H, CH2CHHCH2 and 
CHHi-Pr), 1.40 (dd, J = 13.8, 8.1 Hz, 1H, CHHi-Pr), 0.96 (d, J = 6.6 Hz, 3H, CH(CH3)2), 0.91 (d, J = 
6.6 Hz, 3H, CH(CH3)2). 
13C NMR (75 MHz, CD2Cl2) δ 206.9 (C=O), 64.8 (Cqepo), 61.8 (CHepo), 45.4 (CH2i-Pr), 36.4 
(C(=O)CH2), 26.5 (CH2Cqepo), 25.4 (CHMe2), 23.2 (CH(CH3)2), 22.7 (CH(CH3)2), 17.7 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 168 [M+] (45), 153 (7), 139 (7), 126 (36), 112 (31), 79 (32), 67 (43), 55 (56), 41 
(100), 39 (43), 27 (54). 
HRMS (EI-FE) calcd for C10H16O2 [M+] 168.1149, found 168.1150. 
 
 
(2S,3R)-2,3-Epoxy-3-isopropylcyclohexanone ((2S,3R)-10i): The title compound was isolated after 
48 h at 50 °C and purification by flash column chromatography (silica gel, 5-10% Et2O 
in pentane) as a clear oil (121 mg, 785 µmol, 79%; 99:1 er). The enantiomeric ratio 
was determined by GC using a chiral BGB-178/OV-1701 column 30 m (80 °C, 1.2 




27.79 min, minor enantiomer: R = 29.24 min. 
1H NMR (400 MHz, CD2Cl2) δ 3.03 (s, 1H, CepoH), 2.46 (dt, J = 17.3, 4.7 Hz, 1H, CHHC(=O)), 2.11-
1.99 (m, 2H, CHHC(=O) and CHHCqepo), 1.95-1.83 (m, 2H, CHHCqepo and CH2CHHCH2), 1.70-1.60 
(m, 2H, CH2CHHCH2 and CHMe2), 1.03 (d, J = 6.8 Hz, 3H, CH(CH3)2), 0.97 (d, J = 7.0 Hz, 3H, 
CH(CH3)2). 
13C NMR (100 MHz, CD2Cl2) δ 207.0 (C=O), 69.3 (Cqepo), 61.1 (CHepo), 36.6 (CH2C(=O)), 34.5 
(CHMe2), 23.3 (CH2Cqepo), 18.1 (CH2CH2CH2), 18.0 (CH(CH3)2), 17.9 (CH(CH3)2). 
MS (EI-DE) m/z (%) 154 [M+] (61), 139 (4), 125 (24), 111 (78), 99 (34), 81 (41), 71 (6), 69 (30), 55 
(93), 53 (18), 43 (84), 41 (100), 29 (32), 27 (56) 
HRMS (EI-FE) calcd for C9H14O2 [M+] 154.0993, found 154.0994. 
 
 
(2S,3R)-3-tert-Butyl-2,3-epoxycyclohexanone ((2S,3R)-10j): The title compound was isolated after 48 
h at 50 °C and purification by flash column chromatography (silica gel, 5-10% Et2O in 
pentane) as a clear oil (57 mg, 339 µmol, 68%; 99.5:0.5 er). The enantiomeric ratio 
was determined by GC using a chiral Hydrodex-β-TBDAc column 25 m (100 °C, 1.2 
C/min until 125 C, 18 C/min until 220 C, 10 min at 320 C, 0.5 bar H2); major 
enantiomer: R = 13.22 min, minor enantiomer: tR = 14.25 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.21 (s, 1H, CepoH), 2.46 (dt, J = 17.7, 4.7 Hz, 1H, CHHC(=O)), 2.19-
2.13 (m, 1H, CH2), 2.07-1.99 (m, 1H, CH2), 1.95-1.86 (m, 2H, CH2), 1.67-1.60 (m, 1H, CH2), 0.97 (s, 
9H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 207.3 (C=O), 70.5 (Cqepo), 59.2 (CepoH), 36.1 (CH2C(=O)), 34.0 
(CqMe3), 25.4 (3C, CH3), 23.2 (CqepoCH2), 17.8 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 168 [M+] (22), 153 (5), 139 (14), 125 (39), 113 (15), 96 (87), 83 (24), 69 (61), 55 
(100), 41 (57), 29 (26). 







(2S,3R)-2,3-Epoxy-3-allylcyclohexanone ((2S,3R)-10k): The title compound was isolated after 48 h at 
50 °C and purification by flash column chromatography (silica gel, 2-15% Et2O in 
pentane) as a clear oil (34.8 mg, 229 mol, 23%; 97.5:2.5 er). The enantiomeric ratio 
was determined by GC using a chiral Hydrodex-β-TBDAc column 25 m (21 min at 
125 °C, 14 C/min until 230 C, 10 min at 230°C, 0.6 bar H2); major enantiomer: R = 
24.39 min, minor enantiomer: R = 25.96 min. 
1H NMR (500 MHz, CD2Cl2) δ 5.77 (ddt, J = 17.0, 10.1, 7.1 Hz, 1H, CH=CH2), 5.17-5.13 (m, 2H, 
CH=CH2), 3.06 (s, 1H, CepoH), 2.48-2.38 (m, 3H, CH2CH=CH2 and CHHC(=O)), 2.13-2.09 (m, 1H, 
CH2, cycl.), 2.05-1.98 (m, 1H, CH2, cycl.), 1.93-1.85 (m, 2H, CH2, cycl.), 1.67-1.61 (m, 1H, CH2, cycl.). 
13C NMR (125 MHz, CD2Cl2) δ 206.5 (C=O), 132.3 (CH=CH2), 119.1 (CH=CH2), 64.7 (Cqepo), 60.6 
(CHepo), 40.6 (CH2CH=CH2), 36.3 (CH2C(=O)), 26.7 (CH2Cqepo), 17.7 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 152 [M+] (8), 137 (4), 123 (60), 109 (13), 97 (41), 91 (11), 79 (53), 69 (29), 67 
(61), 55 (85), 53 (23), 41 (100), 39 (55), 29 (18), 27 (31). 
HRMS (EI-FE) calcd for C9H12O2 [M+] 152.0836, found 152.0837. 
 
 
The facile isomerization of 9k is probably enhanced upon formation of the iminium ion with catalyst 
1a, which should lead to increased acidity in the '-position. This effect was used by the group of Deng 
to develop an enantioselective isomerization of 3-cyclohexenones into 2-cyclohexenones using a newly 







                                                 








(E)-3-(1-propenyl)cyclohex-2-enone (S-11): The title compound (70.2 mg, 516 mol, 52%) was 
obtained as a side product in the epoxidation reaction of 3-allylcyclohex-2-enone (9k). 
1H NMR (500 MHz, CD2Cl2) δ 6.30-6.22 (m, 2H, Cq=CH and CH=CHCH3), 5.81-
5.80 (m, 1H, CH=CHCH3), 2.45 (t, J = 5.9 Hz, CH2C(=O)), 2.34 (t, J = 6.6 Hz, 
CH2Cq=CH), 2.00 (quint, J = 6.4 Hz, CH2CH2CH2), 1.87 (d, J = 5.6 Hz, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 202.2 (C=O), 157.9 (Cq=CH), 134.2 (CH=CH), 133.0 (CH=CH), 
126.4 (Cq=CH), 38.2 (CH2C(=O)), 25.4 (CH2Cq=CH), 23.0 (CH2CH2CH2), 19.2 (CH3). 
 
 
(2S,3R)-2,3-Epoxy-3-phenethylcyclohexanone ((2S,3R)-10l): The title compound was isolated after 
48 h at 50 °C and purification by flash column chromatography (silica gel, 1-10% 
Et2O in pentane) as a clear oil (182 mg, 843 µmol, 84%; 98.5:1.5 er). The 
enantiomeric ratio was determined by GC using a chiral BGB-176/BGB-15 column 
30 m (100 °C, 1.2 °C/min until 180 °C, 20 °C/min until 220 °C, 10 min at 220 °C, 0.5 
bar H2); major enantiomer: R = 56.99 min, minor enantiomer: R = 58.46 min. 
1H NMR (400 MHz, CD2Cl2) δ 7.31-7.27 (m, 2H, CHar), 7.23-7.18 (m, 3H, CHar), 3.01 (s, 1H, CepoH), 
2.74 (t, J = 8.3 Hz, 2H, CH2Ph), 2.46 (dt, J = 17.0, 4.7 Hz, 1H, C(=O)CHH), 2.20-2.12 (m, 1H, 
CHHCqepo), 2.08-1.87 (m, 5H, C(=O)CHH, CHHCqepo, CH2CHHCH2, and CH2CH2Ph), 1.71-1.62 (m, 
1H, CH2CHHCH2). 
13C NMR (100 MHz, CD2Cl2) δ 206.5 (C=O), 141.5 (Cqar), 128.8 (2C, CHar), 128.6 (2C, CHar), 126.5 
(CHar, p), 65.1 (Cqepo), 61.4 (CHepo), 38.2 (CH2CH2Ph), 36.3 (C(=O)CH2), 31.2 (CH2Ph), 26.9 
(CH2Cqepo), 17.8 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 216 [M+] (2), 198 (2), 187 (1), 169 (3), 154 (1), 143 (11), 128 (4), 104 (100), 97 
(13), 91 (69), 79 (13), 69 (5), 65 (17), 55 (12), 41 (31). 
HRMS (EI-DE) calcd for C14H16O2 [M+] 216.1149, found 216.1150. 
 
 
3-Benzyl-2,3-epoxycyclohexanone (10m): The title compound (2S,3R)-10m was isolated after 48 h at 
50 °C and purification by flash column chromatography (silica gel, 2-10% Et2O in 
pentane) as a clear oil (158 mg, 781 µmol, 78%; 99:1 er). The enantiomeric ratio was 
determined by GC using a chiral Hydrodex--TBDAc column 25 m (100 °C, 1.2 




45.74 min, minor enantiomer: R = 46.65 min. 
9-amino(9-deoxy)epiquinidine (1b) was used (instead of 1a). The title compound 
(2R,3S)-10m was isolated after 48 h at 50 °C and purification by flash column 
chromatography (silica gel, 2-10% Et2O in pentane) as a clear oil (156 mg, 771 
µmol, 77%; 98.5:1.5 er). The enantiomeric ratio was determined by GC using a chiral Hydrodex-β-
TBDAc column 25 m (100 °C, 1.2 °C/min until 175 °C, 20 °C/min until 220 °C, 10 min at 220 °C, 0.4 
bar H2); major enantiomer: R = 46.37 min, minor enantiomer: R = 45.88 min. 
1H NMR (400 MHz, CD2Cl2) δ 7.34-7.21 (m, 5H, C6H5), 3.04 (s, 1H, CepoH), 2.98 (s, 2H, CH2Ph), 
2.44 (dt, J = 17.7, 4.4 Hz, 1H, C(=O)CHH), 2.10-1.95 (m, 2H, C(=O)CHH and CHHCqepo), 1.89-1.80 
(m, 2H, CHHCqepo and CH2CHHCH), 1.65-1.56 (m, 1H, CH2CHHCH2). 
13C NMR (100 MHz, CD2Cl2) δ 206.4 (C=O), 136.2 (Cqar), 130.0 (2C, CHar), 128.8 (2C, CHar), 127.3 
(CHar, p), 65.4 (Cqepo), 60.8 (CHepo), 42.4 (CH2Ph), 36.4 (C(=O)CH2), 26.7 (CH2Cqepo), 17.6 
(CH2CH2CH2). 
MS (EI-DE) m/z (%) 202 [M+] (60), 184 (5), 173 (53), 156 (4), 145 (12), 129 (46), 117 (21), 91 (100), 
78 (11), 65 (28), 55 (28), 51 (15), 39 (36). 
HRMS (EI-DE) calcd for C13H14O2 [M+] 202.0991, found 202.0994. 
 
 
 (2S,3S)-2,3-Epoxy-4-methylcyclohexanone ((2S,3S)-10q): After 24 h at 30 °C, the conversion was 
determined to be 94% (54:46 dr (anti/syn)) by GC/MS. The enantiomeric ratio was 
determined by GC using a chiral BGB-178/OV-1701 column 30 m (80 °C, 0.8 C/min 
until 105 C, 20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2). anti-10q: 93.5:6.5 
er (major enantiomer: R = 27.25 min, minor enantiomer: R = 29.13 min); syn-10q: 99:1 
er (minor enantiomer: R = 28.64 min, minor enantiomer: R = 29.65 min). 
anti-10q: 1H NMR (500 MHz, CD2Cl2) δ 3.37 (dd, J = 3.7, 2.2 Hz, 1H, CHCHepo), 3.15 (d, J = 4.0 Hz, 
1H, CHepoC(=O)), 2.46-2.40 (m, 2H, CHMe and CHHC(=O)), 2.18-2.04 (m, 2H, CHHC(=O) and 
CHHCH), 1.48-1.41 (m, 1H, CHHCH), 1.08 (d, J = 7.2 Hz, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 206.5 (C=O), 66.0 (CHCHepo), 61.7 (CHepoC(=O)), 33.3 (CH2C(=O)), 
27.9 (CHMe), 25.6 (CH2CH), 15.9 (CH3). 
GC-MS (GC-EI) m/z (%) 126 [M+]. 









syn-10q: 1H NMR (500 MHz, CD2Cl2) δ 3.38 (d, J = 3.9 Hz, 1H, CHCHepo), 3.16 (d, J = 3.8 Hz, 1H, 
CHepoC(=O)), 2.42 (ddd, J = 18.6, 5.0, 3.5 Hz, 1H, CHHC(=O)), 2.19-2.12 (m, 1H, CHMe), 2.07 (ddd, 
J = 18.6, 11.8, 6.9 Hz, 1H, CHHC(=O)), 1.67-1.57 (m, 2H, CH2CH), 1.22 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 205.6 (C=O), 60.1 (CHCHepo), 55.9 (CHepoC(=O)), 36.5 (CH2C(=O)), 
29.3 (CHMe), 24.1 (CH2CH), 18.8 (CH3). 
GC-MS (GC-EI) m/z (%) 126 [M+]. 
HRMS (EI-FE) calcd for C7H10O2 [M+] 126.0680, found 126.0681. 
 
Subjecting a more sterically biased substrate 4-tert-butyl-2-cyclohexenone rac-S-10 gave anti-
epoxide S-1813 in 48% yield, after 4 d at 50 °C, with a diastereomeric ratio of 92:8 (anti/syn). Although 
the remaining starting material (44%) was significantly enantioenriched with 86:14 er, the enantiomeric 
ratio of anti-epoxide S-18 remained relatively low (79.5:20.5 er). 
 
(2S,3S)-2,3-Epoxy-4-tert-butylcyclohexanone ((2S,3S)-S-18):  After 96 h at 50 °C, the conversion 
was determined to be 56% by GC/MS with a yield of epoxide S-10 of 48% 
(92:8 dr (anti/syn)). The enantiomeric ratio was determined by GC using a chiral 
Hydrodex-β-TBDAc column 25 m (100 °C, 1.2 C/min until 220 C, 10 min at 220 
C, 0.5 bar H2). anti-S-1014: 79.5:20.5 er (major enantiomer: R = 26.00 min, minor 
enantiomer: R = 29.01 min).15  
anti-20s: 1H NMR (400 MHz, CDCl3) δ 3.49-3.47 (m, 1H, CHCHepo), 3.15 (d, J = 3.8 Hz, 1H, 
CHepoC(=O)), 2.70-2.62 (m, 1H, CHHC(=O)) 2.15-2.09 (m, 1H,CHHC(=O)), 2.02-1.94 (m, 2H, CHt-
Bu and CHHCH), 1.74-1.64 (m, 1H, CHHCH), 0.99 (s, 9H, CH3). 
13C NMR (100 MHz, CDCl3) δ 208.3 (C=O), 61.5 (CHCHepo), 55.2 (CHepoC(=O)), 43.5 (CHt-Bu), 
34.7 (CH2C(=O)), 32.6 (CqMe3), 27.6 (3C, CH3), 26.1 (CH2CH). 
MS (EI-DE) m/z (%) 168 [M+] (8), 153 (1), 139 (4), 125 (2), 112 (21), 107 (4), 97 (8), 83 (24), 70 (32), 
67 (11), 57 (100), 41 (43), 39 (16), 29 (19). 
HRMS (EI-FE) calcd for C10H16O2 [M+] 168.1152, found 168.1150. 
                                                 
13 The relative configuration of S-11 was assigned by NOE analysis. 
14 The relative configuration was assigned on the basis of NOE correlations 
15 R. W. Rickards, J. L. Rodwell, K. J. Schmalzl, J. Chem. Soc., Chem. Commun. 1977, 849; b)J. Lv, J. Zhang, Z. Lin, Y. 




anti-(2S,3S,5S)-2,3-Epoxy-3-methyl-5-phenylcyclohexanone (anti-(2S,3S,5S)-10r): After 48 h at 50 
°C, the conversion was determined to be 83% by GC/MS with a yield of epoxide 10r of 
75% (97:3 dr (anti/syn)). The enantiomeric ratio was determined to be 98.5:1.5 by 
chiral GC using a Hydrodex-β-TBDAc column 25 m (80 °C, 1.2 C/min until 180 C, 
20 C/min until 220 C, 10 min at 220 C, 0.5 bar H2); major enantiomer: R = 67.61 
min, minor enantiomer: R = 69.91 min). 
1H NMR (500 MHz, CD2Cl2) δ 7.33 (t, J = 7.7 Hz, 2H, CHPh, m), 7.24-7.20 (m, 3H, CHPh, o, p), 3.34 (tt, 
J = 12.3, 4.5 Hz, 1H, CHPh), 3.14 (s, 1H, CHepo), 2.63 (dd, J = 18.7, 4.9 Hz, 1H, CHHC(=O)), 2.34 
(dd, J = 14.3, 3.9 Hz, 1H, CHHCqMe), 2.23 (dd, J = 18.6, 12.7 Hz, 1H, CHHC(=O)), 2.11 (dd, J = 
15.0, 12.4 Hz, 1H, CHHCqMe), 1.49 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 205.3 (C=O), 143.8 (CqPh), 129.0 (2C, CHPh, m), 127.3 (2C, CHPh, o), 
127.1 (CHPh, p), 61.5 (CHepo), 61.4 (Cqepo), 44.0 (CH2C(=O)), 36.8 (CH2Cqepo), 34.3 (CHPh), 21.9 
(CH3). 
MS (EI-DE) m/z (%) 202 [M+] (23), 184 (17), 174 (68), 159 (84), 145 (47), 131 (100), 115 (49), 103 
(84), 91 (74), 85 (33), 77 (62), 69 (50), 65 (22), 51 (31), 43 (54), 27 (16). 
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2,3-Epoxycycloheptanone (12a): The title compound (2S,3S)-12a was isolated after 24 h at 50 °C and 
purification by flash column chromatography (silica gel, 3-15% Et2O in pentane) as a 
clear liquid (78 mg, 621 µmol, 62%; >99.5:0.5 er). The enantiomeric ratio was 
determined by GC using a chiral Hydrodex-β-TBDAc column 25 m (80 C, 1.5 
C/min until 120 C, 20 C/min until 220 C, 10 min at 220°C, 0.6 bar H2); major enantiomer: R = 
20.66 min, minor enantiomer: R = 24.29 min. 
1H NMR (300 MHz, CD2Cl2) δ 3.37-3.35 (m, 2H, CHepo), 2.62 (ddd, J = 13.6, 11.3, 3.8 Hz, 1H, 
C(=O)CHH), 2.48-2.40 (m, 1H, CHHCHepo), 2.30-2.23 (m, 1H, C(=O)CHH), 1.87-1.63 (m, 4H, 
C(=O)CH2CHH, CHHCHepo, and CH2CH2CHepo), 1.06-0.91 (m, 1H, C(=O)CH2CHH). 
13C NMR (75 MHz, CD2Cl2) δ 210.1 (C=O), 59.5 (C(=O)CHepo), 55.1 (CH2CHepo), 40.6 (C(=O)CH2), 
27.5 (CH2CHepo), 23.6 (C(=O)CH2CH2), 23.1 (CH2CH2CHepo). 
GC-MS (GC-EI) m/z (%) 126 [M+] (16), 110 (12), 97 (33), 83 (24), 81 (35), 79 (14), 70 (58), 68 (32), 
55 (79), 41 (100), 39 (52), 27 (37). 
HRMS (EI-FE) calcd for C7H10O2 [M+] 126.0679, found 126.0681. 
 
 
(2S,3S)-2,3-Epoxy-3-ethylcycloheptanone ((2S,3S)-12b): The title compound was isolated after 20 h 
at 50 °C and purification by flash column chromatography (silica gel, 5% Et2O in 
pentane) as a clear oil (127 mg, 824 µmol, 82%; >99.5:0.5 er). The enantiomeric 
ratio was determined by GC using a chiral BGB-176/BGB-15 column 30 m (80 °C, 
1.2 °C/min until 220 °C, 10 min at 220 °C, 0.5 bar H2); major enantiomer: R = 18.25 min, minor 
enantiomer: R = 19.50 min. 
1H NMR (400 MHz, CD2Cl2) δ 3.20 (d, J = 1.3 Hz, 1H, CepoH), 2.67 (ddd, J = 13.5, 11.0, 4.1 Hz, 1H, 
C(=O)CHH), 2.24-2.18 (m, 1H, C(=O)CHH), 2.18-2.12 (m, 1H, CHHCqepo), 1.87-1.66 (m, 5H, 
CHHCqepo, C(=O)CH2CHH, CH2CH2Cqepo, and CHHCH3), 1.59-1.49 (m, 1H, CHHCH3), 1.13-1.02 
(m, 1H, C(=O)CH2CHH), 0.93 (t, J = 7.5 Hz, 3H, CH3). 









(CH2CH3), 31.4 (CH2Cqepo), 25.3 (C(=O)CH2CH2), 23.9 (CH2CH2Cqepo), 9.1 (CH3). 
GC-MS (GC-EI) m/z (%) 154 [M+] (1), 138 (1), 125 (11), 109 (12), 98 (68), 93 (8), 83 (29), 67 (35), 
55 (100), 53 (16), 41 (65), 29 (57), 27 (23). 
HRMS (EI-FE) calcd for C9H14O2 [M+] 154.0995, found 154.0994. 
 
 
(2S,3R)-3-Benzyl-2,3-epoxycycloheptanone ((2S,3R)-12c): The title compound was isolated after 20 h 
at 50 °C and purification by flash column chromatography (silica gel, 5-10% Et2O 
in pentane) as a clear oil (184 mg, 851 µmol, 85%; >99.5:0.5 er). The enantiomeric 
ratio was determined by HPLC using a chiral Chiralpak IA column (2% i-PrOH in 
heptane, 0.5 mL/min); major enantiomer: R = 13.74 min, minor enantiomer: R = 14.83 min. 
1H NMR (400 MHz, CD2Cl2) δ 7.33-7.22 (m, 5H, C6H5), 3.20 (d, J = 1.2 Hz, 1H, CepoH), 2.94 (dd, J = 
18.8, 14.3 Hz, 2H, CH2Ph), 2.67 (ddd, J = 13.4, 11.0, 4.0 Hz, 1H, C(=O)CHH), 2.25-2.16 (m, 2H, 
C(=O)CHH and CHHCqepo), 1.86-1.63 (m, 4H, CHHCqepo, CH2CH2Cqepo, and C(=O)CH2CHH), 1.11-
1.00 (m, 1H, C(=O)CH2CHH). 
13C NMR (75 MHz, CD2Cl2) δ 210.3 (C=O), 136.5 (Cqar), 130.1 (2C, CHar), 128.8 (2C, CHar), 127.2 
(CHar, p), 64.6 (CHepo), 64.1 (Cqepo), 44.6 (CH2Ph), 41.1 (C(=O)CH2), 31.7 (CH2Cqepo), 25.2 
(C(=O)CH2CH2), 23.9 (CH2CH2Cqepo). 
MS (EI-DE) m/z (%) 216 [M+] (22), 198 (3), 187 (19), 169 (6), 159 (3), 143 (7), 129 (12), 118 (30), 
104 (4), 97 (20), 91 (100), 78 (8), 65 (18), 55 (11), 41 (23). 
HRMS (EI-DE) calcd for C14H16O2 [M+] 216.1152, found 216.1150. 
 
 
(2S,3S)-2,3-Epoxycyclooctanone ((2S,3S)-12d): After 24 h at 50 °C and base treatment of the crude 
product in THF, purification by flash column chromatography (silica gel, 10-40% 
Et2O in pentane) provided the title compound as a colorless solid (77 mg, 550 µmol, 
55%; 98:2 er). The enantiomeric ratio was determined by GC using a chiral BGB-
176/SE-52 30 m (80 C, 2 C/min until 135 C, 18 C/min until 220 C, 10 min at 220°C, 0.6 bar H2); 
major enantiomer: R = 23.43 min, minor enantiomer: R = 21.95 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.70 (d, J = 5.4 Hz, 1H, CHepoC(=O)), 3.22 (ddd, J = 9.8, 5.3, 3.7 Hz, 
1H, CH2CHepo), 2.66 (ddd, J = 13.2, 7.7, 4.2 Hz, 1H, CHHC(=O)), 2.30 (ddd, J = 13.6, 10.1, 3.6 Hz, 




1H, CHH(CH2)2CHepo), 1.69-1.62 (m, 1H, CHHCH2C(=O)), 1.60-1.51 (m, 2H, CH2CH2CHepo), 1.49-
1.40 (m, 1H, CHH(CH2)2CHepo), 0.99-0.91 (m, 1H, CHHCHepo). 
13C NMR (125 MHz, CD2Cl2) δ 207.3 (C=O), 58.8 (CHepoC(=O)), 55.7 (CH2CHepo), 43.0 (CH2C(=O)), 
27.2 (2C, CH2CHepo and CH2(CH2)2CHepo), 24.7 (CH2CH2C(=O)), 24.6 (CH2CH2CHepo). 
MS (EI-DE) m/z (%) 140 [M+] (18), 111 (5), 97 (16), 83 (37), 79 (17), 70 (30), 57 (27), 55 (100), 53 
(11), 41 (84), 39 (43), 27 (45). 
HRMS (EI-DE) calcd for C8H12O2 [M+] 140.0836, found 140.0837. 
 
 
(E)-(2S,3R)-2,3-Epoxycyclododecanone ((2S,3R)-12e): The title compound was isolated after 20 h at 
50 °C and purification by flash column chromatography (silica gel, 10-20% Et2O in 
pentane) as a white solid (45 mg, 229 mol, 92%; 99.5:0.5 er). The enantiomeric ratio 
was determined by GC using a chiral Hydrodex-β-TBDAc column 25 m (100 °C, 1.2 
C/min until 170 C, 20 C/min until 220 C, 10 min at 320 C, 0.6 bar H2); major 
enantiomer: R = 54.36 min, minor enantiomer: R = 53.35 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.51 (d, J = 1.6 Hz, 1H, CepoHC(=O)), 2.93 (td, J = 9.5, 2.2 Hz, 1H, 
CH2CepoH), 2.91-2.87 (m, 1H, CHHC(=O)), 2.32-2.67 (m, 1H, CHHC(=O)), 2.23-2.17 (m, 1H, 
CHHCepoH), 1.84-1.69 (m, 3H, -(CH2)n-), 1.54-1.35 (m, 9H, -(CH2)n-), 1.29-1.24 (m, 1H, -(CH2)n-), 
1.20-1.12 (m, 2H, -(CH2)n- and CHHCepoH). 
13C NMR (125 MHz, CD2Cl2) δ 206.9 (C=O), 61.2 (CH2CepoH), 59.2 (CepoHC(=O)), 41.4 (CH2C(=O)), 
32.2 (CH2CepoH), 26.9 (CH2), 26.5 (CH2), 25.7 (CH2), 25.5 (CH2), 24.4 (CH2), 24.0 (CH2), 23.2 (CH2). 
MS (EI) m/z (%) 196 [M+] (8), 178 (1), 168 (1), 149 (2), 139 (4), 135 (6), 121 (14), 111 (29), 107 (8), 
98 (54), 84 (31), 67 (36), 55 (100), 41 (92), 29 (39). 
HRMS (EI-DE) calcd for C12H20O2 [M+] 196.1465, found 196.1463. 
 
(E)-2,3-Epoxycyclopentadecanone (12f): The title compound (2S,3R)-23f was isolated 
after 20 h at 50 °C and purification by flash column chromatography (silica gel, 5-15% 
Et2O in pentane) as a white solid (52 mg, 218 µmol, 87%; 99.5:0.5 er). The 
enantiomeric ratio was determined by GC using a chiral Hydrodex--TBDAc column 
25m (100 °C, 1.2 C/min until 185 C, 18 C/min until 220 C, 10 min at 320 C, 0.6 




9-amino(9-deoxy)epiquinidine (1b) was used (instead of 1a). The title compound 
(2R,3S)-12f was isolated after 20 h at 50 °C and purification by flash column 
chromatography (silica gel, 5-15% Et2O in pentane) as a white solid (51 mg, 215 µmol, 
86%; 99.5:0.5 er). The enantiomeric ratio was determined by GC using a chiral 
Hydrodex--TBDAc column 25 m (100 °C, 1.2 C/min until 190 C, 18 C/min until 230 C, 5 min at 
320 C, 0.6 bar H2); major enantiomer: R = 64.72 min, minor enantiomer: R = 65.60 min. 
1H NMR (500 MHz, CD2Cl2) δ 3.27 (d, J = 1.9 Hz, 1H, CepoHC(=O)), 3.01 (td, J = 8.6, 2.7 Hz, 1H, 
CH2CepoH), 2.47-2.39 (m, 2H, CH2C(=O)), 2.06-2.00 (m, 1H, CHHCepoH), 1.73-1.63 (m, 2H, 
-(CH2)n-), 1.53-1.50 (m, 2H, -(CH2)n-), 1.39-1.21 (m, 17H, -(CH2)n- and CepoHCHH). 
13C NMR (125 MHz, CD2Cl2) δ 207.0 (C=O), 60.2 (CepoHC(=O)), 59.2 (CH2CepoH), 37.6 (CH2C(=O)), 
31.0 (CH2CepoH), 27.5 (CH2), 27.1 (CH2), 26.9 (CH2), 26.6 (CH2), 26.4 (CH2), 26.4 (CH2), 26.2 (CH2), 
25.7 (CH2), 24.9 (CH2), 22.6 (CH2). 
MS (EI) m/z (%) 238 [M+] (19), 220 (1), 209 (1), 195 (3), 177 (3), 163 (3), 149 (3), 121 (12), 111 (29), 
98 (48), 81 (38), 67 (39), 55 (100), 41 (86), 29 (34). 
HRMS (EI-DE) calcd for C15H26O2 [M+] 238.1931, found 238.1933. 
 
Hydroperoxidation of Cycloheptenone (11a) and Cyclooctenone (11d) 
 
The reactions of 2-cycloheptenone (11a) and 2-cyclooctenone (11d) were performed according to the 
general procedure for the catalytic asymmetric hydroperoxidation of acyclic ,-unsaturated ketones 2. 
 
7,8-Dioxabicyclo[4.2.1]nonan-1-ol/ 3-hydroperoxycycloheptanone (13a): 
The reaction mixture was stirred for 24 h at 32 °C. Purification of the crude 
product by flash column chromatography (silica gel, 20-60% Et2O in 
pentane) provided peroxide 13a as a clear oil (79 mg, 551 μmol, 55%; 95:5 
er). The enantiomeric ratio was determined after converting peroxide 13a into 2,3-epoxycyclo-
heptanone (12a). The enantiomers were analyzed by GC using a chiral Hydrodex--TBDAc column 25 
m (80 C, 1.5 C/min until 135 C, 20 C/min until 220 C, 10 min at 220°C, 0.6 bar H2); major 
enantiomer: τR = 24.31 min, minor enantiomer:τR = 28.24 min. 7,8-Dioxabicyclo[4.2.1]nonan-1-ol 
(13a) exists in equilibrium with 3-hydroperoxycycloheptanone (13a’): 80:20 (in THF). 














4.40 (m, 1H, CH), 2.61 (d, J = 12.6 Hz, 1H, CHCHHCq), 2.50 (dd, J = 12.0, 6.7 Hz, 1H, CHCHHCq), 
1.93-1.83 (m, 2H, CH2), 1.77-1.74 (m, 3H, CH2), 1.61-1.53 (m, 2H, CH2), 1.43-1.37 (m, 1H, 
CHHCH); 3-hydroperoxycycloheptanone (13a’): δ 9.39 (br s, 1H, OOH), 4.09-4.04 (m, 1H, CH), 2.77 
(dd, J = 14.7, 3.0 Hz, 1H, CHCHHC(=O)), 2.68 (dd, J = 14.8, 8.8 Hz, 1H, CHCHHC(=O)), 2.42-2.31 
(m, 2H, CH2CH2C(=O)), 1.93-1.83 (m, 2H, CH2), 1.77-1.74 (m, 4H, CH2). 
13C NMR (125 MHz, THF-d8) 7,8-dioxabicyclo[4.2.1]nonan-1-ol (13a): δ 108.1 (Cq), 81.3 (CH), 48.9 
(CHCH2Cq), 37.3 (CH2), 35.9 (CH2), 24.7 (CH2), 24.3 (CH2); 3-hydroperoxycycloheptanone (13a’): δ 
209.3 (C=O), 81.0 (CH), 48.4 (CHCH2C(=O)), 45.1 (CH2CH2C(=O)), 35.0 (CH2), 26.2 (CH2), 25.4 
(CH2). 
MS (EI-DE) m/z (%) 144 [M+] (10), 126 (1), 111 (100), 97 (16), 83 (18), 69 (12), 55 (52), 41 (37), 39 
(15), 29 (23). 
HRMS (EI-FE) calcd for C7H12O3 [M+] 144.0787, found 144.0786. 
 
 
3-Hydroperoxycyclooctanone/ 8,9-dioxabicyclo[5.2.1]decan-1-ol (13b): 
The reaction mixture was stirred for 24 h at 32 °C. Purification of the 
crude product by flash column chromatography (silica gel, 5-35% Et2O in 
pentane) provided peroxide 13b as a clear oil (93 mg, 571 μmol, 59%; 97:3 er). The enantiomeric ratio 
was determined after converting peroxide 13b into 2,3-epoxycyclooctanone (12d). The enantiomers 
were analyzed by GC using a chiral BGB-176/SE-52 30 m (80 C, 2 C/min until 140 C, 20 C/min 
until 220 C, 10 min at 220°C, 0.6 bar H2); major enantiomer: τR = 27.52 min, minor enantiomer: τR = 
25.41 min. 3-Hydroperoxycyclooctanone (13b) exists in equilibrium with 8,9-dioxabicyclo[5.2.1]de-
can-1-ol (13b’): 70:30 (in THF). 
1H NMR (500 MHz, CD2Cl2) 3-Hydroperoxycyclooctanone (13b): δ 8.98 (br s, 1H, OOH), 4.32-4.27 
(m, 1H, CH), 2.91 (dd, J = 12.1, 3.6 Hz, 1H, CHCHHC(=O)), 2.87 (d, J = 11.7 Hz, 1H, 
CHCHHC(=O)), 2.43-2.32 (m, 2H, CH2CH2C(=O)), 1.97-1.91 (m, 2H, CH2), 1.88-1.23 (m, 6H, -
(CH2)n-); 8,9-Dioxabicyclo[5.2.1]decan-1-ol (13b’): δ 4.58-4.56 (m, 1H, CH), 3.02 (br s, 1H, OH), 
2.88-2.84 (m, 2H, CHCH2Cq), 2.19-2.13 (m, 1H, CH2), 1.98-1.28 (m, 8H, -(CH2)n-), 0.88 (t, J = 7.6 
Hz, 1H, CH2). 
13C NMR (125 MHz, CD2Cl2) 3-Hydroperoxycyclooctanone (13b): δ 213.9 (C=O), 82.8 (CH), 44.0 












cyclo[5.2.1]decan-1-ol (13b’): δ 105.5 (Cq), 80.1 (CH), 52.6 (CHCH2Cq), 37.3 (CH2), 35.5 (CH2), 
28.0 (CH2), 26.2 (CH2), 25.3 (CH2). 
MS (EI-DE) m/z (%) 158 [M+] (18), 141 (2), 125 (64), 107 (18), 97 (17), 83 (21), 69 (12), 55 (100), 43 
(56), 41 (44), 29 (21). 
HRMS (CI-FE, i-butane) calcd for C8H15O3 [(M+H)+] 159.1022, found 159.1021. 
 
 




















Under argon, acetic acid (15 μL, 0.25 mmol, 0.5 equiv) was added to an ethanolic solution of sodium 
phenylselenide, prepared by the reduction of diphenylselenide (234 mg, 0.75 mmol, 1.5 equiv) with 
sodium borohydride (57 mg, 1.5 mmol, 3.0 equiv) in ethanol (3 mL), and the mixture was stirred for 
five minutes at room temperature. The resulting solution was added at once to a solution of ,-epoxy 
ketone 12 (0.5 mmol, 1.0 equiv) in ethanol (2 mL) at 0 °C. After five minutes at room temperature, the 
reaction mixture was diluted with Et2O or EtOAc (15 mL) and washed with brine (5 mL). The aqueous 
layer was repeatedly extracted with Et2O or EtOAc (2×10 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, filtered and concentrated under reduced pressure. Purification of 
the crude product by flash column chromatography (silica gel, eluent: Et2O-CH2Cl2) provided the 
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(S)-3-Hydroxycyclohexanone ((S)-15a): The title compound was prepared according to the general 
procedure and obtained as a colorless oil (54 mg, 470 μmol, 94%; 96:4 er) after 
purification by flash column chromatography (silica gel, 25-50% Et2O in CH2Cl2). The 
enantiomeric ratio was determined by GC using a chiral Hydrodex--TBDAc column 
25 m (35 min at 150 °C, 5 C/min until 220C, 10 min at 220 C, 0.5 bar H2); major 
enantiomer: τR = 17.65 min, minor enantiomer: τR = 21.68 min. 
1H NMR (500 MHz, CD2Cl2) δ 4.18-4.13 (m, 1H, CH), 2.59 (dd, J = 14.2, 4.1 Hz, 1H, 
CHCHHC(=O)), 2.35 (dd, J = 14.0, 7.4 Hz, 1H, CHCHHC(=O)), 2.27 (t, J = 6.6 Hz, 2H, CH2C(=O)), 
2.12 (br s, 1H, OH), 2.07-1.95 (m, 2H, CH2CHHCH and CH2CHHCH2), 1.77-1.65 (m, 2H, 
CH2CHHCH and CH2CHHCH2). 
13C NMR (125 MHz, CD2Cl2): δ 209.5 (C=O), 69.8 (CH), 50.3 (CHCH2C(=O)), 40.9 (CH2C(=O)), 
32.8 (CH2CH2CH), 20.7 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 114 [M+] (64), 96 (14), 86 (7), 81 (5), 73 (18), 68 (47), 60 (60), 58 (34), 55 (81), 
44 (100), 42 (85), 31 (9), 27 (28). 
HRMS (EI-FE) calcd for C6H10O2 [M+] 114.0680, found 114.0681. 
 
 
(S)-3-Hydroxy-3-methylcyclohexanone ((S)-15b): The title compound was prepared according to the 
general procedure and obtained as a white solid (46 mg, 357 μmol, 89%; 95.5:4.5 er) 
after purification by flash column chromatography (silica gel, 10-20% Et2O in CH2Cl2). 
The enantiomeric ratio was determined by GC using a chiral Hydrodex--TBDAc 
column 25 m (60 min at 145 °C, 6 C/min until 220C, 10 min at 220 C, 0.6 bar H2); 
major enantiomer: τR = 11.84 min, minor enantiomer: τR = 14.81 min. 
1H NMR (500 MHz, CD2Cl2) δ 2.40 (d, J = 14.0 Hz, 1H, CqOHCHHC(=O)), 2.36 (td, J = 13.9, 1.8 Hz, 
1H, CqOHCHHC(=O)), 2.33-2.22 (m, 2H, CH2C(=O)), 2.08-1.99 (m, 1H, CH2CHHCH2), 1.89-1.76 (m, 
3H, CH2CHHCH2 and CH2CH2CqOH), 1.55 (br s, 1H, OH), 1.33 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2): δ 209.8 (C=O), 74.0 (CqOH), 54.9 (CqOHCH2C(=O)), 40.5 (CH2C(=O)), 
37.7 (CH2CH2CqOH), 30.1 (CH3), 21.4 (CH2CH2CH2). 




(100), 43 (97), 41 (71), 31 (13), 29 (43). 
HRMS (EI-FE) calcd for C7H12O2 [M+] 128.0836, found 128.0837. 
 
 
(S)-3-Hydroxycycloheptanone ((S)-15c): The title compound was prepared according to the general 
procedure and obtained as a colorless oil (31 mg, 242 μmol, 84%; 99:1 er) after 
purification by flash column chromatography (silica gel, 40-60% Et2O in CH2Cl2). 
The enantiomeric ratio was determined by GC using a chiral Ivadex 7/PS086 column 
25 m (40 min at 105 °C, 10 C/min until 220C, 10 min at 320 C, 0.5 bar H2); major 
enantiomer: τR = 27.66 min, minor enantiomer: τR = 29.55 min. 
1H NMR (500 MHz, CD2Cl2) δ 4.06-4.02 (m, 1H, CH), 2.77-2.69 (m, 2H, CHCH2C(=O)), 2.47-2.36 
(m, 2H, CH2C(=O)), 2.03 (br s, 1H, OH), 1.90-1.78 (m, 3H, CH2CHHCH and CH2CH2CH2), 1.77-1.72 
(m, 2H, CH2CH2C(=O)), 1.61-1.55 (m, 1H, CH2CHHCH). 
13C NMR (125 MHz, CD2Cl2) δ 211.5 (C=O), 67.6 (CH), 51.7 (CHCH2C(=O)), 44.3 (CH2C(=O)), 38.9 
(CH2CH2CH2), 24.4 (CH2CH2CH), 23.8 (CH2CH2C(=O)). 
MS (EI) m/z (%) 128 [M+] (26), 113 (6), 100 (16), 95 (8), 85 (15), 71 (44), 69 (17), 58 (60), 55 (25), 43 
(100), 27 (13). 
HRMS (EI-DE) calcd for C7H12O2 [M+] 128.0836, found 128.0837. 
 
 
(R)-3-Hydroxycyclooctanone ((R)-15d): The title compound was prepared according to the general 
procedure. The reaction was stirred for 19 h at room temperature (90% conversion). 
Aldol product 15d was obtained as a colorless oil (5.4 mg, 38 μmol, 53%; 86:14 er) 
after purification by flash column chromatography (silica gel, 40-60% Et2O in 
CH2Cl2). The enantiomeric ratio was determined by GC using a chiral Ivadex 7 
column 25m (80 °C, 1 C/min until 160C, 20 C/min until 220C, 10 min at 220 C, 
0.5 bar H2); major enantiomer: τR = 41.2 min, minor enantiomer: τR = 42.3 min. 
1H NMR (500 MHz, CDCl3) δ 4.07-4.02 (m, 1H, CH), 2.77 (dd, J = 11.7, 3.8 Hz, 1H, CHCHHC(=O)), 
2.66 (dd, J = 11.4, 8.6 Hz, 1H, CHCHHC(=O)), 2.37-2.34 (m, 3H, CH2 and OH), 1.99-1.86 (m, 2H, 
CH2), 1.83-1.77 (m, 1H, CH2), 1.66-1.44 (m, 4H, CH2), 1.28-1.20 (m, 1H, CH2). 
13C NMR (125 MHz, CDCl3) δ 214.2 (C=O), 70.5 (CH), 47.4 (CHCH2C(=O)), 44.4 (CH2C(=O)), 34.6 




MS (EI-DE) m/z (%) 142 [M+] (12), 124 (13), 109 (2), 99 (21), 86 (30), 81 (24), 71 (30), 60 (8), 57 
(64), 55 (100), 43 (88), 41 (55), 39 (33), 29 (36). 
HRMS (EI-FE) calcd for C8H14O2 [M+] 142.0996, found 142.0996. 
 
 





Catalyst 1c (0.01 mmol) and (R)-Mosher’s acid 18 (0.02 mmol) were dissolved in dry 1,4-dioxane 
(0.4 mL). After stirring for 5 min, 16 (0.1 mmol) was added, followed by 50% aqueous hydrogen 
peroxide solution (0.15 mmol). After vigorous stirring for 168 h, the reaction mixture was poured into 
water (3 mL) and extracted with diethyl ether (3 x 5 mL). The organic fractions were dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Purification by flash column 
chromatography afforded epoxyketones 17.  
 
Preparation of Racemates 
 
Cyclopentenone 16 (0.5 mmol) and tert-butyl amine (0.015 mmol) were dissolved in methanol (3 mL) 
and 50% aqueous hydrogen peroxide solution (2.0 mmol) was added. After stirring for 24-48 h, the 
reaction mixture was poured into water and organic layer was extracted with diethyl ether. The organic 
fractions were dried over anhydrous MgSO4 and concentrated under reduced pressure. Purification by 
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(2S,3R)-2,3-Epoxycyclopentanone (17a): Purification: 50% diethyl ether/pentane. Colourless oil, 
87%. The enantiomeric ratio was determined to be 95:5 er by chiral GC using a 
Lipodex E column 25 m (80 C iso, 0.5 bar H2); major enantiomer: R = 8.22 min, 
minor enantiomer: R = 9.60 min. 
1H NMR (300 MHz, CD2Cl2) δ 3.89-3.88 (m, 1H, CH2CHepo), 3.26 (d, J = 2.6 Hz, 1H, CHepoC(=O)), 
2.37-2.17 (m, 2H, CHH), 2.09-1.97 (m, 2H, CHH). 
13C NMR (75 MHz, CD2Cl2) δ 210.3 (C=O), 58.3 (CHepoC(=O)), 55.2 (CH2CHepo), 30.9 (CH2C(=O)), 
23.5 (CH2CHepo). 
GC-MS (GC-EI) m/z (%) 98 [M+] (41), 82 (13), 69 (25), 55 (22), 53 (6), 42 (100), 39 (37), 31 (1), 27 
(18). 
HRMS (EI-FE) calcd for C5H6O2 [M+] 98.0367, found 98.0368. 
The physical data are identical in all respects to those previously reported.17 
 
(2S,3S)-Epoxy-3-(methyl)-cyclopentanone (17b): This compound been described in the literature.18 
The enantiomeric ratio was determined to be 95.5:4.5 er by chiral GC using a BGB-
176/BGB-15 column (80 C iso, 0.5 bar H2); major enantiomer: R = 10.75 min, minor 
enantiomer: R = 12.49 min. 
 
(2S,3R)-Epoxy-3-(tert-butyl)-cyclopentanone (17c): Purification: 50% ethylacetate/hexane. 
Colourless oil, 65%. The enantiomeric ratio was determined to be 96:4 er by chiral 
GC (Lipodex E, 95 °C, 0.5 bar H2), major enantiomer: R = 8.46 min, minor 
enantiomer: R = 11.14 min. 
1H NMR (500 MHz, CDCl3) δ 3.23 (s, 1H), 2.33-2.45 (m, 1H), 2.22-2.29 (m, 1H), 
2.06-2.17 (m, 2H), 1.03 (s, 9H). 
13C NMR (125 MHz, CDCl3) δ 211.4, 125.5, 65.9, 59.1, 32.7, 32.1, 30.3, 26.2, 22.3. 
HRMS (ESI+) m/z calcd for C9H15O2 155.1072, found 155.1073.  
                                                 
17 X. Wang, C. M. Reisinger, B. List, J. Am. Chem. Soc. 2008, 130, 6070-6071. 




(2S,3R)-Epoxy-3-(benzyl)-cyclopentanone (17d): This compound been described in the literature.19 
The enantiomeric ratio was determined to be 97.5:2.5 er by chiral GC using a 
Lipodex E column (130 C iso, 0.5 bar H2); major enantiomer: R = 26.62 min, 
minor enantiomer: R = 27.50  min. 
 
(2S,3S)-2,3-Epoxy-4,4-dimethylcyclopentanone (17e):  This compound been described in the 
literature.20 The enantiomeric ratio was determined to be 96.5:3.5 er by chiral GC 
using a Lipodex G column (50 C iso, 0.5 bar H2); major enantiomer: R = 15.95 min, 
minor enantiomer: R = 16.76  min. 
 
 
                                                 
19 Barco, A.; Benetti, S.; Pollini, G. P.; Taddia, R. Synthesis 1975, 104. 




































Phosphoric acid (R)-21b (25.0 mg, 0.05 mmol, 0.2 equiv) and amine catalyst 1a (8.08 mg, 0.025 
mmol, 0.1 equiv) were dissolved in dry THF (2 mL, 0.125 M) and stirred for 5 min under ambient 
atmosphere at room temperature. The α-branched enal 19 (0.25 mmol, 1 equiv) was added and the 
mixture was stirred for an additional 5 min at room temperature. Aqueous hydrogen peroxide (77 μL, 
50% w/w, 1.25 mmol, 5 equiv) was added, the reaction vessel was sealed and the reaction mixture was 
stirred for 24 h at 50 °C under an atmosphere of air. The reaction can be monitored by the 
disappearance of the starting material; the formed product is masked as a very polar species that 
appears as a poorly stainable spot on the TLC (Rf ~ 0.1) and is presumably a hydroperoxide adduct of 
the aldehyde 20. Workup A: The product 20 is liberated as the free aldehyde when the excess 
peroxide is quenched.  This was performed by stirring the crude reaction mixture with 10% aqueous 
Na2S2O3 (1 mL) for 10 min. The mixture was then diluted with water (5 mL) and diethyl ether (5 mL) 
and partitioned. The aqueous layer was washed with diethyl ether (5 mL x 3), and the combined 
organic layers were washed with brine and dried over Na2SO4. For yield determination, most 
compounds were directly reduced with NaBH4 (14.1 mg, 0.375 mmol, 1.5 equiv) in EtOH (2 mL) at 
room temperature, stirring for 10 min. Saturated aqueous Na,K-tartrate (Rochelle’s salt) was then 
added and the reaction mixture stirred for 1 h. The resulting biphasic solution was diluted with diethyl 




(5 mL x 2), and the combined organic layers were washed with brine and dried over Na2SO4.  
Evaporation of the solvent and flash column chromatography with the specified solvent system 
afforded the corresponding alcohols 20’. 
    
Workup B: In cases when the epoxyaldehyde products 20 were very volatile, a modified workup 
procedure was used before reduction to the corresponding alcohol. The crude reaction mixture was 
quenched by adding solid Na2S2O3 (250 mg) and the suspension was stirred for 1 h. It was then filtered 
through a pad of Celite, washing with 2-5 mL diethyl ether and 2 mL EtOH. To this filtrate was added 
solid NaBH4 (14.1 mg, 0.375 mmol, 1.5 equiv) and the reaction mixture was stirred for 10 min. 
Saturated aqueous Na,K-tartrate (Rochelle’s salt) was added and the reaction mixture was stirred for 1 
h. The resulting biphasic solution was diluted with diethyl ether (5 mL) and water (10 mL) and 
partitioned. The aqueous layer was washed extracted with EtOAc (5 mL x 2), and the combined 
organic layers were washed with brine and dried over Na2SO4.  Evaporation of the solvent and flash 
column chromatography with the specified solvent system afforded the desired product. 
 
 
Preparation of Racemates  
 
All racemates of the aldehydes 20 and 23, as well as their corresponding alcohol derivatives were 
prepared according to the procedure described by Pihko et al.21  
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((2S,3S)-3-ethyl-2-methyloxiran-2-yl)methanol (20a’): Prepared according to the general procedure 
and workup B using commercial (E)-2-methylpent-2-enal (E/Z >20:1, 
0.4 mmol) followed by reduction with NaBH4. Purification by flash 
chromatography (50% Et2O in pentane) afforded 20a’ as a colourless 
oil (19.9 mg, 0.17 mmol, 43%, 92:8 dr, 98.5:1.5 er) 
 
1H NMR (400 MHz, CDCl3) δ 3.69 (dd, J = 12.2 Hz, J = 4.3 Hz, 1H, CH2OH), 3.58 (dd, J = 12.2 Hz, 
J = 8.2 Hz, 1H, CH2OH), 3.00 (t, J = 6.4 Hz, 1H, CHOepox), 2.82 (minor diastereomer, t, J = 6.4 Hz, 
                                                 




1H, CHOepox), 1.72 (br dd, 1H, OH), 1.68-1.50 (m, 2H, CH3CH2), 1.29 (s, 3H, CH3), 1.04 (t, J = 7.5 
Hz, 3H, CH3CH2). 
13C NMR (100 MHz, CDCl3) only major diastereomer peaks detected: δ 65.4, 61.3, 60.9, 21.5, 14.1, 
10.5. 
FTIR (thin film) 3427, 2972, 2937, 2878, 1460, 1348, 1040, 909, 732 cm-1 
HRMS (m/z) calcd for C6H13O2 [M+H]+: 117.0916, found 117.0915. 
[α]D25  – 14.1 (c 0.170, CHCl3); Lit22: [α]D22  =  – 13.5 (c = 0.84, CHCl3). 
Chiral GC (Hydrodex-β TBDAc, 20 min at 100 °C, 8 °C/min until 220 °C, 5 min at 220 °C, 0.5 bar 
H2) R = 9.1 min (major enantiomer, major diastereomer), R = 11.0 min (major enantiomer, minor 
diastereomer), R = 12.0 min (minor enantiomer, major diastereomer), R = 13.2 min (minor 
enantiomer, minor diastereomer). 
 
 
(2R,3S)-3-ethyl-2-methyloxirane-2-carbaldehyde (20a): Chiral GC (BGB-176SE/ SE-52, 45 min at 
40 °C, 8 °C/min until 220 °C, 5 min at 220 °C, 0.5 bar H2): τR = 29.9 
min (minor enantiomer, minor diastereomer), τR =  32.2 min (major 
enantiomer, minor diastereomer), τR = 35.6 min (minor enantiomer, 
major diastereomer), τR = 35.9 min (major enantiomer, major 
diastereomer).  
Conditions for efficient separation of (2S,3R)-enriched mixture: Lipodex G (40 °C, 1 °C/min until 
60 °C,  12 °C/min until 220 °C, 5 min at 220 °C, 0.5 bar H2) R =  8.0 min (major enantiomer, minor 
diastereomer), R = 8.9 min (minor enantiomer, minor diastereomer), R =  9.1 min (major enantiomer, 
major diastereomer), R = 10.9 min (minor enantiomer, major diastereomer). 
 
 
((2S,3S)-2-ethyl-3-propyloxiran-2-yl)methanol (20b’): Prepared according to the general procedure 
and workup B using commercial (E)-2-ethylhex-2-enal (E/Z = 94:6, 0.36 
mmol) followed by reduction with NaBH4. Purification by flash 
chromatography (50% Et2O in pentane) afforded 20b’ as a colourless oil 
(33.1 mg, 0.23 mmol, 64%, 83:17 dr, 99:1 er). 
 
                                                 




1H NMR (400 MHz, CDCl3) δ 3.76 (dd, J = 12.1 Hz, J = 4.5 Hz, 1H, CH2OH), 3.61 (dd, J = 12.1 Hz, 
J = 8.2 Hz, 1H, CH2OH), 3.67 (minor diastereomer, dd, J = 11.8 Hz, J = 5.2 Hz, 1H, CH2OH), 3.05 
(apparent t, J = 5.6 Hz, 1H, CHOepox), 2.87 (minor diastereomer, dd, J = 6.6 Hz, J = 5.7 Hz, 1H, 
CHOepox), 1.95-1.84 (minor diastereomer, 2H, CH2CH3), 1.81-1.71 (m, 2H, CH2CH3), 1.62-1.44 (m, 
4H, CH3CH2CH2), 1.02-0.95 (m, 6H, CH3, CH3). 
13C NMR (100 MHz, CDCl3) major diastereomer: δ 63.96, 62.9, 60.4, 29.9, 21.8, 20.1 14.0, 9.3; 
minor diastereomer: δ 63.94, 63.3, 61.6, 30.0, 26.5, 20.0, 13.9, 8.9. 
FTIR (thin film) 3431, 2963, 2937, 2876, 1465, 1381, 1048, 908, 733 cm-1 
HRMS (m/z) calcd for C8H17O2 [M+H]+: 145.1229. Found 145.1227. 
[α]D25 : – 39.4 (c 0.508, CHCl3). 
Chiral GC (Lipodex G, 70 °C isocratic, 0.5 bar H2) τR = 29.3 min (minor enantiomer, major 
diastereomer), τR = 32.0 min (major enantiomer, major diastereomer), τR = 36.1 min (major 
enantiomer, minor diastereomer), τR = 37.4 min (minor enantiomer, minor diastereomer).  
 
The absolute stereochemistry was assigned by analogy and the relative stereochemistry was confirmed 





(2R,3S)-2-ethyl-3-propyloxirane-2-carbaldehyde (20b): Chiral GC (BGB-177/BGB-15, 35 min at 
70 °C, 8 °C/min until 220 °C, 5 min at 220 °C, 0.6 bar H2): τR = 19.6 
min (minor enantiomer, minor diastereomer), τR = 21.4 min (major 
enantiomer, minor diastereomer), τR = 22.6 min (major enantiomer, 







((2S,3S)-2-benzyl-3-phenethyloxiran-2-yl)methanol (20c’): Prepared according to the general 
procedure and workup A using (E)-2-benzyl-5-phenylpent-2-enal (E/Z 
>20:1, 0.25 mmol) followed by reduction with NaBH4. Purification by 
flash chromatography (20% Et2O in pentane) afforded 20c’ as a 
colourless oil (51.6 mg, 0.19 mmol, 77%, 90:10 dr, 99:1 er). 
 
1H NMR (500 MHz, CDCl3) δ 7.33-7.15 (m, 10H, CHAr), 3.59 (dd, J = 
12.3 Hz, J = 4.2 Hz, 1H, CH2OH), 3.48 (dd, J = 12.3 Hz, J = 8.5 Hz, 1H, CH2OH), 3.19 (dd, J = 7.5 
Hz, J = 5.2 Hz, 1H, CHOepox), 3.05 (minor diastereomer, d, J = 14.1 Hz, 1H, CHOepox), 2.98 (d, 
J = 14.8 Hz, 1H, PhCH2), 2.96-2.89 (m, 1H, PhCH2), 2.86-2.77 (m, 1H, PhCH2), 2.70 (d, J = 14.8 Hz, 
1H, PhCH2), 2.68-2.64 (minor diastereomer, m, 1H), 2.13-1.99 (m, 2H, PhCH2CH2), 1.92-1.80 (minor 
diastereomer, m, 1H), 1.52 (dd, J = 8.5 Hz, J = 4.2 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3) major diastereomer: δ 141.1, 136.5, 129.3, 128.6, 128.54, 128.48, 126.7, 
126.2, 63.7, 63.1, 60.0, 35.0, 33.0; minor diastereomer (not all peaks detected): 136.3, 129.8, 128.44, 
128.41, 126.3, 62.5, 61.6, 34.9, 32.7, 29.9. 
FTIR (thin film) 3437, 3063, 3028, 2928, 1603, 1496, 1454, 1068, 1031, 908, 732, 700 cm-1  
HRMS (m/z) calcd for C18H20O2Na [M+Na]+: 291.1356. Found 291.1353. 
[α]D25 : – 38.0 (c 0.548, CHCl3).  
Chiral HPLC: Diastereomer separation: Zorbax XDB/C18, methanol/water = 70:30, flow rate 
1.0 mL/min, 29.2 MPa, 210 nm. Upon separation, the major diastereomer was switched to a chiral 
column at 3.32 min till 3.42 min: Kromasil - AmyCoat, methanol/water = 98:2, flow rate 1.0 mL/min, 




(1S,6S)-7-oxabicyclo[4.1.0]heptan-1-ylmethanol (20d’): Prepared according to the general 
procedure and workup B using commercial cyclohex-1-
enecarbaldehyde (0.36 mmol) followed by reduction with NaBH4. 
Purification by flash chromatography (50% Et2O in pentane) afforded 
20d’ as a colourless oil (32.2 mg, 0.25 mmol, 70%, 98.5:1.5 er). 
 




Hz, J = 8.4 Hz, 1H, CH2OH), 3.26 (d, J = 3.4 Hz, 1H, CHOepox), 2.01-1.95 (m, 1H, OH), 1.90-1.64 
(m, 4H, CH2), 1.54-1.41 (m, 2H, CH2), 1.34-1.23 (m, 2H, CH2). 
13C NMR (100 MHz, CDCl3): δ 64.5, 60.1, 55.8, 25.3, 24.4, 19.9 19.7. 
FTIR (thin film) 3417, 2938, 2872, 1435, 1032, 916, 731 cm-1 
HRMS (m/z) calcd for C7H13O2 [M+H]+: 129.0916. Found 129.0916. 
[α]D25 : – 22.6 (c 0.504, CHCl3); Lit[185]: [α]D25 : – 22.8 (c 2.6, CHCl3, 93% ee). 
Chiral GC (BGB-177/BGB-15, 90 °C isocratic, 0.6 bar H2) τR = 32.2 min (minor enantiomer), τR = 
32.6 min (major enantiomer).   
 
The physical data are identical in all respects to those previously reported.23  
 
(1R,6S)-7-oxabicyclo[4.1.0]heptane-1-carbaldehyde (20d): Chiral GC 
(BGB-177/BGB-15, 65 °C isocratic, 0.7 bar H2) τR = 31.7 min (minor 




((2S,3S)-2-methyl-3-phenyloxiran-2-yl)methanol (20e’): Prepared according to the general procedure 
and workup A using commercial (E)-2-methyl-3-phenylacrylaldehyde 
followed by reduction with NaBH4. Purification by flash chromatography 
(30% Et2O in pentane) afforded 20e’ as a colourless oil (20.1 mg, 0.12 
mmol, 49%, 97:3 dr, 97.5:3.5 er). 
1H NMR (500 MHz, CDCl3) δ 7.41-7.34 (m, 2H, CHAr), 7.34-7.28 (m, 
3H, CHAr), 4.23 (s, 1H, PhCH), 3.87 (d, J = 12.4 Hz, 1H, CH2OH), 3.77 (d, J = 12.4 Hz, 1H, CH2OH), 
1.99 (br s, 1H, OH), 1.10 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 135.6, 128.1, 127.6, 126.4, 64.9, 63.6, 60.1, 13.5. 
FTIR (thin film) 3412, 3064, 2932, 2870, 1605, 1495, 1451, 1385, 1249, 1070, 1040, 956, 601, 852 
cm-1 
HRMS (m/z) calcd for C10H12O2Na [M]: 164.0837. Found 164.0836. 
m.p.: 52.2 – 53.2 °C. 
[α]D25 : – 14.5 (c 0.815, CHCl3), Lit[185]: [α]D25 : – 16.9 (c 2, CHCl3, >98% ee) 
                                                 




Chiral GC (Hydrodex – β-TBDAc, 60 min at 110 °C, 15 °C/min until 220 °C, 5 min at 220 °C, 0.6 
bar H2): tr 42.6 min (major enantiomer, major diastereomer), τR = 46.3 min (major enantiomer, minor 




(2R,3S)-2-methyl-3-phenyloxirane-2-carbaldehyde (20e): Chiral GC 
(BGB-177, 60 min at 120 °C, 15 °C/min until 220 °C, 5 min at 220 °C, 




4-((2S,3S)-3-(hydroxymethyl)-3-methyloxiran-2-yl)butyl acetate (20f’): Prepared according to the 
general procedure and workup A using (E)-6-methyl-7-oxohept-5-enyl 
acetate 19f (E/Z >20:1, 0.25 mmol) followed by reduction with 
NaBH4. Purification by flash chromatography (50% Et2O in pentane) 
afforded 20f’ as a colourless oil (33.5 mg, 0.160 mmol, 66%, 97:3 er). 
 
1H NMR (500 MHz, CDCl3) δ 4.09 (apparent t, J = 6.6 Hz, 2H, 
AcOCH2), 3.68 (apparent d, J = 12.0 Hz, 1H, CH2OH), 3.58 (dd, J = 12.0 Hz, J = 6.9 Hz, 1H, 
CH2OH), 3.04 (apparent t, J = 5.6 Hz, 1H, CHOepox), 2.85 (minor diastereomer, apparent t, J = 6.1 
Hz, 1H, CHOepox), 2.06 (s, 3H, CH3CO2), 2.01 (br s, 1H, OH), 1.74-1.48 (m, 6H, CH2), 1.29 (s, 3H, 
CH3). 
13C NMR (125 MHz, CDCl3) major diastereomer: δ 171.3, 65.3, 64.2, 60.9, 59.9, 28.4, 27.8, 23.0, 
21.0, 14.2; minor diastereomer (not all peaks detected): 64.6, 64.2, 63.9, 27.7, 23.2, 20.2;  
FTIR (thin film) 3447, 2955, 2868, 2250, 17365, 1458, 1433, 1387, 1367, 1240, 1035, 911, 868, 729 
cm-1 
HRMS (m/z) calcd for C10H18O4Na [M+Na]+: 225.1097. Found 225.1099. 
[α]D25 : – 17.7 (c 0.362, CHCl3). 
Chiral GC (Lipodex G, 60 min at 120 °C, 15 °C/min until 220 °C, 5 min at 220 °C, 0.5 bar H2): τR = 
37.9 min (minor enantiomer, major diastereomer), τR = 39.1 min (major enantiomer, major 
diastereomer), τR = 41.0 min (major enantiomer, minor diastereomer), τR = 42.2 min (minor 






4-((2S,3R)-3-formyl-3-methyloxiran-2-yl)butyl acetate (20f): Chiral GC (BGB-174/BGB-1701, 40 
min at 155 °C, 10 °C/min until 220 °C, 5 min at 220 °C, 0.5 bar H2):  
tr 22.1 min (major enantiomer, minor diastereomer), τR = 23.8 min 
(minor enantiomer, minor diastereomer), τR = 31.6 min (minor 
enantiomer, major diastereomer), τR = 32.5 min (major enantiomer, 
major diastereomer).  
 
((2S,3S)-2-methyl-3-phenethyloxiran-2-yl)methanol (20g’): Prepared according to the general 
procedure and workup A using (E)-2-methyl-5-phenylpent-2-enal (E/Z 
= 20:1, 0.25 mmol) followed by reduction with NaBH4. Purification by 
flash chromatography (50% Et2O in pentane) afforded 20g’ as a 
colourless oil (36.2 mg, 0.19 mmol, 75%, 95:5 dr, 98.5:1.5 er). 
 
1H NMR (500 MHz, CDCl3) δ 7.31-7.28 (m, 2H, CHAr), 7.22-7.19 (m, 
3H, CHAr), 3.63 (dd, J = 12.3 Hz,  J = 3.9 Hz, 1H, CH2OH), 3.52 (dd, J = 12.3 Hz, J = 8.8 Hz, 1H, 
CH2OH), 3.48 (minor diastereomer, dd, J = 11.7 Hz, J = 5.8 Hz, 1H, CH2OH), 3.38 (minor 
diastereomer, dd, J = 11.7 Hz, J = 6.2 Hz, 1H, CH2OH), 3.09 (t, J = 6.2 Hz, 1H, CHOepox), 2.89-2.83 
(m, 1H, PhCH2), 2.76-2.70 (m, 1H, PhCH2), 2.06-1.94 (m, 1H, PhCH2CH2), 1.88-1.81 (m, 1H, 
PhCH2CH2), 1.65 (br s, 1H, OH), 1.12 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3) major diastereomer: δ 141.2, 128.49, 128.47, 126.2, 65.3, 61.2, 59.6, 
32.7, 30.1, 14.1; minor diastereomer (not all signals detected): 142.4, 128.75, 128.6, 126.3, 64.3, 
63.7, 20.1. 
FTIR (thin film) 3427, 3027, 2928, 2861, 1604, 1496, 1454, 1073, 1039, 908, 749, 700 cm-1 
HRMS (m/z) calcd for C12H16O2 [M]+: 192.1150. Found 192.1151. 
[α]D25 : – 27.6 (c 0.521, CHCl3). 
Chiral HPLC: Diastereomer separation: Zorbax XDB/C18, acetonitrile/water = 25:75, flow rate 1.0 
mL/min, 22.2 MPa, 210 nm. Upon separation, each diastereomer was switched to a chiral column at 
5.57 min till 5.62 min for the minor diastereomer and 6.06 min till 6.11 min for the major 
diastereomer: Chiralpak AS-RH, acetonitrile/water = 30:70, flow rate 1.0 mL/min, 10.1 MPa, 210 




enantiomer). Major diastereomer (trans-20g’): τR = 11.5 min (minor enantiomer), τR = 12.21 min 
(major enantiomer).   
 
The absolute stereochemistry was assigned by analogy. The minor (2S, 3R) diastereomer cis-20g’ has 
been described.24  
 
 
(2R,3S)-2-methyl-3-phenethyloxirane-2-carbaldehyde (20g): Chiral GC (BGB-177/BGB-15, 60 
min at 120 °C, 10 °C/min until 230 °C, 5 min at 230 °C, 0.7 bar H2) τR 
= 40.0 min (major enantiomer, minor diastereomer), τR = 40.6 min 
(minor enantiomer, minor diastereomer), τR = 45.1 min (major 
enantiomer, major diastereomer), τR = 45.6 min (minor enantiomer, 
major diastereomer).   
 
Stereoconvergence in the Epoxidation of 19g 
 
Based on our previous studies with enones 2, we expected facile isomerization of the double bond 
under the reaction conditions. Although this assumption was validated when we tested the 
isomerization of (Z)-19 in the absence of hydrogen peroxide (entry 1), the diastereoconvergence of the 
reaction was only partial when hydrogen peroxide was present (entry 2). Presumably, the isomerization 
of the double bond and enal epoxidation occur at similar rates leading to the formation of 20g from 
both (E) and (Z)-configured starting materials. The overall result is a lower diastereo- and 
enantioselectivity of the major product compared to that obtained from pure (E)-19g (entry 3 vs. 2).  
                                                 





entry E/Z of 19ga H2O2 Conv. %
a dra er 20gb er epi-20gb 
E/Z of recovered 
19g 
1 5:95 None - - - - >95:5 
2 5:95 5 equiv 85 76:24 85:15 14:86 76:24 
3 >95:5 5 equiv 93.5 95:5 98.5:1.5 65:35 >95:5 








((2S,3R)-2-methyl-3-phenethyloxiran-2-yl)methanol (epi-20g’): Following the procedure of Prévost 
and Woerpel,25 a solution of (+)-diisopropyl tartrate (13.2 μL, 0.0625 
mmol, 0.22 equiv) in dichloromethane (1 mL) with 4Å molecular sieves 
(16 mg) was cooled to -20 °C. Ti(OiPr)4 (4.6 μL, 0.0129 mmol, 0.16 
equiv) was added, followed by tert-butylhydroperoxide (77.5 μL, 5.5 M 
in decanes, 0.426 mmol, 1.5 equiv). A solution of (Z)-2-methyl-5-
phenylpent-2-en-1-ol (50 mg, 0.28 mmol, 1 equiv) in dichloromethane (0.2 mL) was added. The 
reaction mixture was stirred at – 20 °C for 16 h, warmed up to room temperature at treated with H2O 
(0.3 mL) and 30% NaOH (0.1 mL). After stirring the biphasic solution for 1h at room temperature, the 
mixture was extracted with dichloromethane three times, dried over Na2SO4, filtered and concentrated. 
Flash column chromatography eluting with 35% diethyl ether in pentane afforded epi-20g’ as a 
colourless oil (43.6 mg, 0.23 mmol, 80%). 
 
                                                 




1H NMR (500 MHz, CDCl3) δ 7.31-7.28 (m, 2H, CHAr), 7.23-7.19 (m, 3H, CHAr), 3.47 (d, J = 12.0 
Hz, 1H, CH2OH), 3.38 (d, J = 12.0 Hz, 1H, CH2OH), 2.89-2.84 (m, 2H, PhCH2), 2.75-2.67 (m, 1H, 
CHOepox), 2.05-1.98 (m, 1H, PhCH2CH2), 1.87-1.81 (m, 1H, PhCH2CH2), 1.60 (br s, 1H, OH), 1.32 
(s, 3H, CH3).  
Chiral HPLC: Chiralpak AS-RH, acetonitrile/water = 30:70, flow rate 1.0 mL/min, 10.1 MPa, 210 
nm). τR = 5.55 min (major enantiomer), τR = 6.26 min (minor enantiomer). Since no diastereomer 
separation was required in this case, the sample was not pre-eluted on an achiral HPLC column. 
 
 
((2S,3S)-2-methyl-3-phenethyloxiran-2-yl)methanol (20h’): Prepared according to the general 
procedure and workup A using (E)-2,4-diphenylbut-2-enal (E/Z > 
20:1, 0.25 mmol) followed by reduction with NaBH4. Purification by 
flash chromatography (50% Et2O in pentane) afforded 20h’ as a 
colourless oil (29.4 mg, 0.12 mmol, 49%, 56:44 dr, 95:5 er). 
1H NMR (500 MHz, CDCl3) δ 7.46-7.05 (m, 10H, major + minor 
diast, CHAr), 4.32 (dd, J = 12.3 Hz, J = 4.8 Hz, 1H, major diast, CH2OH), 4.14 (dd, J = 12.3 Hz, 
J = 5.8 Hz, 1H, major diast, CH2OH), 4.06-3.91 (m, 2H, minor diast, CH2OH), 3.61 (t, J = 6.2 Hz, 
1H, minor diast, CHOepox), 3.22 (t, J = 6.4 Hz, 1H, major diast, CHOepox), 3.16 (dd, J = 14.7 Hz, J = 
6.4 Hz, 1H, major diast, PhCH2), 3.10 (dd, J = 14.7 Hz, J = 6.3 Hz, 1H, major diast, PhCH2), 2.58 
(dd, J = 14.7 Hz, J = 6.8 Hz, 1H, minor diast, PhCH2), 2.52 (dd, J = 14.7 Hz, J = 5.8 Hz, 1H, minor 
diast, PhCH2) 1.82 (br s, 1H, minor diast, OH), 1.73 (br s, 1H, major diast, OH). 
13CNMR (125 MHz, CDCl3, mixture of 2 diastereomers) δ 138.9, 137.44, 137.40, 135.6, 128.9, 
128.8, 128.7, 128.6, 128.5, 128.4, 128.1, 127.9, 127.4, 127.0, 126.8, 128.6, 125.9, 68.7, 66.2, 64.4, 
64.1, 63.2, 61.4, 34.9, 34.8. 
FTIR (thin film) 3432, 3062, 3029, 2923, 1603, 1496, 1453, 1085, 1031, 939, 861, 762 cm-1 
HRMS (m/z) calcd for C16H16O2Na [M+Na]+: 263.1042. Found 263.1040. 
Chiral HPLC: Diastereomer separation: Zorbax XDB/C18, elution gradient 0-9.5 min: 
methanol/water = 55:45, 9.5-12.5 min: methanol/water = 80:20, 12.5-20 min: methanol/water = 55:45 
, flow rate 1.0 mL/min, 32.8 MPa, 210 nm. Upon separation, each diastereomer was switched to a 
chiral column at 7.38 min till 7.42 min for the minor diastereomer and 8.28 min till 8.33 min for the 




nm). Minor diastereomer: τR = 18.2 min (minor enantiomer), τR = 19.4 min (major enantiomer). 
Major diastereomer: τR = 18.1 min (major enantiomer), τR = 18.6 min (minor enantiomer).   
 
(2S,3R)-3-heptyloxirane-2-carbaldehyde (20i): Prepared according to the general procedure and 
workup A using commercial (E)-dec-2-enal. The yield (30%) was 
determined by GC analysis (95:5 dr, 70:30 er). 
 
1H NMR (300 MHz, CDCl3) δ = 9.01 (d, J = 6.2 Hz, 1H), 3.18 - 3.15 
(m, 1H), 3.09 (dd, J = 6.2 Hz, 1H), 1.23 - 1.63 (m, 10H), 0.86 (t, J = 
5.3 Hz, 3H) 
Chiral GC: (BGB-176, 90 °C iso, 0.5 bar H2): τR = 12.1 min (major enantiomer, major 
diastereomer), τR = 12.9 min (minor enantiomer, major diastereomer), τR = 5.4 min (major 
enantiomer, minor diastereomer), τR = 1.12 min (minor enantiomer, minor diastereomer). 
 
The physical data are identical in all respects to those previously reported.26 The absolute 
stereochemistry was assigned by comparison of the chiral GC spectra with an authentic sample of 
(2R,3S)-31i which was prepared using the procedure of Wang and List.26  
                                                 












Phosphoric acid (R)-21a (37.6 mg, 0.05 mmol, 0.2 equiv) and amine catalyst 1a (8.08 mg, 0.025 
mmol, 0.1 equiv) were dissolved in dry THF (2 mL, 0.125 M) and stirred for 5 min under ambient 
atmosphere at room temperature. The α-branched enal 22 (0.25 mmol, 1 equiv) was added and the 
mixture was stirred for an additional 5 min at room temperature. Aqueous hydrogen peroxide (77 μL, 
50% w/w, 1.25 mmol, 5 equiv) was added, the reaction vessel was sealed and the reaction mixture was 
stirred for 24 h at 50 °C under an atmosphere of air. The reaction can be monitored by the 
disappearance of the starting material; the formed product is masked as a very polar species that 
appears as a poorly stainable spot on the TLC (Rf ~ 0.1) and is presumably a hydroperoxide adduct of 
the aldehyde 22. Workup A: The product 23 is liberated as the free aldehyde when the excess 
peroxide is quenched.  This was performed by stirring the crude reaction mixture with 10% aqueous 
Na2S2O3 (1 mL) for 10 min. The mixture was then diluted with water (5 mL) and diethyl ether (5 mL) 
and partitioned. The aqueous layer was washed with diethyl ether (5 mL x 3), and the combined 
organic layers were washed with brine and dried over Na2SO4. For yield or er determination, some 
compounds were directly reducted with NaBH4 (14.1 mg, 0.375 mmol, 1.5 equiv) in EtOH (2 mL) at 
room temperature, stirring for 10 min. Saturated aqueous Na,K-tartrate (Rochelle’s salt) was then 
added and the reaction mixture stirred for 1 h. The resulting biphasic solution was diluted with diethyl 




(5 mL x 2), and the combined organic layers were washed with brine and dried over Na2SO4.  
Evaporation of the solvent and flash column chromatography with the specified solvent system 
afforded the corresponding alcohols 23’. 
    
Workup B: In cases when the epoxyaldehyde products 23 were very volatile, a modified workup 
procedure was used before reduction to the corresponding alcohol. The crude reaction mixture was 
quenched by adding solid Na2S2O3 (250 mg) and the suspension was stirred for 1 h. It was then filtered 
through a pad of Celite, washing with 2-5 mL diethyl ether and 2 mL EtOH. To this filtrate was added 
solid NaBH4 (14.1 mg, 0.375 mmol, 1.5 equiv) and the reaction mixture was stirred for 10 min. 
Saturated aqueous Na,K-tartrate (Rochelle’s salt) was added and the reaction mixture was stirred for 1 
h. The resulting biphasic solution was diluted with diethyl ether (5 mL) and water (10 mL) and 
partitioned. The aqueous layer was washed extracted with EtOAc (5 mL x 2), and the combined 
organic layers were washed with brine and dried over Na2SO4.  Evaporation of the solvent and flash 
column chromatography with the specified solvent system afforded the desired product. 
 
Scope of Optically Active ,-Epoxyaldehydes 23 
 
 
(R)-2-benzyloxirane-2-carbaldehyde (23a): Prepared according to the general procedure and workup 
A using 2-benzylacrylaldehyde (0.25 mmol). Purification by flash 
chromatography (20% Et2O in pentane) afforded 23a as a colourless oil 
(31.7 mg, 0.195 mmol, 78%, 99:1 er). 
 
1H NMR (400 MHz, CDCl3) δ 8.94 (s, 1H, CHO), 7.31-7.20 (m, 5H, 
CHAr), 3.21 (d, J = 1.4 Hz, 2H, PhCH2), 3.00 (d, J = 4.6 Hz, 1H, 
CH2Oepox), 2.85 (d, J = 4.6 Hz, 1H, CH2Oepox). 
13C NMR (100 MHz, CDCl3): δ 198.6, 134.8, 129.9, 128.4, 127.0, 61.4, 48.9, 33.1. 
FTIR (thin film) 3064, 3032, 2826, 1726, 1497, 1454, 1077, 1010, 907, 730 cm-1 
HRMS (m/z) calcd for C10H10O2 [M]+: 162.0681. Found 162.0682. 
[α]D25 : + 47.0 (c 0.502, CHCl3). 
Chiral GC (BGB-178/BGB-15, 35 min at 115 °C, 8 °C/min until 220 °C, 0.6 bar H2) τR = 26.0 min 





The physical data are identical in all respects to those previously reported.27 The absolute 
stereochemistry was assigned by analogy. 
 
 
(S)-(2-(oct-7-enyl)oxiran-2-yl)methanol (23b’): Prepared according to the general procedure and 
workup A using 2-methylenedec-9-enal (0.25 mmol) followed by 
reduction with NaBH4. Purification by flash chromatography (30% 
Et2O in pentane) afforded 23b’ as a colourless oil (33.9 mg, 0.184 
mmol, 74%, 98.5:1.5 er). 
 
1H NMR (300 MHz, CDCl3) δ 5.80 (ddt, J = 17.4 Hz, J = 10.2 Hz, 
J = 6.7 Hz, CH=CH2), 5.03-4.99 (m, 2H, CH=CH2), 3.77 (dd, J = 12.2, J = 4.2 Hz, 1H, CH2OH), 3.64 
(dd, J = 12.2 Hz, J = 8.6 Hz, 1H, CH2OH), 2.88 (d, J = 4.7 Hz, 1H, CH2Oepox), 2.66 (d, J = 4.7 Hz, 
1H, CH2Oepox), 2.07-2.00 (m, 2H, CH2=CHCH2), 1.82-1.26 (m, 11H, CH2). 
13C NMR (75 MHz, CDCl3): δ 139.0, 114.3, 62.8, 59.7, 49.8, 33.7, 32.0, 29.6, 28.9, 28.8, 24.6;  
FTIR (thin film) 3429, 3077, 2928, 2857, 2249, 1641, 1464, 1415, 1046, 908, 730 cm-1 
HRMS (m/z) calcd for C11H21O2 [M+H]+: 185.1542. Found 185.1540. 
[α]D25 : – 10.8 (c 0.574, CHCl3). 
Chiral GC (Hydrodex-β TBDAc, 25 min at 150 °C, 10 °C/min until 220 °C, 0.5 bar H2) τR = 14.5 
min (major enantiomer), τR = 15.4 min (minor enantiomer).  
 
 
(R)-2-(oct-7-enyl)oxirane-2-carbaldehyde (23b):  
 
1H NMR (500 MHz, CDCl3) δ 8.88 (s, 1H, CHO), 5.80 (ddt, J = 17.09 
Hz, J = 10.2 Hz, J = 6.6 Hz, CH=CH2), 5.03-4.90 (m, 2H, CH=CH2), 
3.02 (br s, 2H, CH2Oepox), 2.09-1.88 (m, 3H, CH2), 1.76-1.66 (m, 1H, 
CH2), 1.46-1.21 (m, 8H, CH2). 
13C NMR (100 MHz, CDCl3): δ 199.1, 139.0, 114.3, 61.4, 49.6, 33.7, 
29.5, 28.8, 28.7, 27.6, 24.3. 
FTIR (thin film) 3077, 2929, 2857, 1730, 1641, 1464, 1438, 1144, 910, 731 cm-1 
HRMS (m/z) calcd for C11H19O2 [M+H]+: 183.1385. Found 183.1383. 
                                                 





Chiral GC (BGB-174/BGB-1701, 130 °C isocratic, then baked out at 8 °C/min until 220 °C, 5 min at 
220 °C, 0.5 bar H2): τR = 27.8 min (major enantiomer), τR = 29.3 min (minor enantiomer). 
 
 
(S)-(2-octyloxiran-2-yl)methanol (23d’): Prepared according to the general procedure B using 2-
methylenedecanal 22d (0.25 mmol) followed by reduction with NaBH4. 
Purification by flash chromatography (50% Et2O in pentane) afforded 
23d’ as a colourless oil (36.4 mg, 0.196 mmol, 78%, 99:1 er). 
 
1H NMR (500 MHz, CDCl3) δ 3.78 (dd, J = 12.1, J = 3.8 Hz, 1H, 
CH2OH), 3.64 (dd, J = 12.1 Hz, J = 8.4 Hz, 1H, CH2OH), 2.89 (d, J = 
4.7 Hz, 1H, CH2Oepox), 2.67 (d, J = 4.7 Hz, 1H, CH2Oepox), 1.80-1.75 (m, 1H, CH2), 1.68 (br s, 1H, 
OH), 1.53-1.47 (m, 1H, CH2), 1.39-1.23 (m, 12H, CH2), 0.88 (t, J = 6.7 Hz, 3H, CH3).  
13C NMR (125 MHz, CDCl3): δ 62.7, 59.8, 49.8, 32.0, 31.8, 29.7, 29.2, 24.6, 22.6, 14.1. 
FTIR (thin film) 3421, 2927, 2857, 2251, 1466, 1364, 1197, 1053, 908, 808, 731 cm-1 
[α]D25 : – 14.8 (c 0.595, CHCl3); Lit[130] [α]D20 : – 11.7 (c 1.0, CHCl3, 72% ee). 
HRMS (m/z) calcd for C11H23O2 [M+H]+: 187.1698. Found 187.1699. 
Chiral GC (BGB-177/BGB-15, 140 °C isocratic, then baked out at 220 °C, 0.6 bar H2) τR = 19.75 min 
(major enantiomer), τR = 20.8 min (minor enantiomer).  
 




(S)-2-((R)-1-phenylethyl)oxirane-2-carbaldehyde (anti-23e): Prepared according to the general 
procedure and workup A using racemic 2-methylene-3-phenylbutanal 
rac-23e (0.25 mmol). Analysis of the crude reaction mixture after 24 h 
showed 53% conversion of the starting material and two diastereomers 
23e and epi-23e with dr = 83:17. Purification by flash chromatography 
                                                 




(5% EtOAc in pentane) afforded 23e as a colourless oil (13.0 mg, 0.074 mmol, 30%, lowered yield 
due to incomplete separation from (S)-22e, 96:4 er).  
 
1H NMR (500 MHz, CDCl3) δ 8.95 (s, 1H, CHO), 7.31-7.28 (m, 2H, CHAr), 7.26-7.21 (m, 3H, CHAr), 
3.68 (q, J = 7.2 Hz, 1H, PhCH), 2.87 (d, J = 4.6 Hz, 1H, CH2Oepox), 2.58 (d, J = 4.6 Hz, 1H, 
CH2Oepox), 1.38 (d, J = 6.9 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 199.0, 140.4, 128.5, 128.2, 127.1, 64.6, 48.9, 35.8, 16.2. 
FTIR (thin film) 30314, 2979, 2940, 2821, 2255, 1733, 1496, 1454, 907, 865, 729 cm-1 
HRMS (m/z) calcd for C11H12O2 [M]+: 176.0837. Found 176.0839. 
[α]D25 : + 41.5 (c 0.65, CHCl3). 
Chiral GC (G-BP, 40 min at 110 °C, 14 °C/min until 220 °C, 5 min at 220 °C, 0.6 bar H2): τR = 
25.3 min (minor enantiomer, major diastereomer 23e), τR = 27.0 min (major enantiomer, major 
diastereomer 23e), τR = 34.0 min (minor enantiomer, minor diastereomer epi-23e), τR = 36.3 min 
(major enantiomer, minor diastereomer epi-23e).   
The physical data are identical in all respects to those previously reported.[88]  
 
(S)-2-methylene-3-phenylbutanal (S)-22e: The physical data of this compound are identical in all 
respects to rac-22e. This compound was isolated by flash 
chromatography (5% EtOAc in pentane) as a colourless oil (8.79 mg, 
0.055 mmol, 22%, lowered yield due to incomplete separation from 
23e, 97:3 er). 
 
[α]D25 : + 48.6 (c 0.44, CHCl3), Lit (R enantiomer)[135]: [α]D25 : –  38.7 
(c 1.01, CHCl3). 
Chiral GC (G-BP, 40 min at 110 °C, 14 °C/min until 220 °C, 5 min at 220 °C, 0.6 bar H2) τR = 13.9 















Assignment of the absolute configuration:  
 
 
(S)-22e: The absolute configuration was established by comparison of the optical rotation with the 
literature value.29  
 
23e: The relative anti-configuration was assigned by comparison of the chemical shifts in 1H and 13C 
NMR spectra with the literature values.30 The absolute configuration was assigned based on the 
configuration of the recovered enantioenriched starting material (S)-22e. 
                                                 
29 K. S. Yoo, C. P. Park, C. H. Yoon, S. Sakaguchi, J. O’Neill, K. W. Jung, Org. Lett. 2007, 9, 3933. 






epi-23e:  The relative syn-configuration was assigned by comparison of the chemical shifts in 1H and 
13C NMR spectra with the literature values.[88] The absolute configuration was tentatively assigned 
based on the observed dr and er values of all components of the reaction, such that the stoichiometry 
of the (R) and (S) enantiomers at C-3 is balanced. GC and NMR analyses of the crude reaction mixture 
indicated that (S)-22e, 23e and epi-23e were the only components of the reaction.  
 
Preparation of Starting Materials 
 
Preparation of Acyclic -Unsaturated Ketones 
 




Methyl vinyl ketone (MVK; 12.5 mmol, 2.5 equiv) and Grubbs’ second generation catalyst (106 mg, 
0.125 mmol, 2.5 mol%) were successively added to the solution of a terminal alkene (5 mmol, 1 equiv) 
in CH2Cl2 (50 mL). The reaction mixture was heated to reflux overnight (12-16 h) and then allowed to 
cool to room temperature. The volatiles were removed under reduced pressure and the crude product 
was purified by flash column chromatography (silica gel, eluent: Et2O-pentane or Et2O-CH2Cl2) to 






(E)-7-Bromo-3-hepten-2-one (2f): The title compound was prepared according to the general 
procedure A from MVK and 5-bromo-1-pentene. The crude product was purified 
by flash column chromatography (silica gel, 5-15% Et2O in pentane) to give 
enone 2f (748 mg, 3.94 mmol, 78%) as a pale yellow oil. Contains 4% of (E)-7-
chloro-3-hepten-2-one as determined by GC. 
1H NMR (500 MHz, CD2Cl2) δ 6.74 (dt, J = 15.9, 6.9 Hz, 1H, =CHCH2), 6.09 (dt, J = 16.1, 1.4 Hz, 
1H, CH=CHCH2), 3.44 (t, J = 6.6 Hz, 2H, BrCH2), 2.41-2.36 (m, 2H, =CHCH2), 2.21 (s, 3H, CH3), 
2.06-2.00 (m, 2H, CH2CH2CH2). 
13C NMR (125 MHz, CD2Cl2): δ 198.0 (C=O), 145.7 (=CHCH2), 132.1 (CH=CHCH2), 32.9 (BrCH2), 
31.0 (CH2CH2CH2), 30.8 (=CHCH2), 26.8 (CH3). 
GC-MS (GC-EI) m/z 190 [M+]. 
HRMS (EI-FE) calcd for C7H11BrO [M+] 189.9992, found 189.9993. 
 
(E)-Ethyl 6-oxohept-4-enoate (2i): The title compound was prepared according to the general 
procedure A from MVK and ethyl 4-pentenoate. The crude product was 
purified by flash column chromatography (silica gel, 40-55% Et2O in 
pentane) to give enone 2i (679 mg, 3.99 mmol, 80%) as a pale yellow oil. 
1H NMR (300 MHz, CD2Cl2) δ 6.77 (dt, J = 15.9, 6.3 Hz, 1H, =CHCH2), 6.08 (dt, J = 15.9, 1.5 Hz, 
1H, CH=CHCH2), 4.11 (q, J = 7.2 Hz, 2H, CH2CH3), 2.57-2.43 (m, 4H, CH2), 2.20 (s, 3H, 
CH3C(=O)), 1.23 (t, J = 7.1 Hz, 3H, CH2CH3). 
13C NMR (100 MHz, CD2Cl2) δ 198.0 (C=O), 172.2 (CO2Et), 145.7 (=CHCH2), 131.7 (CH=CHCH2), 
60.5 (CH2CH3), 32.5 (CH2CO2Et), 27.5 (=CHCH2), 26.7 (CH3C(=O)), 14.0 (CH2CH3). 
MS (EI-DE) m/z 170 [M+] (26), 155 (3), 141 (5), 124 (76), 109 (18), 97 (41), 83 (40), 68 (3), 55 (20), 
43 (100), 29 (27). 
HRMS (EI-FE) calcd for C9H14O3 [M+] 170.0941, found 170.0943. 
 
(E)-3-Octene-2,7-dione (2j): The title compound was prepared according to the general procedure A 
from MVK and 5-hexen-2-one. The crude product was purified by flash column 
chromatography (silica gel, 30-55% Et2O in pentane) to give enone 2j (698 mg, 




1H NMR (300 MHz, CD2Cl2) δ 6.76 (dt, J = 15.9, 6.7 Hz, 1H, =CHCH2), 6.03 (dt, J = 16.1, 1.6 Hz, 
1H, CH=CHCH2), 2.63-2.58 (m, 2H, CH2), 2.49-2.41 (m, 2H, CH2), 2.19 (s, 3H, CHolC(=O)CH3), 
2.13 (s, 3H, CH3C(=O)CH2). 
13C NMR (100 MHz, CD2Cl2) δ 206.6 (CH2C(=O)), 198.1 (CHolC(=O)), 146.3 (=CHCH2), 131.6 
(CH=CHCH2), 41.5 (CH2C(=O)), 29.7 (CH3C(=O)CH2), 26.7 (CHolC(=O)CH3), 26.2 (=CHCH2). 
MS (EI-DE) m/z (%) 140 [M+] (15), 122 (2), 97 (82), 83 (7), 79 (6), 69 (3), 55 (5), 43 (100), 41 (6), 27 
(4). 
HRMS (EI-FE) calcd for C8H12O2 [M+] 140.0836, found 140.0837. 
 
(E)-9-hydroxy-3-nonen-2-one (2k): The title compound was prepared according to the general 
procedure A from MVK and 7-hydroxy-1-heptene. Flash column 
chromatography (silica gel, 10-30% Et2O in CH2Cl2) afforded enone 2k 
(503 mg, 3.22 mmol, 64%) as a greenish oil (contains ruthenium trace 
impurities). 
1H NMR (400 MHz, CD2Cl2) δ 6.79 (dt, J = 15.9, 7.0 Hz, 1H, CH2CH=), 6.03 (dt, J = 16.2, 1.4 Hz, 
1H, CH2CH=CH), 3.59 (t, J = 6.6 Hz, 2H, CH2OH), 2.21 (app. qd overlapped, J = 7.1, 1.4 Hz, 2H, 
CH2), 2.20 (s, 3H, CH3), 1.75 (br s, 1H, OH), 1.56-1.46 (m, 4H, CH2), 1.41-1.34 (m, 2H, CH2). 
13C NMR (100 MHz, CD2Cl2) δ 198.8 (C=O), 148.6 (CH2CH=), 131.6 (CH2CH=CH), 62.9 (CH2OH), 
32.9(CH2), 32.7 (CH2), 28.3 (CH2), 26.9 (CH3), 25.7 (CH2). 
MS (EI-DE) m/z (%) 156 [M+] (1), 138 (11), 123 (9), 113 (7), 95 (55), 84 (8), 81 (32), 71 (42), 67 (32), 
58 (9), 55 (49), 53 (15), 43 (100), 41 (27), 31 (19). 
HRMS (CI-FE, i-butane) calcd for C9H17O2 [(M+H)+] 157.1230, found 157.1229. 
 









dene)-2-propanone (6.37 g, 20 mmol, 1 equiv) was added at 0 °C. The reaction mixture was allowed to 
warm to room temperature and stirred until TLC or GC/MS analysis indicated complete consumption 
of the starting aldehyde (12-24 h). Then silica gel was added and the solvent was removed under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: Et2O-
pentane) to afford the corresponding (E)-,-enone 2. 
 
(E)-6-Phenyl-3-hexen-2-one (2b): The title compound was prepared according to the general 
procedure B from hydrocinnamaldehyde and 1-(triphenylphosphor-
anylidene)-2-propanone. The crude product was purified by flash column 
chromatography (silica gel, 10% Et2O in pentane) to give enone 2b (2.62 g, 
15.0 mmol, 75%) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.30-7.27 (m, 2H, CHPh, m), 7.21-7.16 (m, 3H, CHPh, o, p), 6.80 (dt, J = 
15.9, 6.9 Hz, 1H, =CHCH2), 6.08 (dt, J = 16.1, 1.4 Hz, 1H, CH=CHCH2), 2.78 (t, J = 7.7 Hz, 2H, 
PhCH2), 2.54 (app. qd, J = 7.3, 1.4 Hz, 2H, =CHCH2), 2.21 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 198.6 (C=O), 147.1 (=CHCH2), 140.7 (CqPh), 131.7 (CH=CHCH2), 
128.5 (2C, CHPh), 128.3 (2C, CHPh), 126.2 (CHPh, p), 34.4 (CH2), 34.1 (CH2), 26.9 (CH3). 
MS (EI-DE) m/z (%) 174 [M+] (5), 159 (4), 131 (5), 116 (16), 104 (2), 91 (100), 77 (2), 65 (10), 51 (3), 
43 (9), 27 (2). 
HRMS (EI-FE) calcd for C12H14O [M+] 174.1045, found 174.1045. 
 
(E)-6-Methylhept-3-en-2-one (2c): The title compound was prepared according to the general 
procedure B from isovaleraldehyde with 1-(triphenylphosphoranylidene)-2-
propanone. The crude product was purified by flash column chromatography (silica 
gel, 5% Et2O in pentane) to give enone 2c (1.51 g, 12.0 mmol, 60% (reduced yield 
due to the high volatility of 2c)) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3) δ 6.74 (dt, J = 16.0, 7.4 Hz, 1H, =CHCH2), 6.03 (dt, J = 16.0, 1.4 Hz, 1H, 
CH=CHCH2), 2.21 (s, 3H, CH3C(=O)), 2.08 (app. td, J = 7.1, 1.3 Hz, 2H, CH2), 1.74 (hept, J = 6.7 Hz, 
1H, CHMe2), 0.90 (d, J = 6.7 Hz, 6H, CH(CH3)2). 
13C NMR (125 MHz, CDCl3) δ 198.6 (C=O), 147.3 (=CHCH2), 132.3 (CH=CHCH2), 41.7 (CH2), 27.8 
(CHMe2), 26.8 (CH3C(=O)), 22.3 (2C, CH(CH3)2). 




HRMS (EI-FE) calcd for C8H14O [M+] 126.1043, found 126.1045. 
 
(E)-4-Cyclohexylbut-3-en-2-one (2d): The title compound was prepared according to the general 
procedure B from cyclohexanecarbaldehyde with 1-(triphenylphosphoranylidene)-
2-propanone. The crude product was purified by flash column chromatography 
(silica gel, 10% Et2O in pentane) to give enone 2d (2.80 g, 18.4 mmol, 92%) as a 
pale yellow oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.71 (dd, J = 16.1, 6.8 Hz, 1H, =CHCH), 5.98 (dd, J = 16.3, 1.2 Hz, 
1H, CH=CHCH), 2.20 (s, 3H, CH3), 2.18-2.11 (m, 1H, =CHCH), 1.79-1.74 (m, 4H, CH2), 1.70-1.66 
(m, 1H, CH2), 1.35-1.27 (m, 2H, CH2), 1.24-1.11 (m, 3H, CH2). 
13C NMR (125 MHz, CD2Cl2) δ 199.0 (C=O), 153.5 (=CHCH), 129.1 (CH=CHCH), 41.0 (=CHCH), 
32.2 (2C, CHCH2), 26.9 (CH3), 26.3 (CH2), 26.1 (2C, CH2). 
GC-MS (GC-EI) m/z 152 [M+]. 
HRMS (EI-FE) calcd for C10H16O [M+] 152.1200, found 152.1201. 
 
(E)-Octa-3,7-dien-2-one (2e): The title compound was prepared according to the general procedure B 
from 4-pentenal and 1-(triphenylphosphoranylidene)-2-propanone. The crude 
product was purified by flash column chromatography (silica gel, 5-10% Et2O in 
pentane) to give enone 2e (2.19 g, 17.6 mmol, 88%) as a pale yellow oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.77 (dt, J = 16.1, 6.8 Hz, 1H, CH2CH=CH), 6.05 (dt, J = 15.9, 1.5 Hz, 
1H, CH2CH=CH), 5.82 (ddt, J = 16.9, 11.7, 6.0 Hz, 1H, CH2=CH), 5.06 (app. dq, J = 17.0, 1.7 Hz, 1H, 
CHtransH=), 5.01 (app. dq, J = 10.5, 1.5 Hz, 1H, CHHcis=), 2.35-2.30 (m, 2H, CH2CH=CH), 2.25-2.21 
(m, 2H, CH2=CHCH2), 2.20 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 198.5 (C=O), 147.6 (CH2CH=CH), 137.7 (CH2=CH), 131.9 
(CH2CH=CH), 115.5 (CH2=CH), 32.5 (CH2=CHCH2), 32.0 (CH2CH=CH), 26.9 (CH3). 
GC-MS (GC-EI) m/z 124 [M+] (trace), 122 (4), 109 (14), 95 (12), 91 (3), 81 (58), 79 (35), 11 (12), 66 
(12), 55 (34), 53 (18), 51 (6), 43 (100), 41 (34), 27 (10). 
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6-(Tetrahydro-2H-pyran-2-yloxy)-1-hexanol: A solution of 1,6-hexanediol (2.36 g, 20.0 mmol, 1.7 
equiv) and dihydropyrane (1.10 mL, 12.0 mmol) in THF (100 mL) in the 
presence of p-toluenesulfonic acid monohydrate (190 mg, 1.0 mmol) was 
stirred at 0 °C for 12 h. Then the solution was poured on saturated aqueous 
NaHCO3 solution and extracted with Et2O. The combined organic layers were dried (Na2SO4), filtered, 
and concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (silica gel, 40% EtOAc in hexanes) to provide the title compound (1.44 g, 7.13 mmol, 
59%) as a colorless oil. 
1H NMR (500 MHz, CD2Cl2) δ 4.55 (t, J = 3.4 Hz, 1H, OCHO), 3.88-3.81 (m, 1H, OCHHTHP), 3.72 
(dt, J = 9.8, 6.8 Hz, 1H, THPOCHH), 3.62 (t, J = 6.6 Hz, 2H, CH2OH), 3.51-3.44 (m, 1H, OCHHTHP), 
3.37 (dt, J = 9.6, 6.5 Hz, 1H, THPOCHH), 1.86-1.35 (m, 15H, CH2 and OH). 
13C NMR (125 MHz, CD2Cl2) δ 98.9 (OCHO), 67.5 (THPOCH2), 62.9 (OCH2), 62.4 (OCH2), 32.7 
(CH2), 30.8 (CH2), 29.7 (CH2), 26.0 (CH2), 25.6 (CH2), 25.5 (CH2), 19.7 (CH2). 
MS (EI-DE) m/z (%) 202 [M+] (trace), 129 (2), 117 (4), 101 (27), 85 (100), 67 (10), 55 (43), 41 (22), 
29 (9). 
HRMS (CI-FE, i-butane) calcd for C11H23O3 [(M+H)+] 203.1644, found 203.1647. 
 
6-(Tetrahydro-2H-pyran-2-yloxy)hexanal: 6-(Tetrahydro-2H-pyran-2-yloxy)-1-hexanol (1.20 g, 5.93 
mmol) was dissolved in CH2Cl2 (15 mL) and anhydrous DMSO (2.36 




were added sequentially at room temperature. The resulting solution was cooled to 0 °C and SO3 • py 
complex (1.42 g, 8.90 mmol, 1.5 equiv) was added in several portions. The reaction mixture was kept 
at 0 °C for 1 h, and was then stirred at room temperature overnight (12 h). The reaction was quenched 
by the addition of water (10 mL) and extracted with Et2O (2×25 mL). The combined organic layers 
were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The crude 
product was purified by flash column chromatography (silica gel, 20-30% Et2O in pentane) to afford 
the title compound (754 mg, 3.77 mmol, 64%) as a colorless liquid. 
1H NMR (500 MHz, CD2Cl2) δ 9.73 (t, J = 1.7 Hz, 1H, CHO), 4.53 (t, J = 3.8 Hz, 1H, CHTHP), 3.83-
3.79 (m, 1H, OCHHTHP), 3.69 (dt, J = 9.6, 6.7 Hz, 1H, THPOCHH), 3.47-3.43 (m, 1H, OCHHTHP), 
3.35 (dt, J = 9.6, 6.4 Hz, 1H, THPOCHH), 2.42 (td, J = 7.3, 1.7 Hz, 2H, CH2CHO), 1.83-1.74 (m, 1H, 
CH2), 1.69-1.47 (m, 9H, CH2), 1.42-1.36 (m, 2H, CH2). 
13C NMR (125 MHz, CD2Cl2) δ 202.9 (C=O), 99.2 (O-CH-O), 67.5 (THPOCH2), 62.5 (OCH2, THP), 
44.2 (CH2CHO), 31.2 (CH2), 29.9 (CH2), 26.3 (CH2), 26.0 (CH2), 22.3 (CH2), 20.1 (CH2). 
 
 
(E)-9-(Tetrahydro-2H-pyran-2-yloxy)-3-nonen-2-one (2g): The title compound was prepared 
according to the general procedure B from 6-(tetrahydro-2H-pyran-2-
yloxy)hexanal with 1-(triphenylphosphoranylidene)-2-propanone. The 
crude product was purified by flash column chromatography (silica gel, 
10-30% Et2O in pentane) to afford enone 2g (613 mg, 2.55 mmol, 85%) as a colorless oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.79 (dt, J = 15.9, 7.0 Hz, 1H, =CHCH2), 6.04 (dt, J = 15.9, 1.5 Hz, 
1H, CH=CHCH2), 4.54-4.52 (br t, 1H, OCHO), 3.84-3.79 (m, 1H, OCHHTHP), 3.71-3.67 (m, 1H, 
THPOCHH), 3.47-3.43 (m, 1H, OCHHTHP), 3.37-3.33 (m, 1H, THPOCHH), 2.26-2.21 (m, 2H, 
=CHCH2), 2.20 (s, 3H, CH3), 1.82-1.75 (m, 1H, CH2), 1.69-1.64 (m, 1H, CH2), 1.60-1.47 (m, 8H, -
(CH2)n-), 1.43-1.36 (m, 2H, CH2). 
13C NMR (125 MHz, CD2Cl2) δ 198.3 (C=O), 148.2 (=CHCH2), 131.4 (CH=CHCH2), 98.9 (OCHO), 
67.3 (THPOCH2), 62.2 (OCH2, THP), 32.4 (=CHCH2), 30.1 (CH2), 29.6 (CH2), 28.1 (CH2), 26.6 (CH3), 
25.9 (CH2), 25.7 (CH2), 19.8 (CH2). 
MS (EI-DE) m/z (%) 225 (2), 185 (1), 156 (11), 140 (10), 126 (6), 111 (2), 97 (17), 85 (100), 81 (10), 
67 (14), 55 (14), 43 (50), 29 (8). 










3-(tert-Butyldimethylsilyloxy)-1-propanol: 1,3-Propanediol (3.62 mL, 50.0 mmol, 1.0 equiv) was 
dissolved in CH2Cl2 (150 mL) and triethylamine (6.93 mL, 50.0 mmol, 1.0 equiv) 
and a solution of tert-butyldimethylsilyl chloride (7.54 g, 50.0 mmol, 1.0 equiv) in 
CH2Cl2 (20 mL) were added. After stirring for 16 h at room temperature, the reaction mixture was 
successively extracted with 10% aqueous NaHCO3 (50 mL), water (50 mL), and brine (50 mL). The 
organic layer was dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography (silica gel, 10-30% EtOAc in hexane) to afford the title 
compound (9.00 g, 47.3 mmol, 95%) as a colorless liquid. 
1H NMR (500 MHz, CDCl3) δ 3.81 (t, J = 5.5 Hz, 2H, TBSOCH2), 3.78 (app. br q, J = 5.1 Hz, 2H, 
CH2OH), 2.59 (br s, 1H, OH), 1.75 (quint, J = 5.6 Hz, 2H, CH2CH2CH2), 0.88 (s, 9H, Cq(CH3)3), 0.05 
(s, 6H, Si(CH3)2). 
13C NMR (125 MHz, CDCl3) δ 63.0 (OCH2), 62.5 (OCH2), 34.2 (CH2CH2CH2), 25.9 (3C, Cq(CH3)3), 
18.1 (CqMe3), -5.5 (2C, Si(CH3)2). 
GC-MS (GC-EI) m/z (%) 133 (14), 115 (3), 105 (41), 91 (3), 75 (100), 59 (5), 45 (6), 29 (2). 
HRMS (ESI+) calcd for C9H22NaO2Si [(M+Na)+] 213.1282, found 213.1281. 
 
 
3-(tert-Butyldimethylsilyloxy)propanal: PCC (13.1 g, 60.6 mmol, 1.5 equiv) was added in one 
portion to a solution of 3-(tert-butyldimethylsilyloxy)-1-propanol (7.69 g, 40.4 
mmol, 1.0 equiv) in CH2Cl2 (130 mL). The mixture was stirred for 3 h at room 
temperature. Then the solution was separated from the black insoluble material, 








through a plug of silica gel and evaporated to afford the title compound (5.20 g, 27.6 mmol) as a 
colorless liquid. The aldehyde was used in the next step without further purification. 
1H NMR (500 MHz, CDCl3) δ 9.78 (t, J = 2.0 Hz, 1H, CHO), 3.97 (t, J = 6.0 Hz, 2H, CH2OTBS), 2.58 
(td, J = 6.0, 2.3 Hz, 2H, CH2CHO), 0.86 (s, 9H, Cq(CH3)3), 0.04 (s, 6H, Si(CH3)2). 
GC-MS (GC-EI) m/z (%) 131 (72), 117 (7), 101 (100), 89 (3), 75 (33), 73 (9), 59 (27), 45 (9), 29 (4). 
 
(E)-6-(tert-Butyldimethylsilyloxy)-3-hexen-2-one (2h): The title compound was prepared according 
to the general procedure B from 3-(tert-butyldimethylsilyloxy)propanal with 1-
(triphenylphosphoranylidene)-2-propanone. The crude product was purified by 
flash column chromatography (silica gel, 5% Et2O in pentane) to afford enone 2h 
(819 mg, 3.59 mmol, 72%) as a pale yellow oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.78 (dt, J = 16.1, 7.1 Hz, 1H, =CHCH2), 6.08 (dt, J = 16.1, 1.6 Hz, 
1H, CH=CHCH2), 3.74 (t, J = 6.3 Hz, 2H, TBSOCH2), 2.42 (app. qd, J = 6.6, 1.3 Hz, 2H, =CHCH2), 
2.21 (s, 3H, CH3C(=O)), 0.89 (s, 9H, Cq(CH3)3), 0.05 (s, 6H, Si(CH3)2). 
13C NMR (125 MHz, CD2Cl2) δ 198.4 (C=O), 145.4 (=CHCH2), 133.1 (CH=CHCH2), 61.9 
(TBSOCH2), 36.3 (=CHCH2), 26.8 (CH3C(=O)), 26.0 (3C, Cq(CH3)3), 18.5 (CqMe3), 5.3 (2C, 
Si(CH3)2). 
MS (EI-DE) m/z (%) 228 [M+] (trace), 213 (3), 198 (5), 183 (2), 171 (93), 141 (100), 127 (33), 115 (4), 
103 (6), 89 (11), 75 (27), 59 (4), 43 (6), 29 (2). 
HRMS (ESI+) calcd for C12H24NaO2Si [(M+Na)+] 251.1437, found 251.1438. 
 
(E)-5-Phenyl-3-penten-2-one (2q): The title compound was prepared according to the general 
procedure B from phenylacetaldehyde with 1-(triphenylphosphoranylidene)-2-
propanone. The reaction was constantly maintained at 0 °C. The crude product was 
purified by flash column chromatography (silica gel, 5-10% Et2O in pentane) to 
afford enone 2q (414 mg, 2.58 mmol, 26%) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.32-7.28 (m, 2H, CHPh), 7.24-7.21 (m, 1H, CHPh, p), 7.16-7.15 (m, 2H, 
CHPh), 6.89 (dt, J = 15.9, 6.9 Hz, 1H, =CHCH2), 6.05 (dt, J = 16.1, 1.6 Hz, 1H, CH=CHCH2), 3.52 
(dd, J = 6.6, 1.3 Hz, 2H, PhCH2), 2.02 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 198.5 (C=O), 146.3 (=CHCH2), 137.6 (CqPh), 132.0 (CH=CHCH2), 




MS (EI-DE) m/z (%) 160 [M+] (59), 145 (27), 127 (31), 117 (100), 102 (3), 91 (38), 89 (8), 77 (5), 65 
(17), 58 (9), 51 (11), 43 (57), 39 (15), 27 (3). 
HRMS (EI-FE) calcd for C11H12O [M+] 160.0886, found 160.0888. 
 
(E)-6,6-Dimethylhept-3-en-2-one (2r): The title compound was prepared according to the general 
procedure B from 3,3-dimethylbutanal with 1-(triphenylphosphoranylidene)-2-
propanone. The crude product was purified by flash column chromatography 
(silica gel, 5% Et2O in pentane) to give enone 2r (1.58 g, 11.3 mmol, 56% 
(reduced yield due to the high volatility of 2r)) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3) δ 6.79 (dt, J = 15.6, 7.9 Hz, 1H, =CHCH2), 6.04 (dt, J = 15.9, 1.4 Hz, 1H, 
CH=CHCH2), 2.22 (s, 3H, CH3C(=O)), 2.08 (dd, J = 7.8, 1.2 Hz, 2H, CH2), 0.92 (s, 9H, Cq(CH3)3). 
13C NMR (125 MHz, CDCl3) δ 198.4 (C=O), 145.8 (=CHCH2), 133.2 (CH=CHCH2), 46.9 (CH2), 31.4 
(Cq), 29.4 (3C, Cq(CH3)3), 26.9 (CH3C(=O)). 
GC-MS (GC-EI) m/z 140 [M+]. 
HRMS (CI-FE, i-butane) calcd for C9H17O [(M+H)+] 141.1280, found 141.1279. 
 
(E)-5-Benzyloxy-3-penten-2-one (13f): The title compound was prepared according to the general 
procedure B from benzyloxyacetaldehyde with 1-(triphenylphosphoranylidene)--
2-propanone. The crude product was purified by flash column chromatography 
(silica gel, 5-15% Et2O in pentane) to afford enone 13f (950 mg, 4.99 mmol, 
88%) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3) δ 7.39-7.35 (m, 4H, CHPh), 7.33-7.29 (m, 1H, CHPh), 6.80 (dt, J = 16.1, 
4.5 Hz, 1H, =CHCH2), 6.31 (d, J = 16.1, 1H, CH=CHCH2), 4.46 (s, 2H, PhCH2), 4.21 (dd, J = 4.5, 1.7 
Hz, 2H, CH2CH=), 2.24 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3) δ 198.4 (C=O), 143.6 (=CHCH2), 138.6 (CqPh), 130.7 (CH=CHCH2), 
128.9 (2C, CHPh), 128.3 (CHPh, p), 128.2 (2C, CHPh), 73.4 (CH2), 69.4 (CH2), 27.6 (CH3). 
MS (EI-DE) m/z (%) 190 [M+] (trace), 160 (6), 145 (5), 132 (9), 117 (1), 107 (2), 99 (2), 91 (100), 84 
(10), 65 (9), 51 (3), 43 (13), 29 (2). 






Synthesis of (E)-2-methyl-4-hexen-3-one (2n) 
 




5-Hydroxy-2-methylhexan-3-one: To a solution of LDA, freshly prepared by addition of n-BuLi (26.8 
ml, 67.0 mmol, 1.05 equiv, 2.5M in hexanes) to diisopropylamine (9.40 mL, 67.0 
mmol, 1.05 equiv) in THF (100 mL) at 0 °C, was added isopropylmethylketone (6.87 
mL, 63.8 mmol) at 78 °C. After 30 min, acetaldehyde (9.01 mL, 159.5 mmol, 2.5 
equiv) was added, and after stirring for 1h, the reaction was quenched by addition of saturated aqueous 
NaHCO3-solution (40 mL) at 78 °C. Then, the reaction mixture was allowed to warm to room 
temperature, and the layers were separated. The aqueous layer was extracted with Et2O (2×75 mL) and 
the combined organic phases were successively washed with cold 1% aqueous HCl (80 mL), saturated 
aqueous NaHCO3-solution (80 mL), and brine (80 mL), dried over Na2SO4, filtered, and concentrated 
under reduced pressure to give the title compound (7.91 g, 60.8 mmol, 95%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.21-4.14 (m, 1H, CH(OH)), 3.23 (d, J = 3.3 Hz, 1H, OH), 2.62 (dd, J 
= 18.1, 3.3 Hz, 1H, CHH), 2.58-2.49 (m, 2H, CHH and CH(CH3)2), 1.16 (d, J = 6.1 Hz, 3H, 
CH(OH)CH3), 1.08 (d, J = 7.0 Hz, 3H, CH(CH3)2), 1.07 (d, J = 6.9 Hz, 3H, CH(CH3)2). 
13C NMR (125 MHz, CDCl3) δ 216.1 (C=O), 63.9 (CH(OH)), 47.9 (CH2), 41.4 (CH(CH3)2), 22.3 




                                                 




5-Methyl-4-oxohexan-2-yl methanesulfonate: The crude aldol product described above (7.91 g, 60.8 
mmol) was dissolved in pyridine (60 mL) and methanesulfonyl chloride (5.59 mL, 
71.7 mmol, 1.18 equiv) was added at 0 °C. The solution was kept at room temperature 
for 16 h. To work-up the reaction, water (120 mL) was added, and the mixture 
repeatedly extracted with Et2O (3×100 mL). The combined organic layers were 
washed with saturated aqueous CuSO4-solution (4×75 mL), and brine (100 mL), dried over Na2SO4, 
filtered, and concentrated in vacuo to give the title compoud (7.95 g, 38.2 mmol, 63%) as a yellow oil. 
1H NMR (500 MHz, CDCl3) δ 5.18-5.12 (m, 1H, CH(OMs)), 3.04-2.98 (m, 1H, CHH), 2.99 (s, 3H, 
OSO2CH3), 2.62-2.54 (m, 2H, CHH and CH(CH3)2), 1.46 (d, J = 6.4 Hz, 3H, CH(OMs)CH3), 1.09 (d, 
J = 6.9 Hz, 3H, CH(CH3)2), 1.08 (d, J = 7.0 Hz, 3H, CH(CH3)2). 
13C NMR (125 MHz, CDCl3) δ 210.7 (C=O), 75.8 (CH(OMs)), 46.3 (CH2), 41.2 (CH(CH3)2), 38.0 
(OSO2CH3), 21.6 (CH(OH)CH3), 17.8 (CH(CH3)2), 17.8 (CH(CH3)2). 
 
(E)-2-Methylhex-4-en-3-one (2n): The crude mesylate described above (7.85 g, 37.7 mmol) was 
dissolved in Et2O (40 mL), and triethylamine (7.84 mL, 56.6 mmol, 1.5 equiv) was 
added. After stirring for 18 h at room temperature, water (80 mL) was added, and the 
mixture was extracted with Et2O (3 × 80 mL). The combined organic layers were 
successively washed with cold aqueous 1% HCl (80 mL), saturated aqueous NaHCO3 solution (80 
mL), water (80 mL), and brine (80 mL). The organic phase was dried (Na2SO4), filtered, and 
evaporated. The crude product was purified by flash column chromatography (silica gel, 3-5% Et2O in 
pentane) to afford enone 2n (2.64 g, 23.6 mmol, 62% (reduced yield due to the high volatility of 2n)) as 
a pale yellow oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.85 (dq, J = 15.4, 6.8 Hz, 1H, =CHCH3), 6.17 (dq, J = 15.4, 1.6 Hz, 
1H, CH=CHCH3), 2.80 (hept, J = 6.8 Hz, 1H, CHal), 1.88 (dd, J = 7.0, 1.9 Hz, 3H, =CHCH3), 1.06 (d, 
J = 6.6 Hz, 6H, CH(CH3)2). 
13C NMR (125 MHz, CDCl3) δ 203.7 (C=O), 142.4 (=CHCH3), 130.3 (CH=CHCH3), 38.6 (CHMe2), 
18.6 (2C, CH(CH3)2), 18.3 (=CHCH3). 
GC-MS (GC-EI) m/z 112 [M+]. 





Synthesis of (Z)-6-phenyl-3-hexen-2-one ((Z)-2b) 
 
(Z)-6-Phenyl-3-hexen-2-one ((Z)-2b) was prepared according to a reaction sequence described by 










THF, 78°C, 15 min
then MeCHO (1.5 equiv)
78°C to r.t., 1 h
PCC (2.2 equiv)
CH2Cl2, r.t., 12 h
5% Pd/BaSO4 (10% w/w)
H2 (1 atm)
Et2O, r.t., 22 h(Z)-2b  
 
6-Phenylhex-3-yn-2-ol: n-BuLi (8.0 mL, 20.0 mmol, 2.5M in hexanes, 1.0 equiv) was added to a 
stirred solution of 4-phenylbut-1-yne (2.81 mL, 20.0 mmol, 1.0 equiv) in 
THF (11 mL) at 78 °C. After 15 min, acetaldehyde (1.70 mL, 30.0 mmol, 
1.5 equiv) was added over 1 min. Then the reaction mixture was allowed to 
warm to room temperature and after 1 h, the reaction was quenched by the 
addition of aqueous saturated NH4Cl-solution (20 mL) and repeatedly extracted with Et2O (3×50 mL). 
The combined organic phases were successively washed with water and brine, dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was purified by flash column 
chromatography (silica gel, 20% Et2O in pentane) and 6-phenylhex-3-yn-2-ol (3.13 g, 18.0 mmol, 
90%) was obtained as a colorless oil. 
1H NMR (500 MHz, CD2Cl2) δ 7.32-7.29 (m, 2H, CHPh, m), 7.24-7.20 (m, 3H, CHPh, o, p), 4.48-4.43 (m, 
1H, CHOH), 2.81 (t, J = 7.5 Hz, 2H, PhCH2), 2.49 (td, J = 7.5, 1.9 Hz, 2H, PhCH2CH2), 1.92-1.88 (m, 
1H, OH), 1.37 (d, J = 6.6 Hz, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 141.4 (CqPh), 129.1 (2C, CHPh), 128.8 (2C, CHPh), 126.8 (CHPh, p), 
84.0 (C≡C), 83.8 (C≡C), 58.9 (COH), 35.5 (PhCH2), 25.1 (CH3), 21.4 (PhCH2CH2). 
GC-MS (GC-EI) m/z (%) 173 (1), 156 (6), 141 (4), 129 (21), 115 (9), 102 (2), 91 (100), 77 (4), 65 (16), 
51 (7), 43 (9), 29 (7). 
HRMS (EI-FE) calcd for C12H15O [(M+H)+] 175.1124, found 175.1123. 
                                                 




6-Phenylhex-3-yn-2-one: A solution of 6-phenylhex-3-yn-2-ol (2.75 g, 15.8 mmol) and PCC (7.50 g, 
34.7 mmol, 2.2 equiv) in CH2Cl2 (80 mL) was stirred at room temperature 
for 12 h. Florisil (5 g) was added to the reaction mixture, and stirring was 
continued for another 15 min. After filtration through a plug of silica gel 
(eluent: Et2O), the solvents were removed in vacuo giving 6-phenylhex-3-
yn-2-one (2.42 g, 14.1 mmol, 89%) as a clear oil, which was used in the next step without further 
purification. 
1H NMR (500 MHz, CD2Cl2) δ 7.34-7.31 (m, 2H, CHPh, m), 7.26-7.23 (m, 3H, CHPh, o, p), 2.89 (t, J = 
7.4 Hz, 2H, PhCH2), 2.67 (t, J = 7.4 Hz, 2H, PhCH2CH2), 2.26 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 184.8 (C=O), 140.2 (Cqar), 128.8 (2C, CHar), 128.7 (2C, CHar), 126.9 
(CHPh, p), 92.9 (CH2C≡C), 82.0 (CH2C≡), 34.2 (PhCH2), 32.9 (CH3), 21.3 (PhCH2CH2). 
MS (EI-DE) m/z (%) 172 [M+] (2), 157 (13), 144 (1), 129 (31), 115 (1), 102 (1), 91 (100), 77 (2), 65 
(13), 51 (4), 43 (14), 27 (1). 
HRMS (CI-FE, i-butane) calcd for C12H13O [(M+H)+] 173.0965, found 173.0966. 
 
(Z)-6-phenyl-3-hexen-2-one ((Z)-2b): A mixture of ketone 6-phenylhex-3-yn-2-one (2.0 g, 11.6 
mmol), quinoline (20 mg, 1 wt%), 5% Pd/BaSO4 (200 mg, 10 wt%), and Et2O (12 
mL) as the solvent were placed under a hydrogen atmosphere (1 atm) and stirred 
at room temperature for 22 h. The catalyst was removed by filtration and the 
volatiles under reduced pressure. 1H NMR of the crude product showed the 
desired (Z)-enone 2b contaminated with 25% of the (E)-isomer, which was separated by flash column 
chromatography (silica gel, 10-15% Et2O in pentane). Pure (Z)-enone ((Z)-2b; 1.40 g, 8.04 mmol, 69%) 
was obtained as a pale yellow oil. 
1H NMR (500 MHz, CD2Cl2) δ 7.30-7.27 (m, 2H, CHPh, m), 7.22-7.17 (m, 3H, CHPh, o and p), 6.15 (dt, J 
= 11.3, 1.3 Hz, 1H, CH=CHCH2), 6.08 (dt, J = 11.4, 7.1 Hz, 1H, =CHCH2), 2.90 (app. qd, J = 7.6, 1.2 
Hz, 2H, =CHCH2), 2.74 (t, J = 7.7 Hz, 2H, PhCH2), 2.15 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 198.9 (C=O), 146.5 (=CHCH2), 141.5 (CqPh), 128.5 (2C, CHPh, o), 
128.4 (2C, CHPh, m), 127.6 (CH=CHCH2), 126.0 (CHPh, p), 35.1 (PhCH2), 31.4 (CH3), 30.9 (=CHCH2). 
MS (EI-DE) m/z (%) 174 [M+] (19), 159 (3), 141 (2), 131 (33), 117 (7), 104 (19), 91 (100), 83 (2), 77 
(3), 65 (12), 51 (3), 43 (21), 39 (4), 27 (2). 




Synthesis of 4,8-dimethylnona-3,7-dien-2-one (S-3) 
 




4,8-Dimethylnona-3,7-dien-2-ol: MeLi (24.4 mL, 39.0 mmol, 1.3 equiv; 1.6M in Et2O) was added at 
78 °C to a solution of citral (5.14 mL, 30.0 mmol, 1.0 equiv; geranial/neral 
64:36) in Et2O (150 mL). After stirring at the same temperature for 1.5 h, 1 N 
aqueous HCl was added slowly. The phases were separated and the aqueous 
phase was extracted twice with Et2O. The combined organic layers were washed with water and brine, 
dried (Na2SO4), and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel; 20-30% Et2O in pentane) to the title compound (4.55 g, 27.1 mmol, 90%; 
E/Z 64:36) as a colorless liquid. Characterized as a mixture of 3E/3Z-isomers. 
1H NMR (500 MHz, CD2Cl2) δ 5.21-5.17 (m, 2H, CHol), 5.14-5.08 (m, 2H, CHol), 4.56-4.47 (m, 2H, 
CHOH), 2.11-1.97 (m, 8H, CH2), 1.71-1.66 (m, 12H, CqolCH3), 1.61 (s, 6H, CqolCH3), 1.42-1.40 (m, 
2H, OH), 1.19-1.16 (m, 6H, CHCH3). 
13C NMR (125 MHz, CD2Cl2) 3E-4,8-dimethylnona-3,7-dien-2-ol: δ 137.4 (CH2Cqol), 131.9 
(Me2Cqol), 129.8 (CHolCH), 124.3 (CHolCH2), 64.9 (CHOH), 39.8 (CH2Cqol), 26.8 (CHolCH2), 25.7 
(CH3), 23.8 (CH3), 17.7 (CH3), 16.4 (CH3); 3Z-4,8-dimethylnona-3,7-dien-2-ol: δ 137.7 (CH2Cqol), 
132.6 (Me2Cqol), 130.7 (CHolCH), 124.3 (CHolCH2), 64.4 (CHOH), 32.5 (CH2Cqol), 26.9 (CHolCH2), 
25.7 (CH3), 23.8 (CH3), 23.3 (CH3), 17.7 (CH3). 
GC-MS (GC-EI) 3E-4,8-dimethylnona-3,7-dien-2-ol: m/z (%) 168 [M+] (trace), 150 (4), 135 (9), 123 
(4), 107 (53), 91 (13), 79 (20), 69 (100), 53 (11), 43 (34), 41 (72), 29 (8); 3Z-4,8-dimethylnona-3,7-
dien-2-ol: m/z (%) 168 [M+] (trace), 150 (6), 121 (5), 107 (72), 93 (18), 82 (28), 69 (100), 65 (6), 59 
(2), 53 (13), 41 (85), 39 (19), 29 (9). 
HRMS (EI-DE) calcd for C11H20O [M+] 168.1513, found 168.1514. 
 
                                                 




4,8-Dimethylnona-3,7-dien-2-one (S-3): To a suspension of alcohol 4,8-dimethylnona-3,7-dien-2-ol 
(2.20 g, 13.1 mmol) and powered 4Å MS (6.54 g) in CH2Cl2 (40 mL) were 
added successively at 0 °C NMO (2.67 g, 19.7 mmol, 1.5 equiv) and TPAP 
(233 mg, 0.66 mmol, 0.05 mol%). After stirring for 45 min at ambient 
temperature, the mixture was filtered through a short pad of silica gel (eluent: EtOAc). The filtrate was 
concentrated under reduced pressure and flash column chromatography (silica gel, 8% Et2O in pentane) 
afforded pure fractions of 3E- and 3Z-isomers in addition to mixed fractions as colorless oils [3E-4,8-
dimethylnona-3,7-dien-2-one ((E)-7; 450 mg, 2.71 mmol, 21%); 3Z-4,8-dimethylnona-3,7-dien-2-one 
((Z)-7; 303 mg, 1.82 mmol, 14%); 3Z/E-4,8-dimethylnona-3,7-dien-2-one (1.17 g, 7.04 mmol, 54%; 
E/Z 73:27)]. 
 
(3E)-4,8-Dimethylnona-3,7-dien-2-one (E-S-3):  
1H NMR (500 MHz, CD2Cl2) δ 6.06 (s, 1H, =CHC(=O)), 5.11-5.07 (m, 1H, 
=CHCH2), 2.17-2.11 (m overlapped, 4H, CH2), 2.13 (s overlapped, 3H, 
CH3C(=O)), 2.09 (d, J = 1.2 Hz, 3H, CH3), 1.68 (s, 3H, CH3), 1.61 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 198.8 (C=O), 158.1 (CH2Cqol), 132.8 (Me2Cqol), 124.0 (CHol), 123.5 
(CHol), 41.4 (CH2Cqol), 31.9 (CH3C(=O)), 26.5 (CHolCH2), 25.7 (CH3), 19.2 (CH3), 17.7 (CH3). 
GC-MS (GC-EI) m/z (%) 166 [M+] (5), 151 (8), 133 (2), 123 (24), 108 (21), 98 (19), 93 (7), 83 (56), 
69 (100), 53 (10), 41 (80), 39 (16), 27 (6). 
HRMS (EI-FE) calcd for C11H18O [M+] 166.1355, found 166.1358. 
 
(3Z)-4,8-Dimethylnona-3,7-dien-2-one (Z-S-3) 
1H NMR (500 MHz, CD2Cl2) δ 6.06 (s, 1H, =CHC(=O)), 5.15-5.12 (m, 1H, 
=CHCH2), 2.55 (dd, J = 7.9 Hz, 2H, CH2Cqol), 2.14-2.09 (m overlapped, 2H, 
=CHCH2), 2.11 (s overlapped, 3H, CH3C(=O)), 1.86 (d, J = 1.3 Hz, 3H, CH3), 
1.68 (s, 3H, CH3), 1.62 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 198.2 (C=O), 158.7 (CH2Cqol), 132.4 (Me2Cqol), 124.5 (CHol), 124.1 
(CHol), 33.9 (CH2Cqol), 31.8 (CH3C(=O)), 27.1 (CHolCH2), 25.7 (CH3), 25.5 (CH3), 17.7 (CH3). 
GC-MS (GC-EI) m/z (%) 166 [M+] (6), 151 (10), 133 (4), 123 (34), 108 (34), 98 (23), 83 (75), 69 
(100), 65 (5), 59 (5), 55 (16), 41 (90), 39 (21), 27 (8). 







Preparation of Cyclic ,-Unsaturated Ketones 




3-Ethoxy-2-cyclohexenone or –heptenone (21.4 mmol, 1.0 equiv) in THF (15 mL) was added dropwise 
to a solution of a Grignard reagent (1 M in Et2O or THF, 1.5-2.0 equiv) at 0 °C under argon. Once the 
addition was complete, the resulting solution was allowed to warm to room temperature and stirred 
until TLC indicated complete disappearance of the starting material (2-18 h). The reaction was slowly 
quenched with diluted aqueous acid (1 N HCl or 5% H2SO4) at 0 °C. The layers were separated, and 
the aqueous layer extracted with Et2O (3×50 mL). The combined organic layers were washed 
successively with saturated aqueous NaHCO3-solution, water, and brine, dried (Na2SO4), filtered, and 
evaporated under reduced pressure. The crude product was purified by flash column chromatography 




3-Isopropyl-2-cyclohexenone (9j): The title compound was prepared according to the general 
procedure A from 3-ethoxy-2-cyclohexenone and isopropyl magnesium chloride (2 M in 
Et2O). Purification by flash column chromatography (silica gel, 20% Et2O in pentane) 
gave enone 9j (2.10 g, 15.2 mmol, 71%) as a pale yellow liquid. 
1H NMR (300 MHz, CD2Cl2) δ 5.81 (q, J = 1.4 Hz, 1H, =CH), 2.41 (hept, J = 6.9 Hz, 
1H, CHMe2), 2.33-2.28 (m, 4H, CH2C(=O) and CH2Cqol), 1.96 (quint, J = 6.2 Hz, 2H, CH2CH2CH2), 
1.09 (d, J = 7.2 Hz, 6H, CH(CH3)2). 
13C NMR (75 MHz, CDCl3) δ 200.3 (C=O), 171.8 (Cq=CH), 123.6 (Cq=CH), 37.6 (CH2C(=O)), 35.7 
(CHMe2), 27.7 (CH2Cqol), 22.9 (CH2CH2CH2), 20.6 (2C, CH(CH3)2). 
                                                 
34 a) G. F. Woods, I. W. Tucker, J. Am. Chem. Soc. 1948, 70, 2174; b) G. F. Woods, P. H. Griswold, B. H. Armbrecht, D. I. 





GC-MS (GC-EI) m/z 138 [M+]. 
HRMS (EI-FE) calcd for C9H14O [M+] 138.1043, found 138.1045. 
 
3-Allyl-2-cyclohexenone (9l): The title compound was prepared according to the general procedure A 
from 3-ethoxy-2-cyclohexenone and allyl magnesium chloride (2 M in THF). 
Purification by flash column chromatography (silica gel, 20% Et2O in pentane) gave 
enone 9l (893 mg, 6.55 mmol, 47%) as a colorless liquid.35  
1H NMR (500 MHz, CDCl3) δ 5.87 (s, 1H, Cq=CH), 5.76 (ddt, J = 16.7, 10.3, 6.8 Hz, 
1H, CH=CH2), 5.14-5.09 (m, 2H, CH=CH2), 2.92 (d, J = 7.1 Hz, 2H, CH2CH=CH2), 2.34 (t, J = 6.8 
Hz, 2H, CH2C(=O)), 2.27 (br t, J = 6.1 Hz, 2H, CH2CH2Cqol), 1.97 (quint, J = 6.4 Hz, 2H, 
CH2CH2CH2). 
13C NMR (125 MHz, CDCl3) δ 199.8 (C=O), 164.1 (Cq=CH), 133.2 (CH=CH2), 126.3 (Cq=CH), 
118.3 (CH=CH2), 42.2 (CH2CH=CH2), 37.3 (C=OCH2), 29.5 (CH2CH2Cqol), 22.6 (CH2CH2CH2). 
MS (EI-DE) m/z (%) 136 [M+] (74), 121 (8), 108 (42), 93 (8), 79 (100), 77 (18), 74 (1), 67 (19), 53 (9), 
41 (19), 39 (43), 29 (2), 27 (13). 
HRMS (EI-FE) calcd for C9H12O [M+] 136.0888, found 136.0888. 
 
3-Benzyl-2-cyclohexenone (9n): The title compound was prepared according to the general procedure 
A from 3-ethoxy-2-cyclohexenone and benzyl magnesium chloride (1 M in Et2O). 
Purification by flash column chromatography (silica gel, 20% Et2O in pentane) gave 
enone 9n (3.02 g, 16.2 mmol, 76%) as a colorless liquid. 
1H NMR (500 MHz, CD2Cl2) δ 7.33-7.30 (m, 2H, CHPh, m), 7.28-7.24 (m, 1H, 
CHPh, p), 7.21-7.18 (m, 2H, CHPh, o), 5.80 (s, 1H, =CH), 3.52 (s, 2H, PhCH2), 2.31 (t, J = 6.8 Hz, 2H, 
CH2C(=O)), 2.25 (br t, J = 6.0 Hz, 2H, CH2Cqol), 1.94 (quint, J = 6.4 Hz, 2H, CH2CH2CH2). 
13C NMR (125 MHz, CD2Cl2) δ 199.6 (C=O), 164.9 (Cqol), 137.8 (CqPh), 129.5 (2C, CHPh, o), 129.0 
(2C, CHPh, m), 127.1 (CHPh, p), 127.0 (=CH), 44.7 (PhCH2), 37.7 (CH2C(=O)), 29.6 (CH2Cqol), 23.1 
(CH2CH2CH2). 
MS (EI-DE) m/z (%) 186 [M+] (100), 168 (8), 158 (91), 142 (9), 129 (58), 115 (34), 102 (3), 91 (30), 
77 (9), 67 (26), 51 (15), 39 (46), 27 (11). 
HRMS (EI-DE) calcd for C13H14O [M+] 186.1043, found 186.1045. 
                                                 





3-Phenyl-2-cyclohexenone (9o): The title compound was prepared according to the general procedure 
A from 3-ethoxy-2-cyclohexenone and phenyl magnesium chloride (2 M in THF). 
Purification by flash column chromatography (silica gel, 30% Et2O in pentane) gave 
enone 9o (3.60 g, 20.9 mmol, 98%) as a white solid.36  
1H NMR (500 MHz, CD2Cl2) δ 7.57-7.55 (m, 2H, CHPh), 7.43-7.40 (m, 3H, CHPh), 6.37 
(t, J = 1.5 Hz, 1H, =CH), 2.77 (td, J = 6.0, 1.4 Hz, 2H, CH2Cqol), 2.44 (app. t, J = 6.8 Hz, 2H, 
CH2C(=O)), 2.14 (quint, J = 6.3 Hz, 2H, CH2CH2CH2). 
13C NMR (125 MHz, CD2Cl2) δ 199.6 (C=O), 159.9 (Cq=CH), 139.3 (CqPh), 130.1 (CHPh, p), 129.0 
(2C, CHPh), 126.4 (2C, CHPh), 125.6 (Cq=CH), 37.6 (CH2C(=O)), 28.4 (CH2Cqol), 23.2 (CH2CH2CH2). 
 
3-Vinyl-2-cyclohexenone (9p): The title compound was prepared according to the general procedure A 
from 3-ethoxy-2-cyclohexenone and vinyl magnesium bromide (1 M in THF). 
Purification by flash column chromatography (silica gel, 15-25% Et2O in pentane) gave 
enone 9p (1.97 g, 16.1 mmol, 75%) as a colorless oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.50 (dd, J = 17.6, 10.7 Hz, 1H, CH=CH2), 5.89 (s, 1H, Cq=CH), 5.70 
(d, J = 17.7 Hz, 1H, CH=CHtransH), 5.45 (d, J = 10.7 Hz, 1H, CH=CHHcis), 2.47 (br t, J = 6.1 Hz, 2H, 
CH2Cqol), 2.37 (t, J = 6.8 Hz, 2H, CH2C(=O)), 2.02 (quint, J = 6.4 Hz, 2H, CH2CH2CH2). 
13C NMR (126 MHz, CD2Cl2) δ 200.1 (C=O), 157.1 (Cq=CH), 138.3 (CH=CH2), 128.4 (Cq=CH), 
120.7 (CH=CH2), 37.8 (CH2C(=O)), 24.6 (CH2), 22.6 (CH2). 
GC-MS (GC-EI) m/z 122 [M+]. 
HRMS (EI-FE) calcd for C8H10O [M+] 122.0730, found 122.0732. 
 
                                                 




3-Ethynyl-2-cyclohexenone (9q): The title compound was prepared according to the general 
procedure A from 3-ethoxy-2-cyclohexenone and ethynyl magnesium bromide (0.5 M 
in THF). Purification by flash column chromatography (silica gel, 10-25% Et2O in 
pentane) gave enone 9q (1.33 g, 11.1 mmol, 77%) as a colorless liquid. 
1H NMR (500 MHz, CD2Cl2) δ 6.21 (t, J = 1.6 Hz, 1H, =CH), 3.59 (s, 1H, ≡CH), 2.45 
(td, J = 6.1, 1.7 Hz, 2H, CH2Cqol), 2.34 (t, J = 6.7 Hz, 2H, CH2C(=O)), 2.02 (quint, J = 6.3 Hz, 2H, 
CH2CH2CH2). 
13C NMR (125 MHz, CD2Cl2) δ 198.4 (C=O), 142.3 (Cq=CH), 134.2 (Cq=CH), 87.0 (Cq≡CH), 82.8 
(Cq≡CH), 37.6 (CH2C(=O)), 30.5 (CH2Cqol), 22.9 (CH2CH2CH2). 
GC-MS (GC-EI) m/z (%) 120 [M+] (44), 92 (100), 89 (2), 77 (4), 64 (54), 50 (12), 42 (5), 39 (15), 27 
(3). 
HRMS (EI-FE) calcd for C8H8O [M+] 120.0576, found 120.0575. 
 
3-Ethyl-2-cycloheptenone (11b): The title compound was prepared according to the general procedure 
A from 3-ethoxy-2-cycloheptenone and ethyl magnesium bromide (3 M in THF). 
Purification by flash column chromatography (silica gel, 20% Et2O in pentane) gave 
enone 11b (570 mg, 4.12 mmol, 61%) as a pale yellow liquid. 3-Ethoxy-2-
cycloheptenone was obtained by heating a mixture of 1,3-cycloheptanedione (0.85 g, 6.74 
mmol), dry ethanol (1.7 mL), and a catalytic amount of p-toluene sulfonic acid monohydrate (17 mg) in 
benzene (40 mL) under reflux with a Dean-Stark trap. After 12 h, the mixture was allowed to cool to 
room temperature and the solvent was evaporated under reduced pressure. The resulting crude 3-
ethoxy-2-cycloheptenone (~90% purity) was used without further purification for the synthesis of 3-
ethyl-2-cycloheptenone (11b). 
1H NMR (400 MHz, CD2Cl2) δ 5.83 (s, 1H, =CH), 2.52 (t, J = 6.1 Hz, 2H, CH2C(=O)), 2.41 (t, J = 5.8 
Hz, 2H, CH2Cqol), 2.22 (qd, J = 7.4, 1.2 Hz, 2H, CH2CH3), 1.81-1.72 (m, 4H, CH2(CH2)2CH2), 1.08 (t, 
J = 7.4 Hz, 3H, CH2CH3). 
13C NMR (75 MHz, CD2Cl2) δ 203.9 (C=O), 163.8 (Cq=CH), 128.2 (Cq=CH), 42.5 (CH2C(=O)), 34.1 
(CqolCH2, cycl.), 32.9 (CH2CH3), 25.5 (CH2, cycl.), 21.7 (CH2, cycl.), 12.3 (CH3). 
MS (EI-DE) m/z (%) 138 [M+] (29), 109 (100), 96 (18), 81 (32), 79 (10), 67 (17), 53 (17), 39 (20), 27 
(17). 





3-Benzyl-2-cycloheptenone (11c): The title compound was prepared according to the general 
procedure A from 3-ethoxy-2-cycloheptenone (vide supra) and benzyl magnesium 
chloride (1 M in Et2O). Purification by flash column chromatography (silica gel, 20% 
Et2O in pentane) gave enone 23c (551 mg, 2.75 mmol, 41%) as a pale yellow liquid. 
1H NMR (400 MHz, CD2Cl2) δ 7.34-7.19 (m, 5H, C6H5), 5.89 (s, 1H, =CH), 3.49 (s, 
2H, CH2Ph), 2.53 (t, J = 6.4 Hz, 2H, CH2C(=O)), 2.37 (t, J = 5.9 Hz, 2H, CH2Cqol), 1.78-1.64 (m, 4H, 
CH2(CH2)2CH2). 
13C NMR (75 MHz, CD2Cl2) δ 203.8 (C=O), 160.2 (Cqol), 138.4 (CqPh), 130.9 (=CH), 129.5 (2C, 
CHPh), 128.9 (2C, CHPh), 127.0 (CHPh, p), 47.3 (CH2Ph), 42.6 (CH2C(=O)), 32.7 (CH2Cqol), 25.6 
(CH2CH2Cqol), 21.7 (CH2CH2C(=O)). 
MS (EI-DE) m/z (%) 200 [M+] (14), 182 (1), 171 (4), 158 (4), 143 (3), 129 (13), 115 (12), 109 (100), 
91 (15), 81 (24), 65 (12), 53 (11), 39 (14), 27 (6). 
HRMS (EI-DE) calcd for C14H16O [M+] 200.1199, found 200.1201. 
 




To a solution of LDA, freshly prepared from n-BuLi (13.2 ml, 33.0 mmol, 1.1 equiv, 2.5M in hexanes) 
and diisopropylamine (5.06 mL, 36.0 mmol, 1.2 equiv) in THF (46 mL) at 0 °C, was added a cyclic 
ketone (30.0 mmol, 1.0 equiv) dissolved in THF (18 ml) at 78 °C. After stirring for 30 min, the 
solution was warmed to room temperature and stirred for additional 30 min at room temperature. After 
re-cooling to 78 °C, TMSCl (6.47 ml, 51.0 mmol, 1.7 equiv) was added, and stirring was continued 
for 1 h. The reaction was quenched with saturated aqueous NH4Cl solution and extracted with Et2O (3 
× 150 mL). The combined organic layers were dried (Na2SO4), filtered, and concentrated in vacuo. The 
crude silyl enol ether was dissolved in DMSO (600 mL), and Pd(OAc)2 (673 mg, 3.00 mmol, 10 mol%) 
                                                 




was added. The flask was carefully evacuated, purged with O2, and equipped with an O2 ballon. After 
stirring for 12 h at room temperature, the reaction mixture was poured into ice water (300 mL), and 
repeatedly extracted with Et2O (2 × 300 mL). The combined organic phases were washed with brine, 
dried (Na2SO4), filtered, and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (silica gel, eluent: Et2O-pentane) to afford the corresponding pure cyclic 
-unsaturated ketones 9 and 11. 
 
 
4-Methyl-2-cyclohexenone (9q): The title compound was prepared according to the general procedure 
B from 4-methylcyclohexanone (1.84 mL, 15.0 mmol). Purification by flash column 
chromatography (silica gel, 10-20% Et2O in pentane) gave cyclohexenone 9r (1.36 g, 
12.3 mmol, 82%) as a clear oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.80 (ddd, J = 10.2, 2.6, 1.3 Hz, 1H, =CHCH), 5.88 (dd, J = 10.1, 2.5 
Hz, 1H, CH=CHCH), 2.58-2.50 (m, 1H, CHMe), 2.42 (dt, J = 16.7, 4.7 Hz, 1H, CHHC(=O)), 2.33 
(ddd, J = 16.8, 12.2, 4.7 Hz, 1H, CHHC(=O)), 2.09 (dqd, J = 13.6, 5.0, 1.3 Hz, 1H, CHHCH), 1.68-
1.61 (m, 1H, CHHCH), 1.14 (d, J = 7.3 Hz, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 199.6 (C=O), 156.5 (=CHCH), 128.8 (CH=CHCH), 37.2 (CH2C(=O)), 
31.5 (CHMe), 31.3 (CH2CH), 20.3 (CH3). 
GC-MS (GC-EI) m/z 110 [M+] (51), 95 (4), 82 (100), 79 (4), 68 (67), 65 (6), 54 (56), 41 (18), 39 (40), 
27 (20). 
HRMS (EI-FE) calcd for C7H10O [M+] 110.0731, found 110.0732. 
 
4-tert-Butyl-2-cyclohexenone (S-12): The title compound was prepared according to the general 
procedure B from 4-tert-butylcyclohexanone (2.31 g, 15.0 mmol). Purification by 
flash column chromatography (silica gel, 5% EtOAc in hexanes) gave 
cyclohexenone S-9 (1.52 g, 9.97 mmol, 66%) as a clear oil. 
1H NMR (500 MHz, CDCl3) δ 6.99 (dt, J = 10.6, 2.1 Hz, 1H, =CHCH), 6.01 (dd, J = 10.4, 2.8 Hz, 1H, 
CH=CHCH), 2.50 (dt, J = 16.9, 3.9 Hz, 1H, CHHC(=O)), 2.32 (ddd, J = 16.4, 14.4, 4.9 Hz, 1H, 
CHHC(=O)), 2.20-2.16 (m, 1H, CHHCH), 2.11-2.05 (m, 1H, CHHCH), 1.76-1.67 (m, 1H, CHt-Bu), 
0.96 (s, 9H, CH3). 







37.8 (CH2C(=O)), 32.9 (CqMe3), 27.3 (3C, CH3), 24.4 (CH2CH). 
MS (EI-DE) m/z 152 [M+] (5), 137 (5), 119 (1), 109 (6), 96 (100), 91 (2), 81 (5), 67 (11), 57 (83), 53 
(6), 41 (53), 39 (23), 29 (36), 27 (19). 
HRMS (EI-FE) calcd for C10H16O [M+] 152.1202, found 152.1201. 
 
 
2-Cyclooctenone (11d): The title compound was prepared according to the general procedure B from 
cyclooctanone (3.79 g, 30.0 mmol). Purification by flash column chromatography 
(silica gel, 5-10% Et2O in pentane) gave 2-cyclooctenone (11d; 2.38 g, 19.2 mmol, 
64%) as a clear oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.33 (dt, J = 12.5, 7.1 Hz, 1H, CH2CH=), 5.94 (d, J = 12.5 Hz, 1H, 
CH2CH=CH), 2.60 (t, J = 6.9 Hz, 2H, CH2C(=O)), 2.52-2.47 (m, 2H, CH2CH=), 1.82-1.77 (m, 2H, 
CH2CH2C(=O)), 1.63-1.53 (m, 4H, CH2CH2CHol and CH2(CH2)2C(=O)). 
13C NMR (125 MHz, CD2Cl2) δ 205.4 (C=O), 141.5 (CH2CH=), 132.2 (CH2CH=CH), 42.7 
(CH2C(=O)), 28.6 (CH2CH=), 25.3 (CH2(CH2)2C(=O)), 23.2 (CH2CH2CH=), 22.7 (CH2CH2C(=O)). 
GC-MS (GC-EI) m/z 124 [M+] (8), 109 (1), 95 (11), 91 (2), 81 (100), 68 (40), 65 (4), 53 (39), 51 (5), 
41 (23), 39 (34), 27 (17). 
HRMS (EI-FE) calcd for C8H12O [M+] 124.0887, found 124.0888. 
 
 
(E)-2-Cyclododecenone (11e): The title compound was prepared according to the general procedure B 
from cyclododecanone (2.73 g, 15.0 mmol). Stoichiometric Pd(OAc)2 (3.37 g, 15.0 
mmol) in acetonitrile (20 mL) was used in the oxidation step. Purification by flash column 
chromatography (silica gel, 2% Et2O in pentane) gave pure (E)-enone 11e (1.40 g, 7.80 
mmol, 52%) as a clear oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.74 (td, J = 15.3, 7.7 Hz, 1H, =CHCH2), 6.29 (d, J = 
16.1 Hz, 1H, CH=CHCH2), 2.46-2.44 (m, 2H, CH2C(=O)), 2.28-2.24 (m, 2H, =CHCH2), 1.71-1.67 (m, 
2H, CH2), 1.62-1.57 (m, 2H, CH2), 1.42-1.37 (m, 2H, CH2), 1.33-1.29 (m, 4H, CH2), 1.28-1.21 (m, 
4H, CH2). 
13C NMR (125 MHz, CD2Cl2) δ 203.1 (C=O), 146.7 (=CHCH2), 131.4 (CH=CHCH2), 40.2 





MS (EI) m/z (%) 180 [M+] (49), 162 (2), 151 (6), 137 (11), 123 (11), 109 (45), 98 (51), 95 (29), 84 
(39), 81 (100), 68 (65), 55 (78), 41 (76), 27 (23). 
HRMS (EI-FE) calcd for C12H20O [M+] 180.1515, found 180.1514. 
 
(E)-2-Cyclopentadecenone (11f): The title compound was prepared according to the general 
procedure B from cyclopentadecanone (3.37 g, 15.0 mmol). Stoichiometric Pd(OAc)2 
(3.37 g, 15.0 mmol) in acetonitrile (20 mL) was used in the oxidation step. Purification 
by flash column chromatography (silica gel, 2% Et2O in pentane) gave pure (E)-enone 
11f (2.16 g, 9.71 mmol, 65%) as a clear oil. 
1H NMR (500 MHz, CD2Cl2) δ 6.78 (td, J = 15.3, 7.7 Hz, 1H, =CHCH2), 6.16 (d, J = 
16.1 Hz, 1H, CH=CHCH2), 2.47-2.45 (m, 2H, CH2C(=O)), 2.29-2.25 (m, 2H, =CHCH2), 1.68-1.62 (m, 
2H, CH2), 1.56-1.51 (m, 2H, CH2), 1.35-1.22 (m, 16H, CH2). 
13C NMR (125 MHz, CD2Cl2) δ 201.5 (C=O), 148.0 (=CHCH2), 130.8 (CH=CHCH2), 40.1 
(CH2C(=O)), 31.7 (=CHCH2), 27.1 (CH2), 27.0 (CH2), 26.8 (3C, -(CH2)n-), 26.6 (CH2), 26.3 (CH2), 
26.1 (CH2), 25.5 (CH2), 25.3 (CH2). 
MS (EI) m/z (%) 222 [M+] (92), 207 (2), 193 (2), 179 (4), 164 (20), 151 (7), 135 (12), 121 (14), 109 
(53), 96 (63), 81 (52), 68 (57), 55 (100), 41 (78), 29 (24). 
HRMS (EI-DE) calcd for C15H26O [M+] 222.1982, found 222.1984. 
 
Synthesis of 3-tert-butylcyclohex-2-enone (9k)38  
A flask was charged with 10% Pd/C (96 mg, 0.09 mmol, 2.5 mol%), CH2Cl2 (70 mL), 
TBHP (3.29 mL, 18.1 mmol, 5.5 M in decane, 5 equiv), K2CO3 (124 mg, 0.91 mmol, 
25 mol%), and 1-tert-butylcyclohexene (500 mg, 3.62 mmol, 54 uL, 0.32 mmol, 1 equiv) 
under argon. The mixture was stirred at 0 °C for 12 h. After removal of the solvent at 
0 °C under reduced, the crude product was purified by flash column chromatography (silica gel, 30-
60% Et2O in pentane) to provide the title compound (320 mg, 2.10 mmol, 58%) as a clear liquid. 
1H NMR (500 MHz, CD2Cl2) δ 5.88 (t, J = 1.3 Hz, 1H, =CH), 2.34 (td, J = 6.0, 1.3 Hz, 2H, CH2Cqol), 
2.30 (app. t, J = 6.6 Hz, 2H, CH2C(=O)), 1.94 (quint, J = 6.3 Hz, 2H, CH2CH2CH2), 1.12 (s, 9H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 200.4 (C=O), 173.9 (Cq=CH), 123.1 (Cq=CH), 37.8 (CH2C(=O)), 
36.9 (CqMe3), 28.4 (3C, C(CH3)3), 26.3 (CH2), 23.7 (CH2). 
                                                 




GC-MS (GC-EI) m/z (%) 152 [M+] (31), 137 (11), 124 (35), 109 (100), 96 (67), 81 (39), 79 (13), 67 
(32), 65 (7), 57 (20), 41 (32), 29 (7). 
HRMS (EI-FE) calcd for C10H16O [M+] 152.1202, found 152.1201. 
Synthesis of (S)-3-Methyl-5-phenyl-2-cyclohexenone (S)-(9r)39  
Acetic acid (36.0 mg, 0.6 mmol, 60 mol%) was added to a solution of 9-amino(9-
deoxy)epiquinine (1a; 64.7 mg, 0.2 mmol, 20 mol%) in toluene. After cooling to –15°C, 
4-phenyl-2,6-heptandione (204 mg, 1.0 mmol) was added. The resulting mixture was 
stirred at –15°C for 48 h. The reaction mixture was then directly subjected to flash 
column chromatography (silica gel, 20% Et2O in pentane) to afford the cyclohexenone derivative 9r 
(159 mg, 842 μmol, 84%; 95.5:4.5 er) as a colorless solid. The enantiomeric ratio was determined by 
HPLC using a chiral Chiralcel OJ-H column (10% i-PrOH in heptane, 0.5 mL/min); major enantiomer: 
τR = 21.71 min, minor enantiomer: τR = 3.86 min. 
1H NMR (500 MHz, CDCl3) δ 7.36-7.33 (m, 2H, CHPh), 7.27-7.23 (m, 3H, CHPh), 5.92 (s, 1H, =CH), 
(hept, J = 5.5 Hz, 1H, CHal), 2.60-2.47 (m, 4H, CH2), 2.00 (s, 3H, CH3). 
13C NMR (125 MHz, CD2Cl2) δ 198.8 (C=O), 162.0 (Cq=), 144.1 (CqPh), 129.0 (2C, CHPh), 127.2 (2C, 
CHPh), 127.1 (CH), 126.6 (CH), 44.3 (CH2C(=O)), 41.2 (CHal), 39.2 (CH2Cqol), 24.4 (CH3). 
MS (EI-DE) m/z (%) 186 [M+] (41), 171 (2), 158 (1), 142 (6), 128 (4), 115 (4), 104 (14), 91 (4), 82 
(100), 77 (7), 65 (3), 54 (10), 39 (10), 27 (2). 
HRMS (EI-DE) calcd for C13H14O [M+] 186.1043, found 186.1044. 
 
Synthesis of Cyclopentenones 16  
 
Starting materials 16b, 16c,40 16d,41 16e,42 have been reported in the literature. 
 
                                                 
39 J. Zhou, V. Wakchaure, P. Kraft, B. List, Angew. Chem. Int. Ed. 2008, 47, 7656. 
40 Iwasawa, N.; Matsuo, T.; Iwamoto, M.; Ikeno, T. J. Am. Chem. Soc. 1998, 120, 3903. 
41 Trost, B. M.; Xie J.; Maulide, N. J. Am. Chem. Soc. 2008, 130, 17258. 





Preparation of -Branhed ,-Unsaturated Aldehydes 
 
Compounds 19a, 19b, 19d and 19e were obtained from commercial sources (Sigma-Aldrich, TCI 
Europe) and used without purification if freshly purchased or distilled prior to use.  
 
(E)-2-benzyl-5-phenylpent-2-enal (19c) Following the procedure of List et al.,43 to a solution of 3-
phenylpropanal (1 g, 7.45 mmol, 1 equiv) in dichloromethane (7.45 
mL) was added morpholinium trifluoroacetate (300 mg, 1.49 mmol, 0.2 
equiv) and the mixture was stirred at reflux for 19 h. Removal of the 
solvent under reduced pressure and flash chromatography (10% Et2O 
in pentane) afforded 19c as a colourless oil (800 mg, 3.2 mmol, 86%, E/Z = 97:3).  
 
1H NMR (500 MHz, CDCl3) δ 9.43 (s, 1H, CHO), 7.30-7.27 (m, 2H, CHAr), 7.24-7.20 (m, 3H, CHAr), 
7.17-7.09 (m, 5H, CHAr), 6.61 (apparent t, J = 6.9 Hz, 1H, C=CH), 3.57 (s, 2H, PhCH2), 2.77-2.70 (m, 
4H, PhCH2CH2). 
13C NMR (125 MHz, CDCl3): δ 194.6, 154.8, 142.8, 140.5, 139.1, 128.6, 128.5, 128.4, 128.3, 126.4, 
126.1, 34.5, 31.1, 29.7. 
FTIR (thin film) 3085, 3062, 3027, 2924, 2821, 2716, 1680, 1639, 1601, 1495, 1453, 1137, 1076, 
1030, 1002, 883, 733, 697 cm-1 
HRMS (m/z) calcd for C18H18O [M]+: 250.1358, found: 250.1357.  
 
The spectroscopic data are identical in all respects to those previously reported.44 
 
 
(E)-6-methyl-7-oxohept-5-en-1-yl acetate (19f): Prepared by Grubbs metathesis from hex-5-en-1-yl 
acetate and methacrylaldehyde according to the reported procedure.45   
1H NMR (500 MHz, CDCl3) δ 9.41 (s, 1H, CHO), 6.47 (tq, J = 7.3 Hz, 
J = 1.3 Hz, 1H, C=CH), 4.10 (t, J = 6.4 Hz, 2H, AcOCH2), 2.40 (q, 
J = 7.5 Hz, 2H, CH2C=CH), 2.06 (s, 3H, CO2CH3), 1.76-1.56 (m, 7H, 
CH3, CH2). 
13C NMR (125 MHz, CDCl3): δ 195.2, 171.1, 153.7, 139.8, 64.0, 28.5, 28.3, 24.9, 21.0, 9.3. 
                                                 
43 Zumbansen, K.; Döring, A.; List, B. Adv. Synth. Catal. 2010, 352, 1135. 
44 Erkkilä, A.; Pihko P. M. Eur. J. Org. Chem. 2007, 4205. 




FTIR (thin film) 2949, 2867, 2715, 2256, 1736, 1684, 1645, 1457, 1388, 1366, 1236, 1047, 908, 729 
cm-1 
HRMS (m/z) calcd for C10H16O3 [M]+: 184.1099, found: 184.1099.  
 
The physical data are identical in all respects to those previously reported. 45 
 
 
(E)-2-methyl-5-phenylpent-2-enal (19g) Following the procedure of Chatterjee et al.,45 to a stirring 
solution of Grubbs second generation catalyst (53 mg, 0.063 mmol, 6.3 
mol%) and 4-phenyl-1-butene (150.2 μL, 1.0 mmol, 1 equiv) in dry 
dichloromethane (2.5 mL) under argon was added methacrylaldehyde 
(82.6 μL, 1.0 mmol, 1 equiv) dropwise via a syringe. The mixture was 
stirred at reflux for 12 h and the solvent was removed under reduced pressure.  Purification by flash 
chromatography (4% Et2O in pentane) afforded 19g as a yellow oil (226 mg, 1.3 mmol, 65%, 
E/Z > 20:1).  
 
1H NMR (500 MHz, CDCl3) δ 9.38 (s, 1H, CHO), 7.33-7.19 (m, 5H, CHAr), 6.50 (tq, J = 7.3 Hz, J = 
1.3 Hz, 1H, C=CH), 2.82 (apparent t, J = 7.5 Hz, 2H, PhCH2), 2.68 (apparent q, J = 7.5 Hz, 2H, 
PhCH2CH2), 1.69 (br. s, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 195.3, 153.3, 140.6, 139.9, 128.6, 128.4, 126.3, 34.4, 30.7, 9.2. 
FTIR (thin film) 3062, 3028, 2926, 2821, 2713, 1684, 1644, 1454, 1360, 1240, 1015, 700 cm-1 
HRMS (m/z) calcd for C12H14O [M]+: 174.1045, found: 174.1046.  
 
The physical data are identical in all respects to those previously reported.46 
 
 
2-methylcyclohex-1-enecarbaldehyde (19j): Following the procedure of Piers et al.,47 to a solution 
of 1-methylcyclohept-1-ene (200 mg, 1.81 mmol, 1 equiv) in MeCN 
(9 mL), CCl4 (9 mL) and water (13 mL) was added NaIO4 (1.6 g, 7.60 
mmol, 4.2 equiv) followed by RuO2•xH2O (4.8 mg, 0.036 mmol, 0.02 
equiv), and the mixture was stirred vigorously for 1h at room 
temperature. The mixture was diluted with water and extracted with 
CH2Cl2 three times. The combined organic layers were washed with brine, dried over Na2SO4 and the 
                                                 
46 Browder, C. C.; Marmsäter, F. P.; West, F. G. Can. J. Chem. 2004, 82, 375. 




solvent was carefully evaporated. The crude reaction mixture was diluted with CH2Cl2 (18 mL) and L-
proline (20.7 mg, 0.18 mmol, 0.1 equiv) was added. After 14h, AcOH (104 uL, 1.81 mmol, 1 equiv) 
was added, and the reaction mixture was stirred at room temperature for 34h after which all of the 
starting material was consumed. The crude reaction mixture was diluted with ether, washed with sat. 
aq. NaHCO3 and extracted with ether three times. The combined organic layers were washed with 
brine, dried over Na2SO4 and evaporated under reduced pressure. Flash chromatography (30% Et2O in 
pentane) afforded 19j as a colourless oil (76.3 mg, 0.61 mmol, 34%).  
 
1H NMR (500 MHz, CDCl3) δ 10.15 (s, 1H, CHO), 2.23-2-16 (m, 4H, CH2C=CCH2), 2.14 (br s, 3H, 
CH3), 1.66-1.57 (m, 4H, CH2).  
 
The spectroscopic data are identical in all respects to those previously reported.47  
 






















Methyl 2-(bis(2,2,2-trifluoroethoxy)phosphoryl)propanoate: Following the procedure of Sano et 
al.,48 to a solution of tBuOK (1.27g, 11.3 mmol, 1.2 equiv) in THF (13 
mL) was slowly added methyl bis(2,2,2-
trifluoroethyl)phosphonoacetate (2 mL, 9.46 mmol, 1 equiv) at 0 °C 
under argon. The mixture was stirred at 0 °C for 30 min under argon, 
and methyl iodide (2.96 mL, 47.3 mmol, 5 equiv) was slowly added at 
0 °C. The solution was warmed up to room temperature, stirred for 23 h and treated with a saturated 
aqueous solution of NH4Cl. The reaction mixture was extracted with EtOAc three times, dried over 
Na2SO4, filtered and concentrated. Flash column chromatography eluting with 30% EtOAc in hexanes 
afforded the title compound as a colourless oil (2.30 g, 6.93 mmol, 73%).  
 
                                                 




1HNMR (500 MHz, CDCl3) δ: 4.49-4.38 (m, 4H, F3CCH2), 3.78 (s, 3H, CO2CH3), 3.20 (dq, 
JH,P = 22.8 Hz, J = 7.4 Hz, 1H, P(O)CHCH3), 1.52 (dd, JH,P = 19.3 Hz, J = 7.4 Hz, 3H, CH3).   
 
 
(Z)-methyl 2-methyl-5-phenylpent-2-enoate: Following the procedure of Still and Gennari,49 a 
solution of methyl 2-(bis(2,2,2-trifluoroethoxy)phosphoryl)propanoate 
(332 mg, 1 mmol, 1 equiv) and 18-crown-6 (1.32 g, 5 mmol, 5 equiv) 
in THF (20 mL) was cooled to -78 °C under argon and treated with 
KHMDS (199.5 mg, 1 mmol, 1 equiv). 3-Phenylpropanal (133 μL, 1 
mmol, 1 equiv) was added and the resulting mixture was stirred at – 78 
°C for 1h. Saturated aqueous solution of NH4Cl was added and the product was extracted with diethyl 
ether three times, dried over Na2SO4, filtered and concentrated. The title compound (Z/E > 20:1 by 
1HNMR) was used without purification. 
 
1HNMR (500 MHz, CDCl3) δ: 7.30-7.17 (m, 5H, CHAr), 5.98 (td, J = 6.9 Hz, J = 1.2 Hz, 1H, C=CH), 
3.72 (s, 3H, CO2CH3), 2.81-2.70 (m, 4H, PhCH2CH2), 1.89 (d, J = 1.2 Hz, 3H, CH3).  
 
The physical data are identical in all respects to those previously reported.49  
 
 
(Z)-2-methyl-5-phenylpent-2-en-1-ol: Crude (Z)-methyl 2-methyl-5-phenylpent-2-enoate descrbied 
above (1 mmol) was dissolved in dichloromethane (3 mL) under argon 
and cooled to -78 °C. DIBAL (4.8 mL, 1M in hexanes, 4.8 mmol, 4.8 
equiv) was added dropwise and the solution was stirred for 1 h at – 78 
°C. The reaction was quenched with aqueous Rochelle’s salt and 
stirred vigorously for 2 h. The crude reaction mixture was extracted 
with dichloromethane three times, dried over Na2SO4, filtered and concentrated. Flash column 
chromatography eluting with 15% diethyl ether in pentane afforded the title compound as a colourless 
oil (93.2 mg, 0.53 mmol, 53% over two steps). 
 
1HNMR (500 MHz, CDCl3) δ: 7.30-7.16 (m, 5H, CHAr), 5.33 (t, J = 7.6 Hz, 1H, C=CH), 3.92 (s, 2H, 
CH2OH), 2.66 (apparent t, J = 7.2 Hz, 2H, PhCH2CH2), 2.37 (c. m, 2H, PhCH2CH2), 1.76 (d, 
J = 1.1 Hz, 3H, CH3). 
                                                 












The physical data are identical in all respects to those previously reported.50  
(Z)-2-methyl-5-phenylpent-2-enal ((Z)-19g): Oxalyl chloride (50.3 μL, 0.59 mmol, 2 equiv) was 
dissolved in dichloromethane (9 mL) and the solution was cooled to 
-78 °C. DMSO (83.2 μL, 1.17 mmol, 4 equiv) was added dropwise at 
-78 °C and the solution was stirred for 30 min. A solution of (Z)-2-
methyl-5-phenylpent-2-en-1-ol in dichloromethane (2 mL) was added 
dropwise and the reaction was stirred for 30 min. Et3N (244 μL, 1.76 mmol 6 equiv) was added 
dropwise and the solution was stirred for 1 h at –78 °C. The reaction was warmed up to room 
temperature, treated with a saturated aqueous solution of NH4Cl and extracted with dichloromethane 
three times, dried over Na2SO4, filtered and concentrated. 1H NMR analysis of the crude reaction 
mixture indicated Z/E ratio of 97:3. Flash column chromatography eluting with 15% diethyl ether in 
pentane afforded (Z)-31g as a colourless oil (38.2 mg, 0.22 mmol, 75%, Z:E = 95:5).  
 
1HNMR (500 MHz, CDCl3) δ: 10.0 (s, 1H, CHO), 9.38 (s, 0.05 H, E-isomer, CHO), 7.31-7.17 (m, 
5H, CHAr), 6.53 (td, J = 8.0 Hz, 1H, C=CH), 2.91-2.78 (m, 4H, PhCH2CH2), 1.76 (d, J = 1.1 Hz, 3H, 
CH3). 
13C NMR (125 MHz, CDCl3): δ 191.0, 147.9, 140.3, 136.6, 128.6, 128.5, 126.4, 35.7, 28.5, 16.4. 
FTIR (thin film) 3063, 3028, 2925, 2859, 1678, 1645, 1496, 1355, 1242, 1016, 907, 730, 700 cm-1. 
 
The physical data are identical in all respects to those previously reported.51  
 
 
2-benzylacrylaldehyde (22a): Prepared from 3-phenylpropanal and formaldehyde according to the 
reported procedure.52  
1H NMR (500 MHz, CDCl3) δ 9.60 (s, 1H, CHO), 7.31-7.17 (m, 5H, 
CHAr), 6.10 (s, 1H, C=CH2), 6.07 (s, 1H, C=CH2), 3.57 (s, 2H, 
PhCH2). 
13C NMR (125 MHz, CDCl3): δ 194.0, 149.8, 138.1, 135.3, 129.2, 
128.6, 126.5, 34.2. 
FTIR (thin film) 3087, 3063, 3029, 2919, 2824, 2701, 1686, 1602, 1496, 1453, 1434, 1245, 1075, 
950, 737, 699 cm-1 
                                                 
50 M. Prévost, K. A. Woerpel, J. Am. Chem. Soc. 2009, 131, 14182. 
51 D. A. Colby, R. G. Bergman, J. A. Ellman, J. Am. Chem. Soc. 2006, 128, 5604. 




HRMS (m/z) calcd for C10H10O [M]+: 146.0732, found: 146.0733.  
2-methylenedec-9-enal (22b): Following the reported procedure,52 pyrrolidine (17 μL, 0.2 mmol, 0.1 
equiv) and 4-(dimethylamino)benzoic acid (66 mg, 0.4 mmol, 0.2 
equiv) were dissolved in dichloromethane (2 mL) and 36.5% aq. 
formaldehyde (160 μL, 2 mmol, 1 equiv) was added followed by dec-9-
enal (365 μL, 2 mmol, 1 equiv). The reaction was stirred at 45 °C for 45 
min and cooled to r.t. The crude mixture was washed with 10% aq. 
NaHCO3, extracted with dichloromethane three times, and the combined organic layers were washed 
with brine, dried over Na2SO4 and evaporated under reduced pressure. Flash column chromatography 
eluting with 5% Et2O in pentane afforded 22b as a colourless oil (128.6 mg, 0.77 mmol, 39%). 
 
1H NMR (500 MHz, CDCl3) δ 9.54 (s, 1H, CHO), 6.24 (c. m, 1H, HC(O)C=CH2), 5.98 (br d, J = 0.7 
Hz, 1H, HC(O)C=CH2), 5.80 (ddt, J = 17.1 Hz, J = 10.1 Hz, J = 6.7 Hz, CH=CH2), 5.02-4.91 (m, 2H, 
CH=CH2), 2.23 (t, J = 7.5 Hz, 2H, H2C=CCH2), 2.06-2.00 (m, 2H, H2C=CHCH2), 1.49-1.29 (m, 8H).   
13C NMR (125 MHz, CDCl3): δ 194.8, 150.5, 139.1, 133.9, 114.2, 33.7, 29.1, 28.9, 28.8, 27.8, 27.7. 
FTIR (thin film) 3078, 2978, 2928, 2857, 1695, 1641, 1464, 1440, 1329, 995, 942, 910, 850 cm-1 
HRMS (m/z) calcd for C11H18O [M]+: 166.1358, found: 166.1359.  
 
The physical data are identical in all respects to those previously reported.53  
 
 
2-methylenepentanal (22c): Prepared from pentanal and formaldehyde according to the reported 
procedure.52  
1H NMR (500 MHz, CDCl3) δ  9.55 (s, 1H, CHO), 6.26 (s, 1H, 
C=CH2), 6.00 (s, 1H, C=CH2), 2.21 (t, J = 7.6 Hz, 2H, H2C=CCH2), 
1.49 (apparent sext, 2H, CH3CH2), 0.93 (t, J = 7.4 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 194.9, 150.2, 134.1, 29.8, 20.95, 14.1. 
FTIR (thin film) 2961, 2932, 2874, 2704, 1686, 1640, 1464, 1379, 1087, 944, 876, 744 cm-1  
HRMS (m/z) calcd for C6H10O [M]+: 98.0732, found: 98.0731  
 
 
2-methylenedecanal (22d): Prepared from decanal and formaldehyde according to the reported 
procedure. 52 
                                                 




1H NMR (500 MHz, CDCl3) δ 9.71 (s, 1H, CHO), 6.25 (br s, 1H, C=CH2), 5.99 (br s, 1H, C=CH2), 
2.23 (t, J = 7.6 Hz, 2H, H2C=CCH2), 1.44 (c. m, 2H, CH2), 1.33-1.23 (m, 10H, CH2), 0.88 (t, J = 6.7 
Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 194.9, 150.5, 134.0, 31.9, 29.4, 29.3, 29.2, 27.77, 27.75, 22.7, 14.1. 
FTIR (thin film) 2926, 2856, 2256, 1694, 1628, 1466, 1330, 1106, 942, 907, 729 cm-1 
HRMS (m/z) calcd for C11H20O [M]+: 168.1514, found: 168.1514.  
 
2-methylene-3-phenylbutanal (rac-22e): Prepared from 3-phenylbutanal and formaldehyde 
according to the reported procedure. 52 
1H NMR (500 MHz, CDCl3) δ 9.54 (s, 1H, CHO), 7.30-7.18 (m, 5H, 
CHAr), 6.24 (br d, J = 1.1 Hz, 1H, , C=CH2), 6.08 (br s, 1H, , C=CH2), 
4.03 (q, J = 7.2 Hz, 1H, CH3CH), 1.43 (d, 7.1 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 193.9, 154.3, 143.6, 133.7, 128.4, 
127.5, 126.4, 37.2, 20.0. 
FTIR (thin film) 3062, 3029, 2972, 2937, 2878, 2817, 2670, 2256, 1693, 1493, 1453, 1245, 948, 907, 
730, 699 cm-1 
HRMS (m/z) calcd for C11H12O [M]+: 160.0888, found: 160.0886. 
 







Mechanistic Studies  
Structure Activity Correlations 
In order to evaluate the role of the primary amine moiety in 1a in covalent aminocatalysis, we 
carried out the epoxidation of 2-cyclohexen-1-one 9a in the presence of derivatives S-13-S-16 and their 
salts as catalysts. The results employing the standard catalyst salt [1a·2 TFA] are provided for 
comparison in entry 1. As expected, the N-methylated amine S-13, which represents a more congested 
secondary amine equivalent of catalyst 1a, mediated the reaction with a significantly diminished yield 
and lower enantioselectivity (entry 2). Catalyst S-14, which is capable of hydrogen bonding catalysis54 
but lacks a primary amine moiety was found to give racemic product in a very low yield (entry 3). 
Interestingly, pairing this catalyst with the Brønsted acid co-catalyst TFA dramatically improved the 
enantioselectivity, although the yield remained low (entry 4). Sulfonamide catalyst S-15 was found to 
give only traces of the product in the presence or absence of the Brønsted acid co-catalyst (entries 5-6), 
though a similar effect of the Brønsted acid co-catalyst was observed on the enantioselectivity of the 
reaction as with the thiourea derivative S-14. Quinine S-16 and its ammonium salt [S-16·TFA] showed 
no activity (entries 8-10). Taken together, these results suggest that although noncovalent catalysis is 
feasible in the reaction, it achieves only very low yields and modest enantioselectivity (entries 4 and 6). 
Indeed, the presence of the primary amine moiety in 1a is crucial for the observed reaction rate and 
enantioselectivity, supporting a mechanism proceeding through iminium activation and not via other 




                                                 





entry catalyst yield, [%]a erb 
1 [1a·2 TFA] 82 96:4 
2 [S- 13 TFA] 13 67:33 
3 S-14 12 rac 
4 [S-14·2 TFA] 18 76.5:23.5 
5 S-15 <5 rac 
6 [S-15·2 TFA] <5 77:23 
7 S-16 0 - 
8c S-16 0 - 
9 [S-16·TFA] 0 - 




We monitored the hydroperoxidation and epoxidation of acyclic enones by using Electrospray-
Ionization Mass Spectroscopy (ESI-MS). For this purpose we carried out the reaction of 3-decen-2-one 
(2a) with aqueous hydrogen peroxide in the presence of catalytic amounts of the 9-amino(9-
deoxy)epiquinine catalyst salt [1a • 2 TXA] (X = F, Cl). In one experiment, the standard conditions of 
the epoxidation reaction were used (Scheme 1a), and in the other, the optimized hydroperoxidation 




Scheme 1. Test reactions for ESI-MS analysis: reaction of 3-decen-2-one (2a) with hydrogen peroxide 




Samples were taken from the reaction mixtures at different time intervals over 24 hours and submitted 
to ESI-MS analysis. Spectra recorded prior to hydrogen peroxide addition (Figure 1) and after 1 and 12 
hours of reaction time, respectively, are depicted in the following figures (Figure 2 and Figure 3). 
It should be noted that 3-decen-2-one (2a), its corresponding epoxide 4a and peroxide 3a could not be 
detected by ESI-MS, as the spectrometer utilized could only detect molecules with molecular weights 
higher than 200 g mol-1. Therefore, neither signals corresponding to the starting material nor to the 
products appear in Figures 1-3. 
The ESI-MS spectra of the samples taken prior to hydrogen peroxide addition (Figure 1) showed a 
signal at m/z 460 which corresponds to the imininium ion A formed by condensation of 9-amino(9-
deoxy)epiquinine (1a) with 3-decen-2-one (2a). Moreover, the signal of 9-amino(9-deoxy)epiquinine at 




Figure 1. ESI-MS spectrum of reaction (a) recorded prior to H2O2-addition.  
 
The fact that the signal at m/z 460 could not be detected any longer after addition of hydrogen peroxide 
(Figure 2), indicates that iminium ion A is consumed by hydrogen peroxide, and thus validates our 
assumption that iminium ions such as A are indeed intermediates in our epoxidation/hydroperoxidation 
reaction. The signal corresponding to 9-amino(9-deoxy)epiquinine at m/z 324 [(1a+H)+] is still present. 
After 1 h of reaction time, two new signals have appeared at m/z 476 and 494, which match the masses 
of the iminium ion B derived from 2,3-epoxy-2-decanone (4a) and iminium ion C derived from the 
corresponding -hydroperoxyketone which upon hydrolysis affords peroxyhemiketal 3a.  




























Figure 2. ESI-MS spectra after 1 hour from the reaction (a) with [1a • 2 TFA] at 50 °C and (b) 
[1a • 2 TCA] at 32 °C. 
 
The fact that the signal of the unsaturated iminium ion A at m/z 460 cannot be detected in the presence 
of hydrogen peroxide suggests that its concentration remains low under reaction conditions. Thus, 
based on these results, we may propose that neither the conjugate H2O2-addition nor the intramolecular 
epoxide closure, but indeed the formation of the iminium ion intermediate A represents the rate-
limiting step of these transformations. 
More specifically, as we have shown that the iminium ion ins generally detectable if present in the 
reaction mixture and at the same time we don’t detect A any more when hydrogen peroxide is present, 

















































































we can conclude that its concentration under these conditions is low. Therefore the iminium ion 
formation has to be slower than the peroxide addition. At the same time, as we can detect the iminium 
ion resulting form peroxide addition C, the iminium ion resulting from ring closure B and the free 
catalyst 1a alongside each other the rates of their formation and consumption have to be of comparable 
magnitude. Thus our proposed catalytic cycle consists of 3 comparably fast reactions and one clearly 
slower one, which leads us to propose that the iminium ion formation is the rate limiting step of our 
reaction.   
Additionally in reaction (a) run at 50 °C, additional signals at m/z 340, 492, and 510 can be detected 
which presumably arise from the oxidation of the catalyst under reaction conditions (Figure 2a). Since 
an excess of oxidant was used and the amine was employed in catalytic amount, we expect that the 
signal at m/z 340 may correspond to monooxygenated 9-amino(9-deoxy)epiquinine 1a+O. Moreover, 
signals at m/z 492 and 510 were assigned to iminium ions B+O and C+O, analogous to B and C, but 
incorporating oxygenated 9-amino(9-deoxy)epiquinine 1a+O instead of 1a. On the contrary, in reaction 
(b) run at 32 °C only one signal of low intensitiy at m/z 510 was detected to witness beginning catalyst 
oxidation (Figure 2b). 
 
After 12 hours at 50 °C, the ESI-MS spectrum of the sample from reaction (a) indicates extensive 
catalyst oxidation (Figure 3a). Strong signals at m/z 340 and 492 match (as mentioned above) 
monooxygenated 9-amino(9-deoxy)epiquinine 1a+O and its corresponding iminium ion formed with 
,-epoxy decanone B+O, respectively. On the contrary, signals at m/z 324, 476, and 494 have suffered 
a considerable loss of intensity. The epoxidation of decenone at 50 °C with [1a • 2 TFA] (10 mol%) 
generally requires 10 hours to go to completion. Partially oxidized amine 1a+O could already be 
detected after 1 h of reaction time (at ~20% conversion). Double oxidation of amine 1a, in other words 









Figure 3. ESI-MS spectra after 12 hours from the reaction (a) with [1a • 2 TFA] at 50 °C and (b) 
[1a • 2 TCA] at 32 °C. 
494.3
1a+O 






































































N-oxidation of catalyst 1a 
 
Synthesis of 9-amino(9-deoxy)epiquinine N-oxide (24)  
 
9-amino(9-deoxy)epiquinine N-oxide (24): 9-Amino-(9-deoxy)epiquinine (1a) (100 mg, 0.31 mmol) 
was dissolved in dichloromethane (3 mL) and cooled to –78 °C. Under 
ambient atmosphere, m-CPBA (60 mg, 0.27 mmol, 0.87 equiv, 77% 
purity) was added, and the reaction mixture was stirred for 1 h at 
-78 °C. The crude reaction mixture was then directly loaded onto a 
silica gel column packed with a 900:100:6.5 solvent mixture of 
CH2Cl2:MeOH:NH3 conc. and eluted with the same solvent mixture. 
The first eluted product corresponds to the excess starting material (1a). Further elution yielded the title 
compound 24 as an oil which becomes a highly hygroscopic amorphous white foam after washing with 
ether and evaporating the solvent under reduced pressure (92.8 mg, 0.27 mmol, quant. based on m-
CPBA.).  
1H NMR (500 MHz, MeOD) δ 8.71 (d, J = 4.6 Hz, 1H, H-2’), 7.98 (d, J = 9.2 Hz, 1H, H-8’), 7.73 (br 
s, 1 H, H-5’), 7.64 (d, J = 4.6 Hz, 1H, H-3’), 7.48 (dd, J = 9.2 Hz, J = 2.5 Hz, 1H, H-7’), 5.92 (ddd, 
J = 17.2 Hz, J = 10.5 Hz, J = 6.8 Hz, 1H, H-10), 5.38-5.08 (m, 3H, H-9 + H-11), 4.08 (c. m, 1H, H-
6b), 4.03 (s, 3H, C-12), 3.89 (br s, 1H, H-8), 3.70 (dd, J = 12.9 Hz, J = 10.6 Hz, 1H, H-2a), 3.53-3.37 
(m, 2H, H-2b + H-6a), 2.99-2.88 (m, 1H, H-3), 2.15-1.79 (m, 3H, H-5 + H-7b), 1.76 (c. m, 1H, H-4), 
1.09-0.99 (m, 1H, H-7a).  
13C NMR (150 MHz, MeOD) δ 160.3 (C-6’), 148.4 (C-2’), 147.6 (C-8a’), 144.9 (C-4’), 139.3 (C-10), 
131.5 (C-8’), 129.7 (C-4a’), 124.15 (C-7’), 121.8 (C-3’), 117.2 (C-11), 102.0 (C-5’), 74.7 (C-8), 71.7 
(C-2), 58.5 (C-6), 56.3 (C-12), 52.0 (C-9), 41.6 (C-3), 28.8 (C-7), 28.0 (C-4), 27.8 (C-5). 
15N-NMR (60 MHz, MeOD, NH3	 =	0	ppm) δ 296.5 (quinoline N), 117.5 (N-oxide), primary amine 
could not be detected. 
FTIR (thin film) 3264, 2943, 2216, 1620, 1590, 1507, 1474, 1432, 1359, 1309, 1263, 1236, 1175, 
1135, 1083, 1028, 987, 909, 856, 830, 725. 
MS (EI): m/z = 339 [M], 322, 305, 214, 187, 156, 136, 108, 98, 81, 67, 56, 41. 






A kinetic study on the oxidation of the amine salt [1a·2TFA] to [24·2TFA] was performed by taking 
aliquots of the reaction over 18 h (Table 1). Two methods were employed to determine the reaction 
conversion: aliquots diluted in THF-d8 (approx. 0.1 mL sample + 0.3 mL THF-d8) were analyzed by 1H 
NMR spectrometry, and aliquots diluted in MeOH (0.2 -1 μL in 1 mL MeOH) were analyzed by ion 
pair chromatography (IPC, 50 mm Zorbax Eclipse Plus C18, 1.8 μm, 4.6 mm i.D.; mobile phase: 
methanol/5 mm DiKGA pH 4.6 = 50:50, 1.0 mL/min, 220 nm, 308K). The conversion vs. time graph 
(Figure 4) was plotted using the average conversion obtained from both methods. This graph shows no 
apparent autocatalytic effect. 
 
Table 4. Conversion of the amine salt [1a·2TFA] to [24·2TFA] in the presence of excess aq. H2O2, 


























Figure 4. Oxidation of the amine salt [1a·2TFA] to [24·2TFA] in the presence of excess aq. H2O2. 
 




9-Amino(9-deoxy)epiquinine N-oxide (24) (20.6 mg, 0.061 mmol) was dissolved in acetone (0.8 mL) 
and H2SO3 (6% wt, 0.1 mL, 0.073 mmol, 1.2 equiv) was added dropwise at 0 °C. The reaction mixture 
was stirred for 17 h, dissolved in dichloromethane, washed with sat. aq. NaHCO3, dried over MgSO4, 
filtered and the solvent was removed under reduced pressure. The resulting white amorphous foam 
(11.1 mg, 0.034 mmol, 56%) was obtained as a spectroscopically pure compound, whose physical data 
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(S,E)-1-(6-methoxyquinolin-4-yl)-N-((E)-2-methyl-3-phenylallylidene)-1-((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methanamine (25): 9-Amino-(9-deoxy)epiquinine (1a) (400 mg, 1.24 mmol) 
and (E)-2-methyl-3-phenylacrylaldehyde 
(183 μL, 1.30 mmol, 1.05 equiv) were 
dissolved in methanol (4 mL) and 
activated 4 Å molecular sieves (0.5 g) 
were added. After stirring the reaction 
mixture overnight, TLC control (CH2Cl2: 
MeOH:NH3 conc.9:1:0.065) showed the 
disappearance of the starting material. 
The mixture was filtered through a pad of 
Celite washing with dichloromethane, and 
the solvent was evaporated under reduced pressure to afford the title compound in quantitative yield, 
containing 5% of the excess (E)-2-methyl-3-phenylacrylaldehyde. This compound was found to be 
fairly stable to hydrolysis and could be handled in the air and with non-dried solvents. For long-term 
storage, it was kept under argon at 4 °C as a solid and in a vacuum-sealed NMR tube as a solution. 
  
1H NMR (600 MHz, CDCl3) δ 8.64 (d, J = 4.5 Hz, 1H, H-2’), 7.96 (s, 1H, H-13), 7.92 (d, J = 9.2 Hz, 
1H, H-8’), 7.87 (d, J = 2.8 Hz, 1H, H-5’), 7.39 (d, J = 4.5 Hz, 1H, H-3’), 7.28 (dd, J = 9.2 Hz, J = 2.8 
Hz, 1H, H-7’), 7.25-7.16 (m, 5H, H-18 + H-19 + H-20), 6.67 (br s, 1H, H-16), 5.69 (ddd, J = 17.3 Hz, 
J = 10.3 Hz, J = 7.4 Hz, 1H, H-10), 4.88 (ddd, J = 17.3 Hz, J < 2 Hz, J < 2 Hz 1H, H-11a), 4.84 (ddd, 
J = 10.3 Hz, J <2 Hz, J <2 Hz, 1H, H-11b), 4.69 (d, J = 9.5 Hz, 1H, H-9), 3.89 (s, 3H, H-12), 3.53 
(ddd, J = 10 Hz, J = 9.5 Hz, J = 8 Hz 1H, H-8), 3.15 (dd, J = 13.8 Hz, J = 10.3 Hz, 1H, H-2a), 3.13 
(dddd, J = 14 Hz, J = 9 Hz, J = 2.5 Hz, 1H, H-6b), 2.69 (ddd, J = 14 Hz, J = 10.5 Hz, J = 5.9 Hz, 1H, 
H-6a), 2.67 (dd, J = 13.8 Hz, J = 6.0 Hz, 1H, H-2b), 2.15 (c. m, 1H, H-3), 2.07 (d, J < 2 Hz, 3H, H-
15), 1.56 (c. m, 1H, H-4), 1.47 (c. m, 2H, H-5a + H-5b), 1.26 (dddd, J = 13.7 Hz, J = 10 Hz, J = 3.7 
Hz, 1H, H-7b), 0.81 (dddd, J = 13.7 Hz, J = 8 Hz, J < 2 Hz, 1H, H-7a). 
13C NMR (150 MHz, CDCl3) δ 165.7 (C-13), 157.3 (C-6’), 147.7 (C-2’), 146.1 (C-4’), 145.1 (C-8a’), 




128.0 (C-4a’), 127.6 (C-20), 121.5 (C-3’), 121.3 (C-7’), 114.2 (C-11), 103.3 (C-5’), 74.8 (C-9), 60.4 
(C-8), 56.6 (C-2), 55.5 (C-12), 41.0 (C-6), 40.0 (C-3), 28.35 (C-5), 28.0 (C-4), 26.0 (C-7), 13.5 (C-
15). 
15N-NMR (60 MHz, CDCl3, NH3	=	0	ppm) δ 333.8 (imine N), 305.2 (quinoline N), 24.3 (quinuclidine 
N). 
MS (EI): m/z = 451 [M], 308, 293, 266, 225, 199, 173, 160, 136, 81, 42. 








vinylquinuclidin-2-yl)methanamine trifluoroacetic acid salt (26a): Imine 25 (20 mg, 0.044 mmol) 
was dissolved in dry CDCl3 in a 
flame-dried two-necked flask 
containing 20 mg activated 4 Å 
molecular sieves. To this suspension, 
trifluoroacetic acid (3.3 μL, 0.044 
mmol, 1 equiv) was added. After 
stirring for 5 min, the solution was 
transferred into a flame-dried NMR 
tube using an HPLC syringe filter to 
remove molecular sieves and sealed under vacuum.  
1H NMR (600 MHz, CDCl3) δ 12.5 (br s, 1H, NH), 8.73 (d, J = 4.4 Hz, 1H, H-2’), 8.02 (d, J = 9.4 Hz, 
1H, H-8’), 7.99 (s, 1H, H-13), 7.75 (br s, 1H, H-5’), 7.38 (dd, J = 9.4 Hz, J = 2.8 Hz, 1H, H-7’), 7.35 
(br s, 1H, H-3’), 7.31-7.22 (m, 5H, H-18 + H-19 + H-20), 6.68 (br s, 1H, H-16), 5.68 (ddd, J = 17.2 
Hz, J = 10.2 Hz, J = 6.6 Hz, 1H, H-10), 5.16-5.07 (m, 2H, H-11a + H-11b), 4.90 (br s, 1H, H-9), 4.28 
(br s, 1H, H-8), 3.98 (s, 3H, H-12), 3.72 (dd, J = 14 Hz, J = 10 Hz, 1H, H-2a), 3.52 (c. m, 1H, H-6b), 
3.35 (c. m, 1H, H-6a), 3.27 (c. m, 1H, H-2b), 2.65 (dt, J = 10 Hz, J = 5.2 Hz, 1H, H-3), 2.18 (d, J = 
1.2 Hz, 3H, H-15), 2.00 (c. m, 1H, H-4), 1.96 (c. m, 2H, H-5a + H-5b), 1.71 (dd, J = 13.2 Hz, J = 10.8 
Hz, 1H, H-7b), 1.35 (d, J = 13.2, 1H, H-7a). 
13C NMR (150 MHz, CDCl3) δ 169.6 (C-13), 162.3 (q, J = 34.3 Hz, COCF3), 158.3 (C-6’), 147.2 (C-
2’), 145.4 (C-4’), 142.1 (2C, C-8a’ + 16), 137.1 (2C, C-14 + C-10), 136.1 (C-17), 132.3 (C-8’), 129.5 
(C-18), 128.3 (C-19), 128.1 (C-20), 127.1 (C-4a’), 122.5 (C-7’), 122.1 (C-3’), 117.3 (C-11), 116.9 (q, 
J = 293.7 Hz, COCF3), 103.7 (C-5’), 74.4 (C-9), 60.0 (C-8), 56.1 (C-12), 53.8 (C-2), 40.5 (C-6), 36.9 
(C-3), 27.0 (C-4), 24.9 (C-5), 24.3 (C-7), 12.7 (C-15) 
15N-NMR (60 MHz, CDCl3, NH3	=	0	ppm,) δ 318.3 (imine N), 310.4 (quinoline N), 40.5 (quinuclidine 
N). 
19F-NMR (376 MHz, CDCl3) δ -79.5. 













vinylquinuclidin-2-yl)methanamine bis-trifluoroacetic acid salt (26b): Imine 25 (19.9 mg, 0.044 
mmol) was dissolved in dry CDCl3 in 
a flame-dried two-necked flask 
containing 20 mg activated 4 Å 
molecular sieves. To this suspension 
trifluoroacetic acid (6.5 μL, 0.088 
mmol, 2 equiv) was added. After 
stirring for 5 min, this solution was 
transferred to a flame-dried NMR tube 
using an HPLC syringe filter to remove molecular sieves and sealed under vacuum.  
 
1H NMR (600 MHz, CDCl3) δ 12.0 (br s, 1H, NH), 8.88 (d, J = 5.0 Hz, 1H, H-2’), 8.23 (d, J = 9.3 Hz, 
1H, H-8’), 8.13 (s, 1H, H-13), 7.98 (br s, 1H, H-5’), 7.77 (d, J = 5.0 Hz, 1H, H-3’), 7.50 (dd, J = 9.2 
Hz, J = 2.4 Hz, 1H, H-7’), 7.30-7.18 (m, 5H, H-18 + H-19 + H-20), 6.74 (s, 1H, H-16), 5.66 (ddd, J = 
17.2 Hz, J = 10.4 Hz, J = 6.4 Hz, 1H, H-10), 5.15 (c. m, 1H, H-9), 5.13 (dd, J = 10.2 Hz, J = 1.2 Hz, 
1H, H-11a), 5.10 (dd, J = 17.2 Hz, J = 1.2 Hz, 1H, H-11b), 4.34 (dt, J = 9.6 Hz, J = 6.0 Hz, 1H, H-8), 
4.03 (s, 3H, H-12), 3.67 (c. m, 1H, H-6b), 3.65 (dd, 1H, J = 13.8 Hz, J = 10.6 Hz, H-2a), 3.34 (c. m, 
1H, H-6a), 3.31 (ddd, J = 13.8 Hz, J = 6.0 Hz, J = 1.6 Hz, 1H, H-2b), 2.65 (dt, J = 10.8 Hz, J = 6.0 
Hz, 1H, H-3), 2.15 (d, J = 1.2 Hz, 3H, H-15), 2.12-1.90 (m, 3H, H-4 + H-5a + H-5b), 1.74 (ddd, J = 
13.6 Hz, J = 9.6 Hz, J = 2.0 Hz,1H, H-7b), 1.40 (d, J = 13.6 Hz, 1H, H-7a). 
13C NMR (150 MHz, CDCl3) δ 171.2 (C-13), 162.1 (q, J = 35.7 Hz, COCF3), 159.7 (C-6’), 147.7 (C-
4’), 143.4 (C-16), 143.0 (C-2’), 139.5 (C-8a’), 136.6 (C-10), 136.5 (C-14), 135.7 (C-17), 129.5 (C-19), 
128.4 (C-20), 128.36 (C-18), 128.0 (C-4a’), 127.3 (C-8’), 125.6 (C-7’), 122.5 (C-3’), 117.6 (C-11), 
116.6 (q, J = 291.4 Hz, COCF3), 103.6 (C-5’), 73.2 (br, C-9), 59.8 (C-8), 56.4 (C-12), 53.8 (C-2), 40.9 
(C-6), 36.6 (C-3), 26.8 (C-4), 24.4 (C-5), 23.9 (C-7), 12.6 (C-15). 
15N-NMR (60 MHz, CDCl3, NH3	 =	 0	 ppm) δ 313.9 (imine-N), quinoline N could not be detected, 
quinuclidine N could not be detected. 
15N-NMR (60 MHz, CDCl3, T = 296 K, NH3	=	0	ppm) δ 294 (quinoline N), 103 (N-oxide), amide N 
not detected under these conditions.  


































































































Imine 25 (20 mg, 0.044 mmol) was dissolved in dry CDCl3 in a flame-dried two-necked flask 
containing 20 mg activated 4 Å molecular sieves. To this suspension, (R)-TRIP (21a) (31 mg, 0.044 
mmol, 1 equiv) was added. After stirring for 5 min, this solution was transferred to a flame-dried 
NMR tube using an HPLC syringe filter to remove molecular sieves and sealed under vacuum. 
1H NMR (600 MHz, CDCl3, 223K, 2 conformers in 3:1 ratio, only major conformer described) δ 
12.72 (br s, 1H, NH), 8.83 (d, J = 4.7 Hz, 1H, H-2’), 8.08 (d, J = 9.3 Hz, 1H, H-8’), 7.88 (d, J = 8.4 
Hz, 2H, H-5a), 7.85 (s, 2H, H-3a), 7.49 (dd, J = 8.2 Hz, J = 5.4 Hz, 2H, H-6a), 7.45 (dd, J = 9.4 Hz, 
J = 2.2 Hz, 1H, H-7’), 7.35 (d, J = 8.5 Hz, 2H, H-8a), 7.30 (dd, J = 8 Hz, J = n.d., 2H, H-7a), 7.22-
7.16 (m, 3H, H-19 + H-20), 7.08 (c. m, 1H, H-13), 7.075 (s, 2H, H-15a), 7.073 (d, J = 4.3 Hz, 1H, 
H-3’), 6.99 (br s, 3H, H-5’ + H-13a), 6.63 (br s, 2H, C-18), 6.05 (s, 1H, H-16), 5.61 (ddd, J = 16.7 Hz, 
J = 10.4 Hz, J = 6.2 Hz, 1H, H-10), 5.12 (d, J = 10.8 Hz, 1H, H-9), 5.06 (d, J = 10.5 Hz, 1H, H-11E), 
4.99 (d, J = 17.1 Hz, 1H, H-11Z), 4.18 (c. m, 1H, H-2ex), 3.91 (s, 3H, H-12), 3.41 (t, J = 10.3 Hz, 1H, 
H-8), 3.08 (br s, 2H, H-40a), 2.91 (sept, J = 6.8 Hz, 2H, H-30a), 2.75 (t, J = 11.5 Hz, 1H, H-6ex), 2.60 
(c. m, 1H, H-6en), 2.62 (sept, J = 6.6 Hz, 2H, H-20a), 2.43 (c. m, 2H, H-3 + H-2en), 1.80 (c. m, 1H, 
H-4), 1.77 (t, J = 12.0 Hz, 1H, H-7en), 1.54 (c. m, 2H, H-5), 1.29 (c. m, 6H, H-31a), 1.28 (c. m, 6H, 
H-32a), 1.20 (s, 3H, H-15), 1.18 (c. m, 6H, H-42a), 1.05 (s, 6H, H-22a), 1.04 (s, 6H, H-41a), 0.96 (c. 
m, 1H, H-7ex), 0.88 (d, J = 6.7 Hz, 6H, H-21a). 
13C NMR (150 MHz, CDCl3) δ 169.4 (C-13), 158.7 (C-6’), 148.75 (d, JP-C = 9.1 Hz, C-1a), 148.5 (C-
16a), 147.6 (C-12a), 147.7 (C-2’), 147.3 (C-14a), 145.1 (C-4’), 133.7 (C-11a), 141.8 (C-8a'), 141.3 
(C-16), 137.6 (C-10 + C-14), 136.1 (C-17), 133.7 (C-11a), 133.45 (d, JP-C = 2.4 Hz, C-2a), 132.9 (C-
9a), 132.5 (C-8’), 131.2 (C-3a), 130.3 (C-4a), 129.3 (C-18), 128.2 (C-19 + C-4a'), 128.0 (C-5a), 127.6 
(C-20), 126.9 (C-8a), 125.5 (C-7a), 124.3 (C-6a), 122.82 (d, JP-C = 2 Hz, C-10a), 121.8 (C-7’), 121.6 
(br, C-3’), 120.6 (C-15a), 119.6 (C-13a), 116.7 (C-11), 102.0 (C-5’), 64.0 (br, C-9), 61.2 (C-8), 55.7 
(C-12), 54.0 (C-2), 39.3 (C-6), 36.6 (C-3), 34.2 (C-30a), 31.1 (C-40a), 30.7 (C-20a), 26.8 (C-4), 26.4 
(C-41a), 25.1 (C-5), 24.3 (C-7), 24.7 (C-21a), 24.3 (C-31a), 24.1 (C-32a), 23.8 (C-22a), 23.69 (C-
42a), 11.9 (C-15). 
15N-NMR (60 MHz, CDCl3, T = 223 K, NH3	=	0	ppms) δ 320.5 (imine N), 307.5 (2JNH21 = 10.3 Hz, 
quinoline N), 40.5 (1JNH+ = 70 Hz, quinuclidine N). 
31P-NMR (202 MHz, CDCl3, T = 223K, 2 species in a 3:1 ratio) δ 6.2 (3:1), 5.6 (3:1)  








Summary of 15N NMR data for salts 26  
 
a in MeOD as solvent 
 
Acid partner HX 
(salt) 
Equiv HX Imine-N21, ppm Quinoline-N22, ppm Quinuclidine-N1, ppm 
None (25) - 333.8 305.2 24.3 
TFA (26a) 1 318.3 310.4 40.5 
(R)-TRIP (26c) 1 320.5 307.5 40.5 
(R)-TRIP (26c)a 1 319.1 297.5 not detected 
TFA (26b) 2 313.9 not detected not detected 























































































26a (1 TFA) 
Shift, ppm 
26b (2 TFA) 
Shift, ppm 
26c (1 TRIP) 
Shift, ppm 
N-H - 12.5 12.0 12.7 
2a (ex) 3.15 3.72 3.65 4.18 
2b (en) 2.67 3.27 3.31 2.43 
3 2.15 2.65 2.65 2.43 
4 1.56 2.00 2.12-1.90 1.80 
5 1.47 1.96 2.12-1.90 1.54 
6a (en) 2.69 3.35 3.34 2.60 
6b (ex) 3.13 3.52 3.67 2.75 
7a (ex) 0.81 1.35 1.40 0.96 
7b (en) 1.26 1.71 1.74 1.77 
8 3.53 4.28 4.34 3.41 
9 4.69 4.90 5.15 5.12 
10 5.69 5.68 5.66 5.61 
11a (Z) 4.88 5.16-5.07 5.13 4.99 




12 3.89 3.98 4.03 3.91 
13 7.96 7.99 8.13 7.08 
15 2.07 2.18 2.15 1.20 
16 6.67 6.68 6.74 6.05 
18 7.25-7.16 7.31-7.22 7.30-7.18 6.63 
19 7.25-7.16 7.31-7.22 7.30-7.18 7.22-7.16 
20 7.25-7.16 7.31-7.22 7.30-7.18 7.22-7.16 
2’ 8.64 8.73 8.88 8.83 
3’ 7.39 7.35 7.77 7.07 
5’ 7.87 7.75 7.98 6.99 
7’ 7.28 7.38 7.50 7.45 
8’ 7.92 8.02 8.23 8.08 
 
NMR-studies on the effect of solvents on the ion pairing 
 
Nevertheless, when we prepared a mixture of 25 with 0.5 equiv of (R)-TRIP (salt 26e), 1H NMR 
analysis clearly indicated the presence of two distinct species and not an average of partly protonated 
structures. DOSY spectroscopy further confirmed two sets of peaks with different diffusion coefficients, 
corresponding to unprotonated imine 25 (7.3e-10 m2/s) and the monoprotonated TRIP salt 26c (5.7e-10 
m2/s) in which [25+H]+ and the negatively charged counteranion of TRIP diffused together (Figure 
4.15 (a)). This implied that despite the lack of geometrically specific binding between 25 and (R)-TRIP, 







Figure 4.15 DOSY spectrum of salt 26e ([25·0.5 (R)-TRIP]) showing the presence of unprotonated 
imine 41 and the monoprotonated (R)-TRIP salt 26c in CDCl3 (a), and ion-separated salt 26c in protic 
solvent MeOD (b).  
 
We next examined how the ion pairing was affected by the presence of a protic solvent or a protic 
additive, since an excess of aqueous hydrogen peroxide is employed in the epoxidation of enals 19. In 
neat methanol, complete ion separation was observed for the salt 26c as indicated by a DOSY 
experiment. Under these conditions, the [25+H]+ cation and the TRIP- anion clearly diffused at 
different rates (Figure 4.15 (b)). However, since the environment of a standard epoxidation reaction is 
only slightly protic, we also examined the effect of a protic additive in chloroform. Under the 
optimized conditions of epoxidation, a combined 144 equiv of H2O2 and H2O with respect to the 
catalyst are present in ca. 987 equiv of solvent (THF), which corresponds to a 1:7 ratio of protic to 
aprotic media. Based on these calculations, we prepared a sample of 26a in CDCl3 containing 7 equiv 
of MeOH55 with respect to 26a, which corresponded to a similar 1:10 ratio of protic to aprotic solvent. 
                                                 
55  Since the presence of water or aqueous hydrogen peroxide would cause immediate and complete hydrolysis of salts 41 




A 1-D 1H,19F HOESY of this sample revealed weak non-specific cross-peaks, suggesting that the ion 
association remained largely undisrupted. Although direct observation of the diffusion coefficient of 
the counteranion by DOSY was not possible as a trifluoroacetate anion lacks protons, the diffusion 
coefficient of the iminium species was found to be between that of 25 alone and the heavier TRIP salt 
26c, further supporting the existence of ion pairing. Hence, we concluded that under the slightly protic 
reaction conditions, the counteranion remains in close association with the iminium cation [25+H]+, 
albeit this association lacks any obvious organization. 
 
Studies on the Effect of the Quinoline Moiety 
 
A significantly weaker and reversed facial selectivity in the epoxidation of enal 19a with an achiral 
Brønsted acid co-catalyst TFA compared to catalyst 1a highlights the role of the quinoline moiety in 
the chiral induction. Pairing catalyst S-17 with the chiral acids (R)-21a and (S)-21a conversely resulted 
in considerably weaker mismatched and matched scenarios, respectively. 
 
 
entry amine  acid  conversion 
[[%]a dr
a er (trans)b 
1 1a 
TFA 
41 78:22 93:7 
2 S-17 18 68:32 35:65 
3 1a 
(S)-21a 
45 71:29 30.5:69.5 
4 S-17 77 78:22 6:94 
5 1a 
(R)-21a 
52 92:8 99.5:0.5 
6 S-17 49 79:21 90:10 





NMR-derived model: computational details  
 
The NMR-derived model for the iminium structures 25 and [25+H]+ structures were calculated using 
XPLOR-NIH Ver. 2.9.7.[149] The low-level force-field defined in the parameter for 25 was simply 
generated by PRODRG. Distance restraints derived from NOE cross peaks integrals over 5 different 
mixing times of 0, 100, 200, 300, 500 and 750 ms were applied using the “RELAXATION”[187] 
function of XPLOR to account for spin-diffusion effect while J-coupling-derived restraints were 
imposed by using the “DIHEDRAL”[149] function of the XPLOR-program. The simulated annealing 
computation operated in the following way: an initial molecular model was first minimized with a 
gradient criterion of less than 0.5 kcal/mol. The molecule is then set to a temperature of 2000K over a 
period of 8.1 ps, in steps of 1.25 fs. The molecule evolves at this temperature for 8.1 ps (6500 steps), 
thus sampling conformational space extensively. This is followed by a first cooling period lasting 6.25 
ps down to 1000 K then by a second cooling period of 2.5ps down to 100K, both followed by Powell 
energy minimisation. This protocol was repeated 500 times and the 20 resulting conformers with 
lowest energy were preserved. During the first cooling period (5000 steps), NOE and J-coupling-
derived dihedral angle terms are gradually raised from their initial weighting (0.02 kcal mol−1Å−2 and 
1.0 kcal mol−1deg−2) to their final weighting of (20.0 kcal mol−1Å−2 and 1000 kcal mol−1deg−2) 
respectively.  
 
List of NOE integrals (no units) used in XPLOR simulated annealing: 
 
  Mixing times (ms) 
Atom 1 Atom 2 0 100 200 300 500 750 
H2' H3' 0 -6807000 -15103500 -25131000 -37046000 -48903000 
H8' H7' 0 8207850 -8459250 -21682500 -42346000 -57675500 
H1 H8 0 -6149300 -10252100 -14155000 -16756000 -15819000 
H1 H2 0 -7559450 -12609000 -16183000 -17430000 -14698000 
H1 H6b 0 -4736050 -7431050 -9396900 -9726150 -7619650 
H1 H6a 0 -5977750 -9125550 -12143000 -12764500 -10202850 




H13 H16 0 -21701500 -39821500 -56816500 -81254000 -99154000 
H13 H9 0 -12194500 -21131500 -28413500 -36035000 -39313000 
H13 H8 0 -618255 -586175 -911640 -1900950 -1395505 
H13 H6b 0 -1236095 -2643150 -3856950 -3041650 -3036050 
H13 H15 0 -1407100 -1780650 -1700650 -4389350 -3098900 
H5' H9 0 -8837850 -16086000 -21475500 -27603000 -30311500 
H5' H8 0 -10018650 -17517000 -23850000 -31637500 -34836500 
H5' H12 0 -12781500 -21535000 -30516000 -43310500 -49277000 
H5' H15 0 -961760 -2261500 -4519400 -5648400 -6149000 
H7' H12 0 -3922550 -2969250 -6618150 -8045500 -11616200 
H3' H7a 0 -3547400 -6404900 -9760500 -9691200 -11085500 
H3' H9 0 -10134600 -17499500 -23422500 -30685500 -32522000 
H3' H8 0 -4793400 -8332300 -10757850 -14911000 -17589500 
H3' H15 0 979860 99365 -1440910 -1061450 -1022205 
H18/19 H16 0 486050 -9185900 -13371000 -22705000 -29305000 
H18/19 H15 0 -7812650 -11562500 -16143000 -26825000 -32687500 
H16 H15 0 1639900 -1197150 -2683100 -2021925 -3798650 
H10 H2b 0 -3443950 -6522900 -8862550 -11840000 -13120500 
H10 H3 0 -4004650 -4982800 -7616550 -11123500 -13869500 
H10 H4 0 -1786550 -4483350 -6601850 -7872050 -9796100 
H10 H7b 0 -4638900 -8361050 -12106500 -15515500 -17732000 
H11a/11b H2b 0 -3399550 -5443400 -7592050 -9246050 -10791000 
H11a/11b H3 0 -2860450 -5766450 -7578300 -11750000 -14224000 
H9 H7a 0 -6351200 -10245000 -12966950 -14218600 -12979250 
H9 H6b 0 -11422500 -18934000 -22933000 -25371500 -22709000 
H9 H4/5a/5b 0 -6225050 -10371350 -13237550 -14085550 -12890300 
H8 H2b 0 -16207500 -25480000 -32718500 -36934000 -35192500 
H8 H7b 0 -13375500 -21747000 -28232000 -32881500 -32498000 






List of dihedral angles used in XPLOR simulated annealing 
 
Atom1 Atom2 Atom3 Atom4 Dihedral (º) ± 
H8 C8 C9 H9 180 40
C9 N21 C13 C14 180 1 
N21 C13 C14 C16 180 40
C13 C14 C16 C17 180 1 
 
List of additional distance restraint used in XPLOR simulated annealing 
 
Atom 1 Atom 2 lower Upper 
H1 N21 1.5Å 2.5Å 
 
XPLOR-based structure calculations: experimental summary 
 
Results for structural models of 25 and [25+H]+  (20 best of 500) 25 [25+H]+ 
   
Average Energy 641 kcal/mol 564 kcal/mol
RMSD <0.1 Å <0.1 Å 
Full Relaxation Matrix violations       
% of peak volumes with deviations within range 0.5-1.5  94% 94%
Other violations       
dihedral angles >5º (>7º) 1 (0) 0 (0) 
bond angles >5º (>7º) 6 (0) 3 (0) 
bond lengths >0.05 Å (>0.07 Å) 5 (0) 5 (0) 
 
Overlay of the resulting five lowest energy structures derived from the NMR data (NOE and J 
couplings are depicted in green for the free imine 25 and in black for the protonated species [25+H]+. 
These structures are in overall agreement with the applied restraints with very low levels of violations 










NMR-Spectra of Previously Unpublished Compounds 
The spectra of compounds previously published by our group are omitted here and can be found in the 
corresponding original publication.56 
                                                 
56 (a) Reisinger, C. M.; Wang, X.; List, B. Angew. Chem. Int. Ed. 2008, 47, 8112; (b) Wang, X.; Reisinger, C. M.; List, B. J. 
Am. Chem. Soc. 2008, 130, 6070; (c) Lifchits, O.; Reisinger, C. M.; List, B. J. Am. Chem. Soc. 2010, 132, 10227; (d) Lee, 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Determination of Enantiomeric Ratios: GC-Traces 
 
 
4f: 
 
 
Br
O
O
C7H11BrO2
207,07
  
S-228
 
4g:  
 
 
 
O
THPO
O
C14H24O4
256,34
  
S-229
 
4h:  
 
 
TBSO
O
O
C12H24O3Si
244,40
  
S-230
 
4i: 
 
 
 
 
EtO
O
O
O
C9H14O4
186,21
  
S-231
 
4k: 
 
 
 
 
 
 
O
HO
O
C9H16O3
172,22
  
S-232
 
4n: 
 
 
 
O
O
C7H12O2
128,17
  
S-233
 
4s:  
 
 
 
O
O
C7H12O2
128,17
  
S-234
 
S-1: 
 
 
 
 
O O
  
S-235
 
S-5: 
 
 
 
O
O
  
S-236
 
6f:  
 
 
OOH
  
S-237
 
10j: 
 
 
 
O
O
t-Bu
C10H16O2
168,23
  
S-238
 
10k: 
 
 
 
 
O
O
C9H12O2
152,19
  
S-239
 
10q: 
 
 
 
 
O
O
Me
C7H10O2
126,15
  
S-240
 
 
  
S-241
 
S-18:  
 
 
 
 
O
O
t-Bu
C10H16O2
168,23
  
S-242
 
10r: 
 
 
 
Ph
O
C13H14O2
202,25
O
  
S-243
 
12d: 
 
 
O
O
C8H12O2
140,18
  
S-244
 
12e: 
 
 
 
 
 
O
O
C12H20O2
196,29
  
S-245
 
12f: 
 
 
 
 
 
O
O
C15H26O2
238,37
  
S-246
 
15a: 
 
 
 
O
OH
C6H10O2
114,14
  
S-247
 
 
15b: 
 
 
O
Me
OH
C7H12O2
128,17
  
S-248
 
15c: 
 
 
 
 
 
OH
O
C7H12O2
128,17
  
S-249
 
15d: 
 
 
 
 
 
 
O
OH
C8H14O2
142,20
